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Introduction 
The purpose of this study is to discuss several aspects of 
facioscapulohumeral disease, also called "autosomal dominant 
facioscapulohumeral muscular dystrophy" or "Landouzy-Dejerine 
type of muscular dystrophy" or "Landouzy-Dejerine' s disease" . We 
consider this disorder we l l defined and recognizable, justifying 
the term facioscapulohumeral disease, abbreviated FSHD. 
We studied the literature, as well as a personal series of 
107 cases of FSHD. Chapter 1 reviews the major historical reports 
pertinent to the recognition of FSHD as an independent entity. 
Chapter 2 describes current knowledge on FSHD: a summary is 
presented at the end of this chapter . Chapter 3 discusses the 
differential diagnosis of FSHD. A great deal has been written on 
this subject, most of it causing more confusion than 
clarification. As it was considered necessary to argue why some 
reports were so obfuscating, this chapter has become quite 
lengthy: for those who feel that this subject should not claim so 
much attention, a summary is proffered. Chapter 4 deals with the 
results of the clinical examination of 107 patients with FSHD and 
Chapter 5 with the laboratory studies in some of these patients. 
The kindreds were ascertained through probands that had been 
studied at the "Muscular Research Center" (head Prof. Dr. J. 
Bethl em) of the University of Amsterdam and at the Neuromuscular 
Clinic (head Dr. A. R. Wintzen) of the Department of Neurology 
(chairman Prof . Dr . G. W. Bruyn) of the University of Leiden. The 
kindreds were examined as extensively as possible. In three 
instances family examination was incomplete or did not reveal 
autosomal dominant inheritance. These cases are discussed briefly 
in Chapter 6. In the last chapter some of our results are 
compared with concepts dominating in the literature . 
In order to provide a framework for the discussion of this 
autosomal dominant disorder, we prefer to summarize FSHD as 
follows: the presenting complaints are mostly those of weakness 
of the shoulder girdle muscles. The c l inical signs at the time of 
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presentation include weakness and atrophy of the shoulder girdle 
muscles with early involvement of the facial muscles in most 
cases. The disease subsequently spreads to the upper arm muscles, 
justifying the adjective facioscapulohumeral (Landouzy and 
Dejerine, 1884, 1885, 1886) and to the peroneal muscles. Weakness 
of the abdominal muscles may occur early. Pelvic girdle weakness 
is a fairly late sign in most cases. The muscle involvement is 
often asymmetrical . The intrafamilial and interfamilial 
expression of the disease is quite variable. The clinical course 
and rate of progression of the disease may also vary considerably 
from case to case. A large number of affected individuals may be 
asymptomatic (abortive cases). The age of onset may range from 
infancy to late adulthood. The penetrance of the gene is almost 
complete. There are no solid grounds to assume to existence of an 
autosomal recessive disorder resembling FSHD. The problem of the 
isolated case in which the examination of the family is negative , 
has no simple answer: there can be low expressivity of the gene 
in the ancestry, non- paternity, a mutation, or a different 
disease altogether. Although FSHD is considered a myopathy, both 
electromyography (EMG) and muscle biopsy may reveal features 
suggesting a neurogenic lesion. 
Chapter I 
Historical notes 
In the middle of the nineteenth century most physicians held 
the opinion that chronic muscular atrophy was caused by anterior 
horn cell disease. Hypertrophy of some muscles in patients with 
atrophy of other muscles was such an intriguing finding that it 
drew the attention of many clinicians. To Duchenne goes the 
credit of having presented the firs t l ucid description of the 
disease that now bears his name. In a series of articles in the 
"Archives Generales de Medicine" of 1868 he published his 
"Recherches sur la para l ysie musculaire pseudo- hypertrophique ou 
paralysie myo-sclero sique" . There he present ed arguments fo r the 
myopathic nature of the condi t ion based on the electrical 
examination and the histology of muscles . Since he never had an 
opportunity to do post-mortem studies, he cited the only 
published autopsy report at that time, in which Eulenburg and 
Cohnheim had shown the brain and the spinal cord to be 
unaffected . The muscle hypertrophy remained a puzzling f i nding. 
Duchenne discussed the possibility of a trophic influence of the 
autonomous nervous system but concluded (page 571) t hat "en 
somme, la pathogenie de la paralysie pseudo- hypertrohique est 
tres obscure" . 
A large part of Duchenne 1 s ar t icles was concerned wi t h the 
differential diagnosis of pseudohypertrophic muscular paralysis 
which included t wo syndromes: these were "la paralysie a t rophique 
graisseuse de 1 1enfance" and "l 1atrophie musculair e graisseuse 
progressive de l 1 enfance" . The former started with fever in most 
cases and had a rapid course. These pa t ients probably suffered 
from poliomyelitis. The latter consisted of a FSH syndrome and 
probably was what we now woul d call FSHD. In his summary Duchenne 
observed that "1 1atrophie musculaire graisseuse progressive de 
1 I enfanCe debUte VerS 1 I age de Cinq a Sept anS par la faCe OU 
e l le atrophie quelques muscles , principalement 1 1orbiculair e des 
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levres et les zygomatiques. Apres une periode stationaire de 
plusieurs annees (de deux a trois ans) elle envahit les membres 
et le tronc, ou elle marche de la meme maniere que chez l 1 adulte, 
c 1 est-a-dire, qu 1 elle suit une marche descendente, en attaquant 
d 1 abord des muscles des membres superieurs et ceux du tronc en ne 
s 1 etendant aux membres inferieurs que dans une periode assez 
avancee". 
This description constitutes the essence of the FSH syndrome 
and would fit FSHD perfectly. The lack of muscular hypertrophy, 
the descending course of muscular involvement and the facial 
weakness distinguished progressive fatty muscular atrophy of 
infancy f r om pseudohypertrophic muscular paralysis. The infantile 
and the adult form of progressive fatty muscular atrophy were 
both considered to be anterior horn cell diseases. The 
description of the infantile form served only to provide the 
differential diagnosis of pseudohypertrophic muscular paralysis. 
Duchenne did not comment specifically on spinal cord involvement 
in progressive fatty muscular atrophy of infancy although that 
seemed a logical possibility since he quoted Cruveilhiers 1 
"memoire sur la paralysie musculaire atrophique" published in the 
"Bulletins de 1 1 Academie de Medicine" of 1852- 1853. This 
quotation referred to Cruveilhiers 1 third observation of a man 
with progressive muscular atrophy with facial and lingual muscle 
involvement who on post-mortem examination was found to have an 
extreme atrophy of the spinal anterior roots and of the 
hypoglossal nerves. Duchenne mentioned this case to illustrate 
that involvement of the facial muscles could occur late in the 
course of the adult form of progressive fatty muscular atrophy. 
But Duchenne did not comment upon Cruveilheirs 1 second 
observation. This concerned an 18-year old man with a severe FSH 
syndrome who had died in 1848 of variola and on whom autopsy 
showed the brain, spinal cord and the periferal nerves to be 
unaffected. This probably represented the first autopsy of FSHD, 
but 1t passed by unnoticed. It apparently required quite a few 
more years for the concept of primary muscle disease to mature. 
By the time Landouzy and Dejerine made their observations, 
the scientific climate had changed. In 1884 Erb wrote "Uber die 
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juvenile Form der progressiven Muskelatrophie und ihre 
Beziehungen zur sog~nannten Pseudohypertrophie der Muskeln", and 
Vulpian presented a summary of Landouzy's and Dejerine's work at 
a meeting of the "Academie des Sciences" on January 17th. One 
year later (1885), Landouzy and Dejerine published their first 
article in the "Revue de Medicine" about "La myopathie atrophique 
progressive; myopathie sans neuropathie debutant d'ordinaire dans 
l'enfance, par la face ". There they described an autopsy on a man 
who died of tuberculosis when he was 24 years old . At the age of 
three, atrophy of the facial muscles was noted and this was his 
only symptom until he developed atrophy of the shoulder girdle 
and upperarm muscles at the age of 17. During the subsequent 
years the atrophy slowly progressed to involve the muscles of the 
trunk and pelvic girdle. There was no sensory abnormality and the 
tendon reflexes were absent. He never had experienced any muscle 
pains . Landouzy and Dejerine stressed the cl i nical and 
histological integrity of the muscles of the tongue, pharynx and 
larynx and also of the masseter, the temporal and the pterygoid 
muscles . The extraocular muscles and the levator palpebrae 
muscles were unaffected as well . At the viscerocranium only the 
facial muscles were involved. (When they mentioned "facial 
muscles" they referred to the muscles innervated by the seventh 
cranial nerve . The terms "facial muscles" and "facial weakness" 
will be used in this text in the same sense) . At post- mortem 
examination they found no abnormalities on the brain, spinal 
cord, periferal nerves and intramuscular nerve endings. Muscles 
which were clinically affected, but had not completely 
disappeared, showed "atrophie simple du faisceau primitif, avec 
sclerose et adipose tras legares". 
Landouzy and Dejerine's patient had a younger brother and 
sister who were similarly affected . The pedigree (Figure 1.1.) 
showed a definite autosomal dominant pattern of inheritance. It 
is interesting to see that the disease seemingly skipped the 
second generation. Of course it is quite possible that the woman 
at issue in the second genera t ion might have represented an 
abortive case. Further more, if one reali zes that the father of 
the proband developed muscle atrophy in the shoulder girdle at 
- 16 -
the age of 26 and noted facial involvement when he was 32 years 
old , all the potential pitfalls involved in the diagnosis of FSHD 
are already obvious f ro m the first published pedigree . 
FIGURE1.1: FAMILY L (LANDOUZY -DEJERINE, 1885) 
IIT 
The proband fi tted t he description of Duchenne•s "infantile 
form of progressive fatty muscular atrophy". Landouzy and 
Dejerine assumed that Duchenne •s and their own descriptions were 
about the same disease and that they had proven its myopathic 
nature. The proband's father and similar familial and sporadic 
cases described i n subsequent articles (1885- 1886), led Landouzy 
and Dejerine to adjust the diagnostic criteria of the disorder 
they had named facioscapulohumeral type of progressive myopathy. 
The age of onset was said not necessarily to be in infancy . 
Furthermore, they stressed that the disease did not always start 
with invo lvement of the facial muscles . In such cases shoulder 
girdle weakness was the presenting symptom, some never developing 
facial weakness. Landouzy and Dejerine described the autopsy of a 
case that had lacked clinical involvement of the facial muscles 
but showed microscopical abnormalities, suggesting a myopathy on 
examination of these muscles. Although these additions brought 
the ideas of French authors about the myopathies somewhat closer 
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to the German views on this matter, the gap was not closed to the 
satisfaction of Erb, who had formulated and defended (1884) his 
unifying concept of "dystrophia muscularis progressiva". Erb was 
convinced that all myopathic syndromes were different 
manifes tations of one disease, because he had seen intermediate 
forms between all the known clinical syndromes and because he had 
found the his to logical changes in the muscles to be essentially 
the same in all these cases. He did not believe that "la 
myopathie atrophique progressive" was different from his 
"juvenile Muskelatrophie". In order to minimize the clinical 
differences he stated (1891) that he personally never had 
observed involvement of the facial muscles to be the first and 
most prominent symptom. To prove the contrary, Remak (-1884) wrote 
an article "Uber die gelegentlichen Betheiligung der 
Gesichtsmuskulatur bei der juvenilen Form 
Muskelatrophie " as did Mossdorf (1886) : "ein 
Betheiligung der Gesichtsmuskulatur bei 
Muskelatrophie". 
der progressiven 
zwei ter Fall von 
der juvenalen 
Although the concept of a primary muscle disease as a cause 
of a slowly progressive muscular atrophy was finally accepted by 
the end of the nineteenth century, the discussion about the 
classification of the human myopathies had only just begun. The 
introduction of genetical criteria proved 
Weitz (1921) was the first to recognize 
to be very useful. 
the possibility of 
autosomal dominant, autosomal recessive and X- linked recessive 
modes of inheritance of the myopathies. Davidenkow (1930) studied 
554 cases of what he called dystrophia musculorum progressiva. 
Most of the cases were collected from the literature. Davidenkow 
was the first to recognize abortive cases of FSHD. He also drew 
attention to the fact that some affected members of families with 
FSHD failed to demonstrate facial weakness. Sjovall (1936) 
investigated 103 families with 161 affected persons in Sweden but 
his material did not include families with an autosomal dominant 
FSH syndrome, probably because, as Becker (1953) suggested, he 
had collected his cases from nursing homes and hospitals where 
"one rarely sees FSHD as this is a relatively benign disease". 
Another explanation could be that there is a large geographical 
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variation in the occurrence of FSHD . Julia Bell (1942, 1943) 
studied 1228 cases of muscular dystrophy from the literature and 
113 records from the National Hospital, Queen Square, London and 
concluded that all three modes of inheritance seemed to occur. 
She divided the clinical material into three groups based on two 
criteria, pseudohypertrophy and facial involvement, hoping to 
find a certain pattern of inheritance for each group . Her first 
group consisted of all cases exhibiting pseudohypertrophy of 
muscles but cases with facial involvement were excluded. The 
second group contained all cases that had unaffected facial 
muscles and no pseudohypertrophy . The third group included all 
cases with weakness of the facial muscle with or without 
hypertrophy of muscles . Bell could not ascribe a single pattern 
of inheritance to each group , perhaps due to the ease with which 
she accepted the diagnosis of reported cases as definitely 
establ ished and to the fact that in many instances the families 
were not completely examined, as Tyler and Winthrobe (1950) 
argued. This argument is of particular relevance with respect to 
FSHD as all Bell ' s 337 cases of group 3 were collected from the 
literature because in the 14-year period covered by the study no 
such cases were seen in the National Hospital . 
Pseudohypertrophy and facial involvement continued to be 
decis i ve criteria in other attempts at classification of the 
muscul ar dystrophies , because the age of onset was considered too 
difficult to establish in many cases. Levison (1951) started from 
clinical criteria and concluded from eight families which he had 
examined personally t hat the FSH type of muscular dystrophy had 
an autosomal dominant mode of i nheritance . He stressed that he 
had not seen patients with marked atrophy or paresis of the 
orbicularis oculi muscles as described by Landouzy and De jerine 
(1885). He a l so distinguished a scapulohumeral type of muscular 
dystrophy that was sporadic in five families and present in two 
brothers of another family. Finally, he discerned an intermediate 
type between the FSH and scapulohumeral type in which the facial 
muscles were only slightly involved. The six cases of this type 
were all sporadic ones . Ho wever it is not stated how extensively 
the families wer e examined . 
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Stevenson (1953) thought an autosomal t"ecessive mode of 
inhet"itance to be pt"esent in his families with facial involvement 
and included these families in his gt"oup of "autosomal t"ecessive 
limb-git"dle muscular' dys tt"ophy", as he judged weakness of the 
facial muscles an insufficient ct"itet"ium for' sepal"ation into two 
diffet"ent diseases. Stevenson ' s examination of the families is 
cet"tainly open fot" ct"iticism, as will be discussed later'. His 
view did not hat"monize with the expet"ience of many clinicians who 
had become accustomed to find an autosomal dominant mode of 
inhet"itance in most families with muscular' dystl"ophy and 
involvement of the facial muscles. Thet"efot"e, Walton and Nattt"ass 
(1954) encountet"ed little objection when they defined the pattet"n 
of inhet"itance of FSHD being usually autosomal dominant and only 
occasionally autosomal t"ecessive. These author's wet"e impt"essed by 
the occut"t"ence of abot"tive cases, that can obscure the true 
pattern of inheritance in many families. Walton and Nattrass 
(1954) stressed that "the question of minor facial involvement is 
of the greatest importance and may well be a reason for confusion 
in published work since many cases which were truly FSH may have 
been classified as scapulohumeral". 
The classification of the muscular dystroph ies given by 
Walton and Nattrass has proven to be very successful and formed 
the basis of all other attempts at classification thereafter. It 
ended several decades of confusion about FSHD. 
Chapter 2 
Facioscapulohumeral disease: review of the 
literature 
2.1. Introduction 
Chung and Morton ( 1959) classified a large number of 
patients with hereditary neuromuscular disorders according to the 
pattern of inheritance. They found that the patients with pedi-
grees suggesting autosomal dominant inheritance fitted the 
clinical picture of FSHD, as outlined by Wal ton and Nattrass 
(1954). Patients with pedigrees suggesting other patterns of 
inheritance demonstrated only a slight overlap of clinical find-
ings with FSHD. Chung and Morton (1959) concluded that nearly all 
cases of FSHD could be diagnosed on clinical criteria only. 
Statistical comparison of anamnestic and clinical data revealed a 
high degree of resemblance of cases within one family, while a 
significant difference was found when families were compared 
among each other. This was interpreted as possibly due to multi-
ple alleles or alternative loci determining FSHD, although the 
possibility could not be excluded that the apparent similarities 
of sibs were the result of systematic biases in reporting the 
onset of the disease. Chung and Morton (1959) could not separate 
the group of patients with autosomal dominant inheritance into 
more homogeneous subcategories of the basis of the available 
evidence. The evidence consisted of personal cases collected in 
the Sta te of Wisconsin and of cases selected from the literature, 
including the reports of Sjovall (1936) from Sweden, Levison 
(1951) from Denmark, Stevenson (1953; 1955) from Northern 
Ireland, Beck er ( 1953) from Bad en, Germany, La my and Grouchy 
(1954) from France, and Walton (1955) from Durham and 
Northumberland, England . These studies still from much of the 
basis of our kno wledge of the clinical picture of FSHD. Only few 
other family studies of FSHD were reported since 1950. (Tyler and 
Stephens, 1950; Boyes, 1950; Walton, 1956; Kazakov et al., 1974). 
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Many authors though, have written on neuromuscular disorders and 
commented on FSHD from personal experiences. 
2.2. Presenting symptoms 
Facial weakness wil l often go unnoticed: in over 60% of 
Walton's cases (1955) neither the patients nor their families 
were aware of it. Inability to whistle or to close the eyes 
completely when asleep, are often considered a mild quirk of 
nature. Chung and Morton (1959) reported facial onset of FSHD in 
20% of their cases. I t is unclear whether they accepted inability 
to whistle as a symptom indicating facial weakness. Several 
authors like Brooke (1977), suggested a higher frequency of 
facial onset by pointing out that many patients with FSHD never 
had been able to whistle . The frequency of this symptom in an 
unselected population is unknown nor is it clear how often this 
symptom is due to facial muscle weakness . If facial onset is 
present, it is a strong argument for the diagnosis FSHD, since it 
was not noticed in any other type of muscular dystrophy as 
described by Chung and Morton (1959). 
The most frequently encountered presenting symptoms are 
those of shoulder girdle weakness Chung and Morton (1959) 
reported shoulder girdle onset in 77% of their cases. Difficul-
ties at gymnastics while climbing a rope or using the trapeze or 
the bars, excessive fatigue when writing on a blackboard, dif-
ficulties in placing objects on a shelf or working above shoulder 
level , and drooping of the shoulders are the complaints most 
often heard. Combing hair or shaving will require special tricks 
like resting the arms on a table. Several articles mention pain 
in the shoulder girdle in relation to the development or a 
exacerbation of the disease (Dubowitz and Brooke, 1973; Bradley, 
1979). The significance of this symptom is not known. It may be 
related to the extensive inflammatory infiltrates occasionally 
found in the muscle biopsies of patients with FSHD (Munsat et 
al., 1972) . Quite often it may take a fair degree of shoulder 
girdle weakness before complaints arise. Judging the onset of the 
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disease by symptoms is likely to result in a much higher age of 
onset than if the onset could be estimated from the first detec-
table signs. If peroneal weaknes is present early in the course, 
occasionally this may lead to the first symptoms, such as 
tripping over small obstacles, or difficulty running. 
Chung and Morton (1959) reported pelvic girdle onset in 12% 
of their cases, but Becker (1953) never noted symptoms suggesting 
pelvic girdle onset. He stressed the descending order of muscle 
involvement in FSHD. This descending course was also reported by 
Tyler and Stephens (1950). 
2.3. Presenting signs 
Knowledge of the presenting signs in FSHD is important for 
the discussion of the differential diagnosis (see chapter 3): 
FSHD may start either in the racial muscles or in the shoulder 
girdle muscles, as was demonstrated in the first family described 
by Landouzy and Dejerine (1885). The exact number of cases with 
facial onset probably will never be known, since facial weakness 
frequently remains unnoticed. One finds facial weakness as the 
only sign of the disease when abortive cases are discovered 
during a family examination or when anxious parents, who are 
familiar with the disease, bring a child to the doctor. The most 
common presenting signs are facioscapular weakness and atrophy 
(Tyler and Stephens, 1950). Probably next in frequency is 
shoulder girdle weakness, although accurate numbers are not 
known. Humeral i . e. upper arm weakness will develop later in the 
course of the disease and is never reported to be the presenting 
sign in FSHD. In those cases where peroneal weakness gives rise 
to the presenting symptoms, on clinical examination shoulder 
girdle weakness is also found. Therefore (facio )scapuloperoneal 
weakness may be the presenting syndrome in FSHD, and the 
disorders described as scapuloperoneal syndromes, should be 
included in the differential diagnosis of FSHD. Pelvic girdle 
weakness being the sole and presenting sign of FSHD has not been 
reported. 
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2.4. Precipitating factors 
Trauma, especially to the shoulder girdle, has been 
implicated by physicians (Boyes et al., 1950) and by patients 
(Becker, 1953) to precipitate the disease. Becker (1953) noticed 
this phenomenon to be more frequent in his group of sporadic 
cases of FSHD and thought this the result of a need of explana-
tion when visible heredity was lacking. Boyes et a1 . (1950) also 
considered unusual physical strain as a possible provoking 
mechanism in individuals who are "genetically susceptible" to the 
disease . This could explain the asymmetric onset of the disease 
in the right arm of a waitress who was under his care . Becker 
(1953) who discussed the problem of physical strain at length, 
was very sceptical about this mechanism and did not accept this 
explanation in hereditary cases . 
Other factors which, especially in the older literature, 
were considered to play a role were infectious diseases. Becker 
(1953) had found no infectious diseases in relation to the onset 
of symptoms in his autosomal dominant cases but cited Robinson 
(1925) who had observed that typhoid fever in one case and 
influenza in tho other cases had aggravated the muscle weakness. 
Becker (1953) concluded that the evidence was too flimsy to 
accept a causal relation. Tyler and Stephens (1950) noted that 
intercurrent illnesses had little effect on the rate of progres-
sion but that immobilisation, paricularly by body casts, resulted 
in rapid progression of the muscular atrophy. The latter obser-
vation has been confirmed by many authors. At present no one 
believes in a particular precipitating factor in the onset of 
FSHD. 
2 . 5. The facial muscles 
In the majority of cases , facial weakness is present early 
in the course of the disease, but facial weakness is not obliga-
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tory to the diagnosis FSHD. Becker (1953) found the facial 
muscles to be spared in 18.7% of his cases of autosomal dominant 
FSHD, and Chung and Morton (1959) in 16.8% of their collected 
cases. This implies that in families with FSHD quite a few 
members will start with shoulder girdle weakness while facial 
weakness may develop later or not at all. Tyler and Stephens 
(1950) found the zygomaticus and orbicularis oris muscles the 
first to be affected, although the early detection of weakness in 
these muscles may be related to their particular function. 
Weakness of the zygomaticus muscles results in an inability to 
raise the corners of the mouth and, when the patient smiles, his 
mouth moves in a horizontal direction producing a grin more than 
a smile, thereby depriving the smile of its emotional quality 
( "rire en travers" or transverse smile). When the orbicularis 
oris is weak, pursing of the lips, whistling, and retaining air 
under pressure becomes impossible. When viewed from the side, the 
lips have a pouting appearance due to loss of the normal upward 
curvature of the lower lip. In many cases the lips appear to be 
thickened (Becker, 1953). In severe cases the upper lips lose all 
their mobility and appear to be elongated forming the so-called 
"bouche de tapir". Brooke (1977) drew attention to the small 
dimples that sometimes are present on both sides of the corners 
of the mouth. They deepen when the patient smiles or tries to 
show his teeth. 
The orbicularis oculi muscles generally seem to be less 
affected than the muscles of the lower part of the face. In the 
beginning the eyelashes cannot be buried completely on forceful 
closure of the eyes. If the weakness progresses, a small rim of 
the sclera becomes visible on an attempt to close the eyes, 
because the extraocular muscles are never involved in this 
disease and a normal Bell's phenomenon can occur. In these cases 
usually blinking is slowed and incomplete. At this stage other 
facial muscles may become involved as well, resulting in an 
unlined forehead and a smooth and expressionless face, that 
originated the term "facies myopathica" or myopathic face 
(Landouzy and Dejerine, 1885). A frequent finding is the occur-
rence of an asymmetric involvement of the facial muscles some-
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times resulting in an awkward expression. The literature offers 
no expl anation for the asymmetric facial weakness. Data on the 
frequency of asymmetric involvement are not available. There are 
also no data on the degree of facial weakness. Probably this is 
partl y due to the fact that there is no proper grading system for 
weakness of the facial muscless. Although the degree of facial 
involvement is quite variable, severe weakness without involve-
ment of the shoulder girdle muscles has never been reported. The 
early and servere involvement of the facial muscles as described 
in the f'1rst family of Landouzy an Dejerine (1885) has led 
several authors like Erb, Levison, and Becker to remark explicit-
ly that they never had observed this phenomenon. On clin1car and 
post-mortem examination the muscles innervated by the trigeminal, 
the glossopharyngeal, the vagal and the hypoglossal nerve were 
never found to be affected. Bradley (1979) reported weakness of 
the masseter and tongue muscles in a small percentage of his 
cases, but his numbers are sometimes misleading since he included 
the family with a FSH syndrome previously reported by Hudgson et 
al. (1972) in his series. This family had a mitochondrial myo-
pathy (see section 3.5.), and the clinical findings were defi-
nite l y distinct from the ones in FSHD as were the 
histopathological and biochemical examinations. Therefore, 
Bradley's figures are not quite representative for FSHD. 
A progressive ptosis and extraocular weakness are no part of 
FSHD. The patient reported by Winkler and Van Der Weijde (1889) 
as FSHD with progressive ophthalmoplegia was probably suffering 
from another disease. 'Ihese same authors suggested a defect in 
the motor end plate in this case, a rather modern view at that 
time. 
2 . 6. The upper extremities, shoulder girdle and neck muscles 
It is convenient to describe the weakness and atrophy in 
FSHD in sections on the upper extremities, the trunk and the 
l ower extremities respectively, as this is the general course of 
spread of the disease. It is impossible to describe the spread 
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from one muscle to another, since there is no constant sequence. 
This descending course and the autosomal dominant inheritance are 
the main features of FSHD (Becker , 1953) . 
Grading of muscle weakness by manual testing has only been 
done by a few authors (Bradley, 1979). The reasons for this are 
obvious. The axial muscles are difficult to grade if one uses a 
system like the M.R.C. scale. If the scapula loses its fixation, 
proper testing of shoulder girdle muscles becomes extremely 
difficult. The causes of the change of position of the scapula 
have not been properly described. It is not clear if this is the 
result of a lack of strength of certain muscles or relatively too 
much strength of other muscles or bOth . If the scapula cannot be 
fixed, with a certain manoeuvre one might not be testing the same 
muscles as in the case of an unaffected person. One could over-
come this problem by testing only certain skills and abilities as 
suggested by Brooke (1977), but then one tests functions and not 
individual muscles. Manual muscle testing may only be more or 
less accurate and reproducible in testing extremity muscles. 
Mechanical testing of muscles in FSHD has never been reported. 
Apart from facial muscle weakness, one of the earliest findings 
in FSHD is the gradual loss of fixation of the scapula . The 
muscles involved are the rhomboids, the lower part of the trape-
zius and the serratus anterior muscles. This will result in 
several visible changes. The scapulae rotate slightly laterally, 
and move upward, laterally and anteriorly over the thorax. If the 
rhomboid and serratus weakness progresses, scapulae alatae 
appear. The change of position of the scapulae contributes to the 
development of drooping of the shoulders. The clavicles lose 
their normal upward slope, assuming a horizontal position, rotate 
anteriorly for reasons poorly explained and ultimately sometimes 
they may even slope downwards. Another early finding in FSHD is 
the involvement of the latissimus dorsi and the sternocostal part 
of the pectoralis muscles (Tyler and Stephens, 1950; Chyatte et 
al . , 1966). Wasting of the latter will result in a flattened out-
line of the anterior thoracic wall, with a change of the direc-
tion of the axillary crease, running more horizontally instead of 
vertically, and pointing at the sternoclavicular joint . In more 
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advanced cases wasting of the ante~io~ neck muscles and the 
pecto~alis muscles ~esult 
clavicles at the base of 
in a distinct p~ominence of the 
the neck (B~ooke, 1977). When the 
patient is seen f~om the f~ont a small, typical, but unexplained 
lump may sometimes be seen in the contou~ of the t~apezius on its 
slope to the ac~om1on. At~ophy of the sup~aspinatus and inf~asi­
natus may be visible and, due to the localisation of these musc-
les, quite st~iking. Landouzy and Deje~ine (1885) found these 
muscles to be spared but most subsequent authors noted weakness 
and wasting of these muscles, the f~equency of which amounted to 
90% of B~adley ' s cases (1979). If the scapula has lost its 
fixation, the deltoid muscle cannot be properly tested, but if 
the scapula is held to the thorax by the examine~ ' s hand, the 
deltoid muscle is often obse~ved to be minimally affected. The 
sparing of the deltoid muscle which Chyatte et al. (1966) thought 
characteristic of FSHD, occasionally, and falsely, induces the 
unwary physician to pose the diagnosis of hypertrophy, parti-
cularly so when the su~rounding muscles are conspicuously 
atrophic. Others found incomplete sparing of the deltoid muscles 
(Tyler and Stephens, 1950; Bradley, 1979) and noted proximal 
atrophy with distal sparing or atrophy of only the posterior 
muscle bellies. Another feature on inspection may be the internal 
rotation of the arms so that the backs of the hands are presented 
when one sees the patient from the front. This may be due to the 
changed position of the scapula but it is not clear if relatively 
strong internal rotators play a role as well. Chyatte et al. 
(1966) pointed out specifically that the teres major and 
subscapularis muscles , just like the deltoid muscles, are spared 
in FSHD . This has not been confirmed by others. The teres major 
and subscapularis muscles were often not specifically mentioned 
(Tyler and Stephens, 1950; Bradley, 1979). The time between the 
onset of shoulder gi~dle weakness and the onset of uppe~ a~m 
weakness may be quite variable. The atrophy in the upper arms may 
become quite seve~e sometimes even ea~ly in the cou~se of the 
disease resulting in so-called "Popeye" arms, because of the 
~elative sparing of the lower a~m muscles. 
The visible signs as desc~ibed so fa~ all ~eflect a certain 
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degree of involvement. Early detection of shoulder girdle 
weakness is difficult. There appears to be a great variety of 
shoulder build. In many slender people the scapula may be pro-
minent and many healthy women have horizontal clavicles. Sloping 
of the shoulders becomes more prominent with age and also the 
distance between the medial margins of the scapulae varies 
greatly, depending, among others, upon thoracic build. Testing of 
individual muscles, as described for instance by Kendall et al. 
(1971) , is often very helpful but is not quite reliable for 
testing the shoulder fixators in FSHD since these tests depend 
upon a good function of other shoulder girdle muscles. The 
shoulder girdle emerges from this picture as a complex structure 
in which no muscle ever acts on its own. A large number of varia-
bles are involved in any position and movement of the scapula, 
and this is the reason why t here is still debate about normal 
scapular function, let alone the function in pathological states . 
Therefore, many clinicians rely on functional tests like the 
ability to slowly elevate the arm to a vertical position, and the 
ability to hold the arm horizontally against pressure. A slowly 
lowering of the raised arms is a sensitive test for minimal 
serratus anterior weakness (Brooke, 1977) demonstrating a light 
degree of scapula alata in this manoeuvre. If the scapula 
fixation becomes weaker , the arms cannot be raised completely but 
are swung up to catch an object that is above shoulder height. If 
the hands are clasped together, the arms can be raised more 
easily , a phenomenon r epeatedly described, but never properly 
explained. When scapular fixation and especially the serratus 
function worsens, elevation of the arm above shoulder level 
becomes impossible . At attempts at abduction of the arms, the 
scapulae ride upwards over the back and their upper borders rise 
high up into the normal location of the trapezius muscles. '!his 
phenomenon is said to be typical of FSHD (Brooke, 1977), but an 
explanation was never offered. A factor that could be important 
in the genesis of this sign is the fact that the del to id muscle 
in FSHD remains strong for a long time, producing a maximum rise 
of the completely unfixed scapula. The extremity muscles are more 
accessible for manual testing of individual muscles which will be 
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so- called prime movers in certain defined circumstances . Tyler 
and Stephens (1950) noted the brachioradialis muscles to be af-
fected in a very early stage, even before the involvement of the 
biceps and triceps muscles, a finding not confirmed by others. 
Although affected later, the biceps and triceps muscles atrophy 
rather faster, resulting in a remarkable thin upper arm amid 
relatively spared del to id and lower arm muscles . In general the 
forearm muscles retain their strength for a long time . Only in 
severe cases weakness of the wrist extensors may develop, 
occasionally leading to a wristdrop. The wrist and finger flexors 
will maintain good strength much longer. The instrinsic muscles 
of the hand will only be affected in severe cases (Becker, 1953). 
Bradley (1979) noticed involvement of these muscles in more than 
50% of his cases with more than 20 years duration of the disease. 
Chyatte et al. (1966) found that the extensors of the neck were 
always spared but Bradley (1979) observed that these muscles were 
affected as well in several cases. He even noticed weakness of 
the neck flexors in as much as 75% of his patients. This 
contrasts sharply with the experiences of Van Wijngaarden and 
Bethlem (1973), who found the neck flexors rarely involved in 
FSHD. They even used this as a criterion for the diagnosis. The 
sternocleidomastoid muscles may become weak quite early in the 
course of the disease (Tyler and Stephens, 1950), but they are 
almost never absent contrary to their early and severe involve-
ment in myotonic dystrophy. 
2.1. The truncal muscles 
Little has been written about the truncal muscles in FSHD. 
Tyler and Stephens (1950) noted that the abdominal muscles were 
involved only after the disease had spread to the foot extensors 
and glutaeal muscles. Others, on the other hand, (Wintzen, 1979) 
found the abdominal muscles often affected rather early in the 
course of the disease resulting in a protruding abdomen. Weakness 
of the abdominal muscles adds to the pelvic tilt and the increa-
sed lumbar lordosis. Weakness of the glutaeus maximus muscles may 
- 30 -
play a role as well. Also part of the increased lordosis may be a 
compensatory mechanism to retain balance while standing or 
walking. 
In more severely affected patients the increased lumbar 
lordosis can result in an almost horizontal sacrum, and the line 
of weight bearing from shoulders to feet passes posteriorly to 
the sacrum. In this form, the increased lumbar lordosis was 
already described by Landouzy and Dejerine and demonstrated in 
their case "Leon M." (1885). Duchenne (1868) had suggested that 
the lumbar hyperlordosis in FSHD was caused by normally 
functioning erector trunci muscles unopposed in their action by 
the abdominal muscles. It is not clear if ligamentous or other 
factors also play a role in producing this extreme lordosis in 
FSHD, since this has never been studied. Carroll (1979) stated 
that this lordosis becomes more marked when a patient is bound to 
a wheelchair, whereas patients with other types of hereditary 
myopathies tend to become more scoliotic when they are in a 
wheelchair, but he fails to explain why or to document how often 
this phenomenon, typical for FSHD, does occur. A thoracic 
kyphosis is rarely found in FSHD and a scoliosis, if present, is 
usually very mild, probably because the major symptoms of the 
disease usually develop after the spinal growth is completed. 
2.8. The lower extremities and the pelvic girdle muscles 
Weakness of the anterior tibial muscles was mentioned in the 
earliest descriptions of FSHD (Landouzy and Dejerine, 1885; 1886) 
and it was the sole finding in the legs in many cases reported by 
Boyes et al. (1950) but 1t was not recognised as an early sign 
until the publication of the extensive family of Tyler and 
Stephens (1950). Chyatte et al. (1966) and Vignos et al. (1967) 
found early weakness of the anterior tibial muscles unique and 
typical for their group of FSHD patients. Seitz (1957) and 
Erbsl~h (1958) paid special attention to this sign and confirmed 
Ty1er's and Stephen ' s experience, but at the same time Becker 
(1953), Walton and Nattrass (1954), Chung and Morton (1959) and 
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Walton and Gardner-Medwin (1974) still found the pelvic girdle 
and the proximal muscles of the legs the main sites of involve-
ment in the lower part of the body . Kazakov et al. (1974) studied 
55 personal cases and 145 cases from literature and found that 
the disease could spread in two different ways to the lower part 
of the body. The first type, which they called "the gradually 
descending variety", spread initially to the pelvic girdle 
muscles and then gradually to the upper and lower leg muscles . 
The second type, which they called "the descending type with a 
jump", first spread to the lower legs, especially the anterior 
tibial muscles and from there on to the upper legs and pe_lvic 
girdle muscles . The second type was said to be more common. These 
authors stated that within each family only one type occurred and 
they argued that this homology or clinical similarity within 
families indicated that FSHD was genetically heterogeneous and 
consisted of at least two diseases. Carron (1979) stated that 
these findings could not be confirmed, but did not mention on 
what grounds. Walton and Gardner- Medwin (1981) argued that the 
patients of Kazakov et al. (197 4) were not studied up to modern 
standards and might very well have included cases with neurogenic 
atrophy . Weakness of the peroneal muscles will develop somewhat 
later than the anterior tibial weakness , and by the time this i s 
found, weakness of the gluteal, quadriceps and hamstrings muscles 
will be clinically present as well. In the majority of cases the 
calf muscles remain unaffected for a long time: they become 
involved in the latest stages of the disease only (Tyler and 
Stephens, 1950) . The extensor digitorum brevis muscles remain 
unaffected for a long period and are sometimes found to be hyper-
trophied (Brooke, 1977) as a compensatory mechanism for an early 
foot drop. This finding can be helpful in distinguishing FSHD 
from neurogenic atrophy . The other intrinsic foot muscles were 
reported unaffected by Tyler and Stephens (1950) . These muscles 
are only involved in cases with diseases of long duration 
(Bradley, 1979). Weakness of the foot extensors interferes with 
walking, resulting in a steppage gait and inability t o run. 
Patients tend easily to trip over small objects , falling forward 
on their knees. If pelvic girdle weakness develops , a waddling 
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gait will be visible and gradually rising from a chair or clim-
bing stairs becomes more and more difficult. 
The waddling steppage gait with the impressive lumbar 
lordosis, the drooping shoulders and the myopathic face are very 
characteristic for FSHD. Finally, walking and standing becomes 
impossible and the patient becomes wheelchair-bound. 
2.9. Pseudohypertrophy of muscles 
Pseudohypertrophy 
Gardner- Medwin, 1981). 
ved pseudohypertrophy 
is not a hallmark of FSHD 
Landouzy and Dejerine (1885; 
in the supraspinatus and 
(Wal ton and 
1886) obser-
infraspinatus 
muscles of several cases and considered this to be typical of 
FSHD. Fur t her observations could not confirm this. Becker (1953) 
observed one case with pseudohypertrophy of the deltoid muscles 
but most authors mention a seeming hypertrophy as the deltoid 
muscle remains intact for a long time amid rather atrophic 
muscles: the same can be said of the calf muscles. Pseudo-
hypertrophy of the glutaei muscles was occasionally observed by 
Becker (1953) but is was not mentioned by others. True hypertro-
phy was described in the extensor digitorum brevis muscle by 
Brooke (1977) as a compensatory mechanism for an early foot drop. 
This has not been reported before. Histological studies on these 
muscles were not undertaken. 
2.10 . Reflexes 
The stretch reflexes diminish rather early in the course of 
the disease and may eventually disappear. This is a common, but 
ill- explained finding in myopathic disorders. There are no speci-
fic studies on the stretch reflexes in FSHD. Pathological 
reflexes do not occur in FSHD. Sensory and cerebellar functions 
are invariably intact. 
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2.11. Contractures 
Contractures are said to be very rare in FSHD (Walton and 
Nattrass, 1954). Exact numbers and sites are not reported . 
Occasionally ankle contractures are found. If contractures are a 
prominent sign in a patient, other diagnoses must be considered, 
as will be discussed in the next chapter. 
2 . 12. Asymmetry of muscle invo lvement 
An important feature of FSHD is a distinct asymmetry of 
muscle involvement (Carroll , 1979). This can be present in the 
facial as well as in the shoulder girdle muscles , and in t he 
extremities. 
Mingazzini (1912) and Becker (1953) mentioned a case of 
unilateral involvement. Seeker (1953) noted that the right side 
was more involved than the left one in 30% of his cases, the left 
side more than the right one in 15%, while in 55% of his cases 
both sides were more or less equally affected . He was careful not 
to draw any conclusions from these figures, since the criteria on 
which asymmetry was decided were rather crude. These criteria 
were an asymmetric configuration of the shoulder, an asymmetr i c 
strength on arm abduction and an asymmetric onset of muscles 
weakness. If he also included asymmetry of facial or pelvic 
girdle muscles, very few symmetric cases remained. Becker consi-
dered this asymmetry to be a strong argument for environmental 
influences on the expression of the gene. He did not mention the 
possibility of a relation with right or left handedness. 
2 . 13. Skeletal deformities 
Skeletal deformities are rare in FSHD. Tyler and Stephens 
(1950) noted a pectus excavatum in most of their severely disa-
bled patients. This was also present in one unaffected indivi-
dual. These findings have not been confirmed by others. A mild 
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scoliosis is often found in the more advanced cases but numbers 
about its frequency are lacking. Occasionally a kyphoscoliosis 
has been reported. The increased lumbar lordosis may be a result 
of muscle weakness itself, and a mechanism compensating for a 
pelvic tilt in order to maintain balance. The increased lordosis 
is present in most cases where the disease has spread beyond the 
shoulder region but again, precise figures are not available. The 
autopsy case described by Landouzy and Lortat Jacob (1909) had a 
pectus excavatum, severe muscle contractures, and an increased 
lumbar lordosis attributed to skeletal changes , but an autosomal 
dominant pattern of inheritance was not apparent in the family of 
this patient. Foot deformities are no part of FSHD. 
2.14. The cardiac muscles in FSHD 
Cardiac involvement in FSHD is considered to be rare. There 
are only few and no recent reports on this subject . The older 
literature is hampered by an absent or an inadequate classifica-
tion of the hereditary myopathies. Most studies report only a few 
cases of FSHD (Rubin and Buchberg, 1952; Weisenfeld and 
Messinger, 1952). Schott et al. (1955) studied three patients 
with FSHD and emphasized the absence of electrocardiographic ab-
normalities. Manning and Cropp (1958) reported ten patients with 
"adult type muscular dystrophy". Five of them had left axis 
deviation which was attributed to rheumatoid heart disease in one 
case and to coronary sclerotic heart disease in another patient. 
In the remaining three patients, left axis deviation may have 
reflected cardiomyopathy. The classification of the myopathy in 
these cases has been disputed (Perloff et al., 1966 ; 1971). 
Gailani et al. (1958) reported on a thyroidectomized FSHD patient 
with a first degree A- V block , a QRS prolongation and a right 
branch block, who had a slightly reduced cardiac output. The case 
discussed by Lisan et al. (1959) had P and T wave abnormalities, 
a radiological cardiomegaly and congestive heart failure at the 
age of 32. In this case the diagnosis of FSHD is doubtful because 
of the early and severe involvement of the triceps surae muscle. 
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Kilburn et al. (1959) made no distinction between the "limb 
girdle type" and the "FSH type" of muscular dystrophy . Only two 
of this eight patients had facial weakness and predominantly 
shoulder girdle weakness as well. Both had thoracic muscle weak-
ness and pulmonary restrictive defects. One of them had a normal 
ECG and the other had an incomplete right bundle branch block. 
The four patients reported by Welsh et al. (1963) had no history 
of cardiac complaints. They all had normal blood pressure and an 
normal chest X-ray. One female patient had a heart rate of 52 and 
a six-year old boy a tachycardia of 102 . In another patient a 
left ventricular conduction delay and a left ventricular hyper-
trophy "were suggested but not all criteria were present to 
establish a definite diagnosis". Otherwise the ECG ' s in these 
patients were normal. Perloff et al. (1966) studied three 
patients with FSHD . One of them, a 36- year old woman, had both 
atrial and third heart sounds and an abnormal brachial arterial 
response to the Valsalva manoeuvre that could be "compatible with 
occult cardiac failure". Another patient had a slightly elevated 
wedge pressure . There were no other findings in these patients 
suggesting cardiomyopathy. There are three reports of persistent 
atrial paralysis (PAP) associated with FSHD (Bloomfield et al. , 
1965; Caponetto et al., 1968; Balwin et al., 1973). All three 
patients were men. Autosomal dominant inheritance could not be 
demonstrated and photographs of the patients suggested abduction 
contractures of the shoulder joints. These patients most likely 
suffered from what has been described as X- linked recessive 
scapuloperoneal syndrome with cardiomyopathy, in which the ex-
treme rare condition of PAP is know to develop with age. This 
syndrome will be discussed in the next chapter. Autopsy reports 
on FSHD patients are rare. Landouzy and Dejerine (1885) could not 
detect any cardiac abnormality on macroscopical examination. In 
the case described by Landouzy and Lortat Jacob (1909) the condi-
tion of the heart was not discussed. The case reported by Justin-
Besanscon et al. (1964) demonstrated tuberculous lesions in the 
pericard but the myocard was found to be normaL In summary , no 
specific cardiac complaints and no specific abnormalities 
concerning cardiac function are known to occur in FSHD. 
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2.15 . Concomitant diseases 
Few authors studied the association of FSHD with other 
diseases. Tyler and Stephens (1950) mentioned thyreotoxicosis in 
nine of their patients but thought the association fortuitous. 
Becker (1953) noticed a goitre in nine of the 94 cases under 
study. The same author found mental retardation to be present in 
five patients with FSHD. This association has never been 
confirmed. There were also two cases (a father and a son) with 
Huntington's chorea in Becker's series; mitral valve disease was 
present in three patients, and myocarditis and hypertension each 
in another patient , but these findings could not be related to 
the muscle disease. Tyler and Stephens (1950) noted hypertension 
in six patients of which two had suffered a myocardial 
infarction. Rheumatic fever was also frequently present in their 
patients but they found no statistically significant difference 
between the incidence of rheumatic manifestations in FSHD 
patients and in unaffected persons. 
2.16. Abortive cases 
Davidenkow (1930) was the first who drew attention to the 
frequent occurrence of mildly affected cases in FSHD . He stressed 
the fact that often neither these patients nor their families 
were aware that they had the disease. Tyler and Stephens (1950) 
noted absence of symptoms in 24 out of 58 patients (48%). 
Thirteen patients were 20 years or older of whom four had 
"minimal involvement" defined as "just detectable on exami-
nation". Walton and Nattrass (1954) were very impressed by these 
mildly affected cases and introduced the term "abortive" . They 
reported five stationary or abortive cases out of 15 studied 
(33%). Kazakov et al. (1974) reported 22 (11%) asymptomatic cases 
among 200 cases of FSHD most of which were taken from the litera-
ture. The lack of definition of abortive cases makes it difficult 
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to study the frequency of this phenomenon in the literature. It 
should be noted that neither Becker (1953) nor Chung and Morton 
(1959) mentioned abortive cases in their material. The best 
definition of abortive cases appears to be "without symptoms but 
found affected on clinical examination". This definition also 
includes young persons in whom the disease has just started and 
who will develop complaints later. A definition of abortive cases 
such as "without symptoms and beyond the mean age of first 
complaints" probably would be more correct but is unpractical 
because the mean age of onset of FSHD is not quite established. 
In this study the first definition will be used. The clinical 
picture of abortive cases might then include facial weakness 
and/or slight shoulder girdle weakness with atrophy. On clinical 
examination in a rare case, minimal foot extensor weakness might 
be present as well. Although several authors (Davidenkow, 1930) 
suggest that FSHD runs a milder course in women, there are no 
data that would indicate that there are more female than male 
abortive cases . 
2.17 The infantile form 
If Duchenne 's famous case Henri Juliard (1862) suffered from 
FSHD -which is likely because of the clinical picture and the 
pattern of heredity in his family- he represented the earliest 
report of congenital facial weakness in FSHD. This patient was 
seen by Duchenne at the age of 13 because of shoulder girdle 
weakness, noticed one year earlier. He was, l ike his mother 
reportedly born with facial weakness . When his mother was 
examined at the age of 30 the disease had not spread beyond the 
facial muscles. Her mother and her brother both had shoulder 
girdle weakness and atrophy as wel l . The first patient of 
Landouzy and Dejerine (1885) developed facial weakness at the age 
of three and shoulder girdle weakness when 15 years old: his sis-
ter had suffered from facial weakness since the age of four. 
Hanson and Rowland (1971) described similar patients. Three 
unrelated cases were diagnosed as M~bius' syndrome because of 
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facial weakness found to be present in the first years of life. 
All these cases passed the motor milestones at normal ages and 
developed severe muscle weakness in the first years of the second 
decade. EMG and muscle biopsy supported the diagnosis FSH myo-
pathy. The first patient had a mother wi th facial weakness and 
two brothers who were minimally affected. The second patient had 
a sister with facial weakness but other family members could not 
be examined. In the third patient, the father and one sibling 
were not available for examination; the mother and three siblings 
were unaffected. Autosomal dominant inheritance has not been 
ruled out and could very well be present in these cases. 
Brooke (1977) was the first to describe infantile FSHD as a 
special form of this disease. He suggested a specific clinical 
course and mode of inheritance in this presentation of FSHD, but 
he omitted to give precise numbers and data. It is unclear how 
many patients he studied, but he reported that facial weakness is 
noted in the first two years of life in all cases, leading to an 
early facial paralysis . Weakness of the shoulder girdle and 
pelvic girdle muscles develop early, and the progression is so 
fast that according to h i m, most children are dependent on a 
wheel chair by the end of the first decade . The expressionless 
face limits the emoti onal, non-verbal communication and isolates 
the child, making it (in Brooke 's experience) more depressed than 
children with other comparable diseases. The most interesting 
aspect of Brooke ' s descr iption is the way this infantile form is 
transmitted. In all cases except one , Brooke observed in one of 
the parents slight facial weakness as the only sign of the 
disease. There was no comment on the exception nor on other 
members of the families of these patients. Brooke suggested a 
modifying gene to be present in the non - affected parent of 
these patients, but in view of the limited data such conclusions 
appear to be rather premature. At present there is no basis to 
assume that infantile FSHD is a distinct form of FSHD. 
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2 . 18 The late onset adult form 
In his monograph on neuromuscular disorders, Brooke (1977) 
described another extreme of the clinical spectrum of FSHD as the 
late onset adult form of FSHD. This clinical variety involves 
patients with a lifelong mild facial weakness having a rapid 
progression at some stage in their life, commonly in middle age, 
leading to severe shoulder and pelvic girdle weakness within a 
couple of years. Muscle biopsy may reveal inflammatory changes, 
but, according to Brooke, they differ from polymyositis. These 
patients seem not to respond to corticosteroid treatment . The 
lifelong presence of facial weakness was suspected upon 
heteroanamnestic information and induced Brooke to consider this 
presentation a variant of FSHD. In an earlier publication he 
suggested that these cases were sporadic ones (Dubowitz and 
Brooke, 1973) . In 1977 he did not comment upon the pattern of 
inheritance in these cases. Also lacking are data regarding 
family members . Thus the description of this variant is 
incomplete and vague, as Brooke himself did admit . 
2.19. Age of onset 
The onset of FSHD has never been observed objectively. The 
reported age of onset is therefore based on anamnestic data. Such 
an approach leaves out the abortive cases because they are with-
out complaints . It is also known from family studies that 
patients with a considerable amount of facial and shoulder girdle 
weakness and atrophy, may nevertheless be without complaints. 
Therefore, the true age of onset of the disease may be several 
years earlier than is indicated by the complaints of patients. 
Another problem around the age of onset lies in the involvement 
of the facial muscles. Most patients are not aware of their 
facial weakness, nor do they appreciate the meaning of signs, 
l ike inability to whistle, or inability to close their eyes 
completely. Occasionally someone else -a doctor, a mother or an 
attentive family member- has pointed this out to them. In those 
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cases the onset of the disease is likely to be reported much 
earlier. Many people with FSHD will tell that they were never 
able to whi stle. This could indicate facial weakness but, on the 
other hand, they may never have tried to whistle for various 
r easo ns, so this symptom is of little help as it has not been 
properly studied. The reported age of onset reflects more upon 
the age of awareness of the disease in patient s than upon a true 
begi nning of the disease . 
The diagnosis of FSHD may be difficult in the early stages 
of the disease.Faci al weakness may go unnoticed even for a 
trained phys i cian (Walton, 1955). Atrophy and weakness of the 
scapular fi xators may be difficult to diagnose early in the 
cour se of t he disease, particularly when the patient is young. 
Tyler and Stephens (1950) and Becker (1953) all claimed that they 
were unable to diagnose the disease with certainty below the age 
of seven. On the other hand, facial weakness was found at the age 
of three in the proband of Landouzy and Dejerine's first descrip-
t i on (1885) . Hanson and Rowl and (1971) reported patients with 
congenital facial weakness, later developing FSHD. Also Brooke ' s 
(1 977) cases , repor t ed as the infantile presentation of FSHD, had 
facial weakness in the first years of life. 
Tyler and Stephens (1950) observed in one large pedigree 
with 58 living pat i ents that the symptoms or signs recognizable 
by t he patient or his family usually developed between the ages 
of seven and 20 years, the most common age of onset being between 
13 and 15 years. Only five persons (9%) were older than 20 years 
when they firs t noticed symptoms . Becker (1953) examined 11 
families with autosomal dominant (facio )scapulohumeral muscular 
dystrophy. The age of onset was thought to be between seven and 
27 years, with a peak around 15- 16 vears. There were only four 
persons (5%) with an onset later than 27 years (29, 31, 39 and 49 
respectively) . By the age of 21, 85% of all his cases had been 
diagnosed as such. Walton and Nattrass (1954) found two cases 
among 15 with the onset at seven and nine years respectively , ten 
with the onset in the second decade and three with the onset at 
22 , 26 and 27 years respectively. It was concluded that the age 
of onset could "vary from infancy untill late in adult life". 
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Chung and Morton (1959) presented the ages of onset in a 
diagram (Fig. 2.1.). It shows that 87% of all patients can be 
diagnosed at the age of 20 and 93% at the age of 30 years. The 
diagram is also used to estimate the risk for individuals in 
families with FSHD to become affected under the assumption that 
all gene carriers will develop detectable signs of the disease at 
a certain time in their lives. The probability that a child of a 
patient will carry the abnormal gene is 0.5 in autosomal dominant 
diseases, and the risk of such a child, that is unaffected at age 
z, to develop the disease does not exceed the ratio 100 - G(z) : 
200 - G(z) in which G(z) is the percentage of gene carr~ers 
clinically affected at that age. This risk is probably even 
lower, because G(z) in this study was based on recollection data 
and the disease can be d iagnosed on clinical examination years 
before the onset of first symptoms. In addition Chung and Morton 
noted a significant higher mean age at ons~t for males (16. 8 
years) than for females (13.7 years); they suggested that puberty 
might be a factor in precipitating the onset of the disease. 
Becker (1953) found that the age of onset, based on anamnestic 
data, in ten sporadic cases of FSHD ranged from 15 to 32 years, 
with an average of 22 years. This figure differed from the 
average age of onset in the group with proven autosomal dominant 
inheritance. This difference could reflect genetic heterogeneity 
but could also be the result of the unexpected playing an impor-
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2.20 The mode of inheritance 
An autosomal dominant pattern of inheritance was found by 
most authors who reported on FSHD (Landouzy and DeJerine, 1885; 
1886; Pearson, 1933; Boyes et al., 1950; Tyler and Stephens, 
1950; Becker, 1953; Walton and Nattrass, 1954; Walton, 1956; 
Chung and Morton, 1959; Kazakov et al., 1974). Myopathies with an 
autosomal recessive mode of inheritance and presenting themselves 
with shoulder girdle muscle weakness have been described, but are 
uncommon (Walton and Gardner-Medwin, 1981). In general, these 
cases are included in the 11mb- girdle group of muscular 
dystrophy . A small percentage of these cases appear to develop 
facial weakness in the course of their disease. Yet, an autosomal 
recessive myopathy identical to FSHD has been poorly documented. 
Brown (1951) reported on in-patients but did not study their 
families. Therefore her report cannot be accepted as an argument 
for the existence of a recessive form of FSHD. Stevenson (1953) 
studied nine families with shoulder girdle and facial muscle 
weakness in Northern Ireland. In one family a father and a 
daughter were affected: in the other families the patients only 
occur red in single sib ships. Stevenson did not describe clearly 
which of the supposedly unaffected persons were examined . In some 
families the parents were not examined and in others it is evi-
dent that he could have studied only one of them. Stevenson's 
conclusion that FSHD is inherited in an autosomal recessive way 
is unwarranted on the basis of the data presented. Moser et al. 
(1966) described four patients in two families suggestive of 
autosomal recessive inheritance . Only one patient had shoul der 
girdle onset with facial weakness. In the other three patients 
the disease had started in the lower extremities. All in all, it 
appears that an autosomal recessive myopathy, clinically iden-
tical to FSHD, has never been properly described . 
Apparent sex limitation was only mentioned by Walton (1955) 
who studied a family wi th seven affected females in two gene-
rations. The same author (1981) referred to a report of a family 
with an autosomal dominant neuromuscular disorder affecting five 
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women in two generations (Hertrich 1957). The disorder always had 
started in the shoulder girdle muscles . Only one patient had a 
questionable facial weakness . Muscle biopsies were not performed. 
As long as chance factors cannot be excluded, such families are 
no proof of sex-limited inheritance. 
Sporadic cases of a facioscapulohumeral myopathy constitute 
another problem. A careful examination of the parents and their 
families is such cases is always warranted, particularly if 
genetic advice is sought, while one should have to be sure that 
non-paternity is excluded. But even when the offspring of such a 
patient is not affected, a new mutation to FSHD cannot be 
excluded. Becker (1953) suggested that the 11 sporadic cases of 
his group of descending shoulder girdle myopathy were different 
from his autosomal dominant group because of a later age at 
onset. But is not quite clear whether all these cases were 
sporadic ones, because in several instances the families could 
not be examined properly, while in other cases there was a his-
tory suggestive of more affected persons in the family, and in 
one case (family 15) the mother of the proband had a paresis of 
the orbicularis oris muscle. Walton and Nattrass (1954) included 
sporadic cases in their limb-girdle group, which was shown to be 
heterogeneous (Chung and Morton, 1959) and in which sporadic 
cases with autosomal recessive inheritance could be distinguis-
hed. Moser et al. (1966) reported three sporadic cases with 
facioscapulohumeral myopathy of which two had facial onset of the 
disease; one of these two patients had no children and her 
parents and only brother were dead: the parents and the two 
children of the other patient were examined and found to be 
healthy. 
The literature clearly suggests, that the approach of the 
clinician who tries to attach modes of inheritance to sets of 
signs leads to more discussion and confusion than that of the 
geneticist , who describes the signs at a given mode of inheri-
tance. The geneticist ' s approach avoids an a priori discussion on 
semantic problems, such as the meaning of the term facioscapulo-
humeral, and has the advantage that the patterns of inheritance 
are well defined. As this approach is felt to be more fruitful , 
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we should like to define FSHD as an autosomal dominant neuro-
muscular disorder. Moreover it can be concluded that autosomal 
recessive disorders closly resembling FSHD have not been properly 
documented; sporadic cases, resembling FSHD, have been described 
and might be mutants or phenocopies. 
2 . 21. The penetrance 
The penetrance of FSHD was always thought to be complete but 
this was based on the findings in relatively small pedigrees. 
Only some authors studied large kindreds. Tyler and Stephens 
(1950) found the ratio of affected versus non-affected sibs in 
their large kindred close to 1 : 1 (the actual numbers were 130 
versus 143). No correction for the probands could have been made, 
because they were not indicated in this study. Several patients 
had died, and only 58 living patients had been examined . Still 
the authors considered these results to be compatible with 
complete penetrance. Becker (1953) made corrections for the pro-
bands and found that in sibships with at least one affected 
person, 41% of the sibs were affected and that 46% of the sibs of 
an affected parent were affected themselves. These figures did 
not differ significantly from the expected 50% and therefore the 
penetrance was thought to be complete . Similar numbers were 
reported by Kazakov et al. (1979) who studied 55 personal cases 
and 145 histories taken from the literature. They found 49% of 
the children to be affected if one of the parents had FSHD . These 
authors stated that FSHD occasionally skipped a generation but 
they did not document this observation. If their statement is 
based on published reports only, such as the first family of 
Landouzy and Dejerine (1885), it is of little value because the 
skipped generation in this family was never examined . 
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2.22 Sex influence 
Since the recognition of muscle disorders, clinicians have 
been intrigued by the differences between the sexes . This was 
largely caused by the presence of the X-linked myopathies . But 
even when these were separated from the other myopathies, the 
question remained if the X-chromosome or the hormonal or other 
biochemical differences between males and females had any 
influence on the onset or the expression of the hereditary muscle 
diseases. Several authors have discussed thi s matter when repor-
ting on FSHD. Becker (1953) found more females than males affec-
ted but the numbers did not differ significan tly from the 
expected 1 1 ratio . Wal ton (1955) reported on 17 females and 
five males in four families but considered the informa t ion too 
limited to draw firm conclusions . Most au t hors agree tha t men are 
as frequently affected as women. 
Chung and Morton (1959) reported a s t atistically signi ficant 
difference in the mean age of onset in males and females . The 
authors suggested that the onset of puberty might play a role. 
However these findings have never been confirmed by others . 
Several authors like Davidenkow (1930) had the impression 
that FSHD runs a milder cour se in females, but only Becker (1953) 
came with evidence from his own material. Using pelvic gir dle 
involvement as a criterion for the severity of the disease, he 
found that 80% of the males and 23% of the females in his study 
were severely affected . The difference in frequency i s statist i -
cally significant. But, again, nobody so far has confirmed these 
observations. Bradley (1979) - using his own inde x of severity-
found women to be slightly more severely affected than men, but 
his material does not consist purely of FSHD . 
2 . 23. Linkage studies 
Linkage or association with a known trait or disease has 
never been observed in FSHD . Tyler and Stephens (1950) did not 
find linkage of FSHD with the loci of the ABO , MN and RH blood 
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groups in their large kindred. Chung and Morton (1959) anal ysed 
Walton's (1955) limited data on the bloodgroups ABO, RH, MN, P, 
FY, and JK in more detail but, again, no suggestion for linkage 
was found. 
2 . 24 Prevalence and incidence 
The prevalence of a disease is defined as the frequency of 
affected individuals in a population at a given time. The preva-
lence of FSHD reported by different authors is quite variabl e, 
suggesting lar ge regional differences, even if one assumes that 
not all affected persons are ascertained in the regions with the 
reported low prevalence. Morton and Chung (1959) reported the 
prevalence of FSHD being 1 per 435.000 in Wisconsin, after cor-
rection had been made for an estimated ascertainment probability, 
and 1 per 179.000 when based on pooled data from several surveys. 
Becker (1953) reported a prevalence of 1 per 17 . 000 in South-
Baden (Germany), calculated from familial and non-familial cases. 
If the 11 sporadic cases were excluded, the prevalence of FSHD 
amounted to 1 per 20 . 000 approximately. Walton and Nattrass 
(1954) reported 22 affected persons in a population of approxi-
mately 2 million (1 per 91.000) . Moser et al. (1966) found two 
patients with FSHD among the 910.000 inhabitants of the Kanton 
Bern in Switzerland, i.e • • 1 per 455 . 000. Prot (1971) reported 
the prevalence of FSHD in the region of Warsaw (Poland) to be 1 
per 250 . 000 individual s . 
There are several definitions of incidence. The incidence 
might be defined as the frequency of new occurrences of a disease 
among individuals of a specific population within a certain 
period of time , or as the frequency of individuals born in a cer-
t ain population who wi l l become affected. If the latter defini-
tion is used , the incidence is always higher than the preval ence 
because it may take some years for a defective gene to come to 
expression, and such a gene may lead to an earl y dea t h . Morton 
and Chung (1959) made a correction for the ascertainment proba-
bility and found the incidence of FSHD in Wisconsin to be 1 per 
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263.000 individuals born, and for their combined sources as 
mentioned in section 2.1., 1 per 109.000 . 
2.25 Fitness 
Fitness is defined as the ability to transmit one's genes to 
the next generation and have them survive in that generation to 
be passed on to the next. Seeker (1953) reported a normal fitness 
in patients with FSHD, based on the ratio of children of affected 
and non-affected sibs. Morton and Chung (1959) stressed the 
biased ascertainment of more fertile persons, and the possible 
difference in fertility between non- affected sibs and the general 
population. Using methods which reduce these biases , they esti-
mated the relative fitness coefficient for patients with FSHD to 
be about o. 741. (Morton et al., 1963). Emery and Walton (1967) 
reported a normal fitness if affected sibs were compared with 
unaffected sibs, but Prot (1971) reported a relative fitness 
coefficient of 0 . 80 for her patients with FSHD, when compared 
with healthy sibs . 
2 . 26 Mutation rate 
Seeker and Lenz (1955, 1956), using the direct method, 
estimated the mutation rate of FSHD to be 4.7. x 10 - 6 per gene 
per generation. Assuming a relative fitness coefficient of 0.89 
they arrived at a mutation rate of 5.0 x 10 -6 by an indirect 
method . Morton and Chung (1959) found a mutation rate of 5.0 x 
10- 7 by an indirect estimate and Prot (1971) reported a mutat i on 
rate of 3. 0 x 10-1 per gene per generation. These large 
differences are related to the reported regional differences in 
the prevalence of FSHD, and apart from the problems of complete 
ascertainment of this rare and relatively mild disease , many 
sources of error such as illegitimacy , low expressivity , and 
possibly incomplete penetrance are involved in establishing the 
correct number of mutations in a population. 
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2.21 Clinical course and disabilty 
There are no longitudinal studies of FSHD. The clinical 
course of FSHD has been judged f['Om anamnestic data, and is 
thought to be slowly progressive in most cases, covering many 
decades (Tyler and Stephens, 1950). Most authors agree that long 
periods of arrest are not unconunon (Wal ton and Nattrass , 1954), 
but occasionally a rapid progression is noted (Brooke, 1977). The 
time lapse between involvement of the upper part and lowe[' part 
of the body varies g['eatly from patient to patient. Exact figures 
are rarely given. Walton and Natt['ass (1954) mentioned a duration 
of 20- 30 years before the disease had sp['ead to the pelvic girdle 
muscles . In a late[' text, Walton and Ga['dner-Medwin (1981) stated 
that some cases may run a rapid cou['se, while in others long 
periods of appa['ent arrest may be noted. In some instances the 
pelvic girdle muscles will never be involved. Becker (1953) found 
that if the pelvic girdle becomes affected, this will happen in 
38% of the cases within five years and in 62% within 15 yea['S 
after the onset of the disease . 
Kazakov et al. ( 197 4) studied the way the disease could 
spread to involve the lower part of the body (see 2.8.). "The 
descending type with a jump" and "the g['adually descending type" 
never occurred within one family and those two types were thought 
to suggest genetic heterogeneity of FSHD. 
Becker (1953) studied the severity of the disease and 
suggested that the sex and physique had an influence on the 
course and severity 
significantly less 
gi['dle weakness as 
of the disease. He found that women were 
severely affected than men, using pelvic 
the criterion for severe involvement (see 
2.22) . When the disease was studied in relation to the physical 
build, he found that in general the onset of the disease was 
later and the disease ran a milder course in the pycnic type, 
whi le the leptosome type was affected earlier and more severely. 
The group of the athletic types and the group of the aspecific 
types had an onset and a course of the disease somewhere in 
between the t wo other groups. There were 76% leptosome types and 
24% pycnic and pycno-a thletic types in the severely affected 
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group with pelvic girdle weakness, while there were 71% pycnic 
and pycno-athletic types and 29% leptosome types in the group of 
mildly and moderately affected persons. 
Other factors that might influence the course of the disease 
are rarely mentioned. Infectious deseases and traumata are 
believed to have no influence (Tyler and Stephens, 1950; Becker, 
1953). Immobilisation for a long time may aggravate muscle 
weakness. Boyes et al. (1950) suggested that physical strain 
could aggravate the disease, but Becker (1953) rejected such 
explanations. 
The degree of disability in FSHD at a certain age is 
dependent on the clinical course of the disease and is therefore 
extremely variable. There is no current grading of the disability 
in FSHD in use, nor 
the grading of the 
involvement occurred 
is there a generally accepted agreement on 
severity of this disease. Pelvic girdle 
in 56% of Seeker's cases (1953), in 45% of 
Walton's cases (1955), in 59% of Chung and Morton's cases (1959) 
and in 60% of the cases described by Ricker and Mertens (1968). 
Their figures included all age groups. Sometimes inability to 
walk is considered an indication of severe disability. This was 
noted to occur in three out of 51 men (6%) and in six out of 72 
(8%) women in Becker's material. Ricker and Mertens (1968) 
observed this in two out of 30 patients ( 7%), and then only in 
later life. It can be concluded from this limited information 
that the frequency of serious disease and disability appears 
higher at older age. Tyler and Stephens (1950) made similar 
general statements, and most authors agree with their conclusion 
that FSHD is a relatively benign disease, even if reports about 
the infantile form of FSHD (Brooke, 1977) are taken into account. 
2.28 Therapy 
The best way to preserve muscle strength is through normal 
daily physical activity . Vignos and Watkins (1966) suggested that 
an active excercise program, particularly in the early stages of 
FSHD, could increase muscle strength. The degree of improvement 
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in strength was correlated with the initial strength of the 
exercised muscles . Prevention of obesity is of great importance 
since excessive weight gain has adverse effects on the ability to 
maintain independent ambulation (Vignos, 1979). Contractures 
should be treated with stretching. There is no information about 
the results of Achilles' tendon elongation operation in FSHD, 
probably because such contractures do not occur frequently in 
this disease. Experiences with patients with Duchenne type of 
muscular dystrophy suggest that such operations are contrain-
dicated in the ambulatory phase because the contractures recur 
rapidly; the postoperative immobilisation might result in disuse 
a trophy, and the mechanism to maintain ex tension of the knee 
might become disturbed, resulting in loss of ambulation (Spencer , 
1967). 
Operations to improve the function of the arm by stabili-
sation of the shoulder have been designed specifically for FSHD . 
In many cases abduction and anteflexion of the arms are impaired 
quite early in the course of the disease because of a severe 
paresis of the scapular fixators . In patients with relatively 
strong deltoid muscles, manual fixation of the scapula will show 
a remarkable improvement of these functions. In these patients 
surgical fixation of the scapula might be warranted . The optimal 
position of fixation appears to be at 20 degrees e x ternal rota-
tion. Two techniques have been proposed recently: thoracoscapular 
bony fusion (Bunch, 1973; Copeland and Howard, 1978) and thoraco-
scapular immobilisation by fastening the scapula to several 
underlying ribs with fascia (Ketenjian, 1978) . With the former 
technique the patient will be in a shoulder spica for several 
weeks, while the la t tcr technique has the advantage that early 
shoulder motion is allowed postoperatively with the arm supported 
in a sling. All authors claimed excellent results with their 
techniques. 
2 . 29 Life expectancy and causes of dea t h 
As cardiac and respiratory functions are usually spared , the 
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life expectancy of patients with FSHD does not differ 
significantly from the average in the general population. (Chung 
and Morton, 1959; Prot, 1971). The cause of death does not appear 
to be related to the myopathy (Seeker, 1953) but extensive and 
systematical studies with regard to this problem are lacking. 
Walton and Gardner-Medwin (1981) remarked that death through 
respiratory failure may occur but happens rarely. 
2 . 30 Biochemical studies 
The number of biochemical studies specifically on FSHD is 
rather small. A mild creatinuria is often present with FSHD : 
being a rather non-specific finding in patients with neuro-
muscular disorders, it has little importance . 
Hurwi tz et al. (1967) reported a family in which FSHD and 
aminoaciduria inherited independently as autosomal dominant 
disorders . There was an increased excretion of lysine, cystine, 
ornithine and arginine as a result of a renal tubular defect . An 
increase of urinary excretion of several aminoacids has been 
reported in other myopathies but these findings were inconsistent 
and appeared to be non-specific (Pennington, 1981). An increase 
of creatine kinase (CK) activity in the serum was found to be the 
most sensitive biochemical characteristic of neuromuscular dis-
order . The greatest increase of serum CK activity is found in the 
rapidly evolving myopathies while smaller elevations or even nor-
mal values are found in slowly progressive myopathies like FSHD 
and denervating disorders . Several other intramuscular enzymes 
including aldolase, SGOT (serum glutamic oxaloacetic 
transaminase), SGPT (serum glutamic pyruvic transaminase) and LD 
(lactic dehydrogenase) are elevated in chronic muslce disease but 
to a smaller extent than CK. Munsat et al. (1972) found an ele-
vation of the serum LD activity in 20% of his patients with FSHD. 
The serum aldolase activity was elevated in 15% and the SGOT and 
the SGPT activities were both elevated in 5% of his cases. 
Fowler and Pearson (1964) found the serum CK activity only 
occasionally raised . Munsat et al. (1972) reported an elevation 
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in 50% of his cases with FSHD but these values were never higher 
than four times the upper limit of normal. The same range of CK 
activity was found by Hughes (1971) in 13 out of 19 cases (68%) 
with FSHD. Bradley (1979) reported the serum CK levels to be 
above normal in most cases, but his material included patients 
with a mitochondrial myopathy resembling FSHD. Hughes (1971) 
observed CK levels to have a tendency to be raised in subjects up 
to the age of 45- 50 years and to have a gradual drop to normal in 
older age. There was apparently no correlation between the level 
of CK activity and the severity of the disease. Munsat et al. 
(1972) found no correlation between the levels of CK activity and 
the age of the patients or the duration of the disease. Bradley 
(1979) was the only author who reported a relation between the 
level of the CK activity and the rate of progression of the 
disease. Hughes' (1971) hopes that the serum CK activity would 
serve to distinguish FSHD and neurogenic atrophy came to nothing 
since similar elevations of CK activity were observed in spinal 
muscular atrophy, motor neuron disease and other denervating 
disorders (Munsat et al., 1973), in the same percentage of cases 
(Williams et al., 1970; Welch et al., 1972) as in FSHD. Therefore 
the determination of the serum CK activity is of little help to 
the differential diagnosis of FSHD (Munsat et al., 1973). Walton 
and Gardner -Medwin (1981) stated the serum enzyme levels are not 
raised in preclinical cases. 
Many studies have been carried out on the serum CK 
isoenzymes in muscle diseases, but few included FSHD patients. 
Jockers-Wretou (1976) found the serum CK-MB fraction in one 
patient to be 7% of the total serum CK activity which was 54 U/1 
(normal values up to 50 U/1). Elevation of the CK-MB fraction, 
which should not exceed 6% (Klapdor et al. , 1977), is frequently 
observed in muscular dystrophies, and is felt to reflect skeletal 
muscle disease rather than cardiac muscle disease ( Silverman et 
al., 1976). Zweig et al. (1980) observed an increased serum CK-MM 
and CK- BB fraction activity in one patient with FSHD, which they 
attribu t ed to "leakage of degenerating and regenerating muscl e 
fibres" . 
Ibrahim et al. (1981) studied serum enzymes and the serum LD 
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isoenzymes in seven male patients with FSHD. All patients had a 
mild elevation of the serum CK, aldolase, SGOT and LD activities: 
also the average serum activity of the fifth LD isoenzyme 
fraction was significantly raised in these patients. 
Elevated serum pyruvate kinase (PK) levels were found in 
seven out of ten patients with FSHD, all of whom had normal serum 
CK levels (Alberts and Samaha, 1974). These ten patients showed 
an average 12-fold elevation of serum PK activity when compared 
to their controls. Seay et al. (1978) could not confirm these 
observations: three of their seven patients with FSHD had an 
elevated serum CK activity and five of them had an elevated serum 
PK activity. But Zats et al. (1978) found an increased serum PK 
activity in 18 out of 20 patients with FSHD while only nine had 
an elevated serum CK activity. Only one patient had normal 
activities of both enzymes. These authors suggested that the 
determination of the serum PK activity might be a more sensitive 
test than the determination of the serum CK activity in some 
neuromuscular disorders and particularly in FSHD. 
Hische and Van Der Helm (1979) studied the serum myoglobin 
concentrations in 230 patients with neuromuscular diseases of 
which eight patients had FSHD. In six of these eight patients 
both CK and myoglobin levels were raised, in one patient both 
were normal, and in one patient the serum CK activity only was 
raised. It appeared that the estimation of the serum myoglobin 
concentration was not a more sensitive test than the deter-
mination of the serum CK activity for the detection of patients 
with FSHD . 
Ionasescu et al. (1972) reported on ribosomal protein 
synthesis in muscle extracts of patients with FSHD. In a previous 
in vitro study they had found an abnormally large synthesis of 
collagen by muscle polyribosomes in contact with soluble enzymes 
derived from the same muscles of patients with Duchenne type of 
muscular dystrophy. This could not be demonstrated in FSHD but 
they did find an increased incorporation of labelled aminoacids 
in the muscle polyribosomes in four patients who were in an early 
stage of the disease, whereas three patients in advanced stages 
of the disease showed a lowered, and in one case a normal, incor-
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poration of these aminoacids. These findings suggested an 
increased protein synthesis in muscles in the early stages of 
FSHD and the authors speculated that this could be the synthesis 
of a contractile (but possibly inactive) protein, and that the 
increased protein synthesis thus reflected a failing attempt at 
regeneration (Ionasescu et al., 1975). This abnormality appeared 
controlled by an undetermined factor belonging to the so l uble 
(non-ribosomal) fraction of muscle homogenates . (Ionasescu and 
Zellweger, 1979). 
2 .31. Electromyography 
At present it is impossible to differentiate the clinical 
varieties of muscular dystrophy from each other by electrodiag-
nostic methods. The principal value of electromyography (EMG) is 
to differentiate the myopathies from the neurogenic a trophies 
with which they may be confused. The EMG abnormalities in the 
myopathies are explained in general by the loss of individual 
muscle fibres within a motor unit while the total number of motor 
units that can be activated remain unchanged. In needle EMG a 
polyphasic motor unit action potential is observed as a result of 
non-synchronous firing of remaining muscle fibres. On an average 
the action potentials of myopathic muscles are of shorter dura-
tion than those of healthy muscles. This is explained by the 
lowered muscle fibre density in the motor units reducing the 
early and late components of the action potential at first 
(Buchthal et al., 1960). The voltage of the motor unit action 
potentials is usually normal or slightly diminished. On maximal 
effort, a full interference pattern of normal or slightly reduced 
amplitude is obtained in most instances. In severely affected 
muscles the disproportion between the degree of weakness and the 
reduction in the interference pattern provides an argument for a 
myopathic disorder. Automatic frequency analysis of the inter-
ference pattern may reveal a shift to the higher frequencies in 
the myopathies, but this is of limited diagnostic value as a 
substantial shift of frequencies is usually accompanied by a 
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recognisable excess of polyphasic motor unit action potentials. 
Most authors use the term "myopathic EMG" when an 
interference pattern of motor unit potentials of brief duration 
and small amplitude with an excess (> 12%) of polyphasic poten-
tials is found (Buchthal and Kamieniecka, 1982). Engel (1975) 
criticized this term since, theoretically, brief small abundant 
polyphasic potentials (BSAPP) can be present as well in neuro-
genic disorders. Introduction of new terms like BSAPP- pattern are 
equally unsatisfactory (Daube, 1978) because the value of the 
term lies solely in the meaning it carries to the reader, and it 
does not absolve the electromyographist to describe in detail all 
the findings of his examination. 
Spontaneous activity has been described in cases of muscular 
dystrophy (Buchthal and Rosenfalck, 1963) and consists of brief 
discharges of repetitive activity following insertion or movement 
of the needle electrode and of fibrillation potentials. 'lhis 
spontaneous activity is rather uncommon in muscular dystrophy but 
it is frequently found in polymyositis. In polymyositis positive 
sharp waves may be present as well. Munsat et al. (1972) found 
them in patients with FSHD who had rather extensive cellular 
infiltrations, histologically resembling polymyositis. 
Fasciculations have never been found in FSHD. Motor nerve 
conduction is said to be normal in FSHD when measured by conven-
tional methods, but Bethlem et al . (1973) reported slowing of the 
peroneal nerve conduction velocity in two of their seven cases. 
Hausmanova-Petrusewicz and Jedrzedowska (1972) demonstrated 
enlargement of the motor unit territories , large po tentials and 
pseudomyotonic discharges in some of their patients with muscular 
dystrophy, features normally indicative of neurogenic disorders. 
In many instances of FSHD, on routine EMG examination McComas 
(1977) found in some muscles "myopathic " a,nd in other muscles 
"neuropathic" features in the same patient: or in some members of 
a family "myopathic " and in other members of the same family 
"neuropathic" characteristics : but, unfortunately , these findings 
are not specified. 
Sica and McComas (1971) advanced arguments for a neurogenic 
factor in FSHD. Using a method described earlier, (McComas et al . 
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1971) they found a reduced number of functioning motor units in 
the extensor d1g1torum brevis muscle in three out of four 
patients with FSHD. The size of the motor unit was normal in all 
four cases. Isometric twitch studies showed decreased twitch ten-
sion in two cases, a prolonged contraction time in four cases and 
a prolonged relaxation time in three cases. These findings were 
thought to be compatible with chronic partially denervated musc-
les. Maximal impulse conduction velocities and terminal 1atenc1es 
in the peroneal nerves were normal. In the discussion of their 
results, Sica and McComas (1971) treated patients with FSHD and 
patients with a 11mb-girdle myopathy as one group, which led them 
to premature conclusions about FSHD, since their actual studies 
on those four patients showed only minor abnormalities, often 
only in a couple of patients. The technique, methods and inter-
pretations have been severely cri t1cized by Panayiotopoulos et 
al. (1974; 1976) who were unable to reproduce the findings in 50 
patients including three patients with FSHD after appropriate 
modification of the technique (Panayiotopoulos and Scarpalezos, 
1977). 
Ballantyne and Hansen (1974) used a computerized method to 
estimate the quantity of motor units and found this within normal 
range in the extensor d1gitorum brevis muscles in three cases of 
FSHD. The number of motor units was reduced only in cases of 
myotonic dystrophy. The authors thought that S1ca and McComas 
(1971) had arrived at low numbers of motor units because their 
method failed in diseases where quantitative alteration in the 
configuration of the motor unit potentials occurred. A computer 
method was also used for analysis of evoked motor unit potentials 
(Ballantyne and Hansen, 1975). These potentials were recorded 
from surface electrodes over the extensor d1g1torum brevis 
muscles and evoked by stimulation of the deep peroneal nerve at 
the ankle. The latencies and duration of the motor unit 
potentials were significantly increased in cases with FSHD as 
compared to controls, which is in contrast to the findings of 
conventional needle electromyography. The fastest motor 
conduction velocities were significantly reduced and the shortest 
distal motor latencies were significantly prolonged in patients 
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with FSHD. These findings seemed to support the hypothesis of a 
neurogenic factor in FSHD , but Jennekens et al. (1972) 
demonstrated with muscle biopsies that, from the second decade 
onwards and increasing with age, neurogenic features such as type 
grouping and group atrophy were observed in the extensor 
digitorum brevis muscles of individuals who had not suffered from 
neuromuscular disorders. These findings were explained as the 
result of a slow proces of denervation and reinnervation, 
occurring as part of the normal ageing processes . This study 
suggested that the extensor digitorum brevis muscle is not quite 
suitable for EMG studies such as the ones mentioned above . 
2 . 32. Muscle biopsy studies 
Muscle biopsy in FSHD occasionally shows no abnormalities ; 
in classical, slowly progressive cases the changes can be mini-
mal. All histological findings traditionally attributed to 
myopathies can be found in FSHD. Histochemical studies of the 
muscle biopsies have contributed a great deal to our knowledge of 
muscle diseases but these studies included only fe w cases of FSHD 
(Brooke and Engel, 1966: five patients; Dubowitz and Brooke, 
1973: 11 patients; Bethlem et al., 1973: seven patients; Buchthal 
and Kamieniecka, 1982 : 21 patients) . Therefore the histopathology 
in FSHD is not as clearly established as in the Duchenne type of 
muscular dystrophy (Munsat , 1972) . The reason could be that FSHD 
is a rare disease and that many patients are not interested in 
extensive studies once the diagnosis is made in a family member 
and once they know the relatively good prognosis. 
First , the organisation of the muscle fibres (i.e . changes 
in size and distribution) and secondly , the structural changes 
will be discussed. 
2!:~~!:!!~~~!~!:! 
A very constant finding on histological examination is an 
increased variation in fibre size with rounding of the fibres. 
Dubowitz and Brooke (1973) frequently observed an increase of the 
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mean fibre diameter of all fibre types. Abnormal hypertrophy 
factors were more often found than abnormal atrophy factors. The 
same authors noted small angulated fibres scattered between large 
fibres in 70% of their biopsies. "They were frequently not the 
heavily stained angulated fibres seen in denervation, but merely 
normally staining very minute fibres". Buchthal and Kamieniecka 




with FSHD. The significance of small angulated fibres in 
uncertain. A neurogenic lesion cannot be ruled out 
most authors (Buchthal and Kamieniecka, 1982) appear to 
accept only dark angular fibres that stain intensely with the 
NADH- tetrazo lium reductase stain, as a definite proof of dener-
vation in FSHD. Groups of atrophic fibres were not observed by 
Brooke and Engel (1966) nor by Dubowitz and Brooke (1973) who 
specifically stated that "this would serve to differentiate from 
classical denervation" . Bethlem (1970) did not mention angulated 
fibres in relation with FSHD, but later (1977) he stated that 
small groups of small angular fibres are sometimes present. 
Hausmanowa-Petrusewicz and J edrzedowska (1971), and Das tur and 
Razzak (1973) also reported small groups of atrophic fibres in 
cases of muscular dystrophy but it was not clear if cases of FSHD 
were included. If fibre type predominance is present, type 2 
predominance is more frequently observed than type 1 predomi-
nance . This helps to differentiate FSHD from other myopathies 
which have a tendency to type 1 predominance (Dubowitz and 
Brooke, 1973). Engel and Kossman (1963) reported a case of FSHD 
with selective involvement of type 1fibres . 
~~£~£~~£~~-~~~~~~~ 
Hyaline fibres and necrotic fibres with phagocytosis are fre-
quently, but not abundantly, present. They are apparently more 
prominent in the rapidly progressive cases. Basophilic fibres 
with vesicular nuclei and prominent nucleoli can be found which 
are regarded to represent regeneration. Internally located nuclei 
are present in some biopsies but this is never a prominent fea-
ture. Increase of fat and endomysical fibrosis, which can be 
found in an early phase of the Duchenne type of muscular 
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dystrophy, is only rarely present in FSHD and never to a great 
extent (Ionasescu et al ., 1972; Dubowitz and Brooke, 1973). 
A rather distinct inflammatory reaction is a remarkable and 
not unusual finding in FSHD (Brooke and Engel, 1966; Munsat et 
al ., 1972; Dubowitz and Brooke, 1973; Bethlem, 1977) . This reac-
tion may be so prominent that it resembles polymyositis. Munsat 
et al. (1972) reported four rather severe cases of FSHD: two 
showed a clearly autosomal dominant pattern of inheritance in 
their families, and in the two other cases the family data were 
inadequate. The perivascular and interstitial inflammatory 
responses found on histopathological examination wer e so exten-
sive that they were treated with corticosteroids. Three patients 
showed a clinical improvement but later reports (Munsat and 
Bradley, 1977) attest that this improvement was transient and 
deterioration ensued as in other cases with FSHD. Lowering of 
serum CK activity was observed during corticosteroid treatment 
but the authors stressed that this did not imply therapeutic 
benefit. Munsat et al. (1972) suggested that the imflammatory 
reactions they observed were only a stage in the development of 
FSHD. 
Papapetropoulos and Bradley (1974) observed inflammatory 
infiltrations in six patients with different types of muscular 
dystrophy (three cases of FSHD, three sporadic cases of other 
types). They suggested that this was an immunological reaction 
secondary to the underlying muscle degeneration, leading to 
muscle damage in its own right. A similar explanation was given 
by Jennekens et al. (1975) for the inflammatory responses they 
found in the muscle biops ies of five members of their two 
families with autosomal dominant neurogenic atrophy in a scapulo-
personeal distribution, accompanied by a cardiomyopathy at a more 
advanced age. These two families are rather exceptional indeed as 
they do not fit properly in any known category . They will be dis-
cussed later. 
Target fibres and targetoid fibres have never been described 
in FSHD. Moth-eaten fibres seem to be present in more than half 
of the cases (Dubowitz and Brooke , 1973). These small fibres are 
predominantly type 1 fibres, in which the intermyofibrillar net-
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work that normally has a very regular pattern, assumes a whorling 
appearance with areas that do not stain with oxidative enzyme 
reactions. These fibres appear to be identical to the lobulated 
fibres described by Bethlem et al. (1973). The authors found that 
bundles of myofi brils ran an aberrant course in these fibres and 
that accumulations of normal mitochondria and glycogen were found 
in between these bundles. The significance of these moth-eaten 
fibres is unclear as they were observed in other myopathies, in 
spi nal muscular atrophies (Bethlem et al . , 1973) and in diseases 
like Parkinson ' s disease and polymyalgia rheumatica (Dubowitz and 
Brooke , 1973). Yet their frequency in FSHD is remarkable: Bethlem 
et al. (1973) observed moth-eaten fibres in 13 out of 300 biop-
sies . Seven out of 11 patients with FSHD showed moth- eaten 
fibres. 
Ringed fibres are occasionally discovered in FSHD: their 
presence suggest a myopathy although they are observed in 
diseases such as spinal muscular atrophy and rheumatoid arthritis 
(Dubowitz and Brooke , 1973) and also in normal muscles (Behtlem 
and Van Wijngaarden, 1963) . 
Ultrastructural abnormalities characteristic of FHSD have 
not been reported (Ma i r and Tome, 1972; Price and Van De Velde, 
1981) . 
2.33. Summary 
FSHD shares with other autosomal dominant disorders such as, 
for example, Huntington's chorea or myotopnic dystrophy, a con-
fusing history of descriptions of the diseases. After the first 
report many observations were made, each emphasizing a peculair 
aspect of the variable clinical picture. This often led to sug-
gestions that different diseases were hidden under one clinical 
presentation. But autosomal dominant disorders tend to favour the 
"lumpers" above the "splitters" and , at present , a variable 
clinical picture appears to be a feature of autosomal dominant 
disorders . The same applies to FSHD. Still there are some charac-
teristic findings in FSHD: 
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- The main features of the disease are early weakness and atrophy 
of the shoulder girdle muscles, in many instances preceded by 
facial weakness, although, apparently, facial weakness is ab-
sent in approximately 20% of the cases. 
- There is an early 'spread of the disease to the muscles of the 
upper arms and to the foot elevators . The further extension to 
other muscles is variable. 
- Pelvic girdle involvement is usually a late stage in the course 
of the disease . 
- Asymmetry of muscle involvement is very common. 
- Pseudohypertrophy of muscles is extremely rare. 
- Contractures and skeletal deformities are not common, but exact 
figures are lacking. 
- Cardiac involvement has never been properly described. 
- Abortive cases with minimal or mild muscle involvement and 
without complaints related to muscle weakness are quite common. 
- The mode of inheritance is autosomal dominant . Autosomal 
recessive myopathies , clinically identical to FSHD, have never 
been sufficiently documented. Sporadic cases with a myopathy 
identical to FSHD have been described. As long as it cannot be 
proven or disproven that they are mutants of FSHD , their 
classification remains an open question. 
- The penetrance of the abnormal gene appears to be complete . 
- Men and women appear equally frequently affected . There are no 
solid grounds to assume that either sex is more severel y 
affected than the other. 
- Serum CK activitity is mildly elevated in approximately 50% of 
all cases but is rarely more than four times the upper limit of 
normal. 
- FSHD runs a benign course, leading to a severe disability in 
only a small percentage of cases . Only a few persons become 
wheelchair- bound, and if so, mostly at an older age . 
- The patients' ages at death do not differ significantly from 
the average. 
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Apart from these characteristic findings, there are several as-
pects of FSHD that lack the quality of constancy. 
- The sequence in which individual muscles become affected is 
quite variable. 
- The rate of progression of the disease differs from case to 
case: in some instances the disease is steadily progressive, in 
others l ong periods of arrest are noted . Occasionally a rapid 
progression within years is observed . 
- The age of onset may vary from the first year of life till late 
in middl e life . There are no good grounds to assume that the 
infantile form of FSHD constitutes a separate entity. 
- The prevalence of FSHD in different parts of the world is quite 
variable, ranging from 1 in 20 . 000 to 1 in 455.000 individuals 
in a population. 
- EMG mostly shows abnormalities thought to be compatible with 
myopathic disorders i.e. an interference pattern with brief, 
small and polyphasic action potentials . Occasionally recordings 
suggesting a neurogenic lesion have been reported . 
- Muscle biopsies often demonstra t e mild changes, that are 
compatible with primary muscle disease . Sometimes inflammatory 
reactions of an impressive degree are found . In a number of 
cases small angulated f i bres are seen, suggesting a neurogenic 
factor in FSHD. 
Finally three negative remarks are pertinent to the definition of 
the present state of kno wledge of FSHD. 
- Factors precipitating the onset of the disease are not known , 
although physi cal exertion has been implied to play a role in 
the development of asymmetric muscle involvement. 
- Association or linkage with a specific disease or genetic 
marker has never been reported. 
- The pathogenesis and the cause of this disease are not known . 
Chapter 3 
The facloscapulohumeral syndrome: 
differential diagnosis of facioscapulo-
humeral disease 
3.1. Introduction 
Van Wij ngaarden and Bethlem (1973) studied several patients 
in whom facial and shoulder girdle muscle weakness and atrophy, 
which was called a facioscapulohumeral syndrome (FSHS), were the 
main features of their disorder. These patients suffered from 
different neuromuscular diseases. The authors concluded that such 
a syndrome is not specific for any disease. Yet the use of the 
term facioscapulohumeral syndrome (FSHS) became en vogue. Some 
authors used the adjective FSH in the literal sense, denoting the 
major sites of muscle involvement. Others (Carroll, 1979) 
confused the issue and used the term FSHS to discuss the 
differential diagnosis of FSHD, thereby including several 
disorders that demonstrate so many particular features in 
addition to facial, scapular and humeral weakness, that FSHD is 
rarely considered. These disorders with remote resemblance to 
FSHD will be mentioned briefly below. In the following sections 
we will discuss only those disorders that may resemble FSHD 
clinically . Shoulder girdle weakness is essential. Detectable 
muscular atrophy is expected if a fair degree of weakness is 
present. Additional weakness of the facial muscles heightens the 
resemblance to FSHD, but it is not obligatory. As peroneal 
weakness may lead to presenting symptoms in FSHD, scapuloperoneal 
(SP) syndromes should be included in the dtfferential diagnosis 
of FSHD. FSHD presenting with pelvic girdle weakness has not been 
reported in the large series of Tyler and Stephens (1950) and 
Becker (1953). Neuromuscular disorders with pelvic girdle onset 
will not be considered in the differential diagnosis of FSHD. 
Patients with myasthenia gravis may exhibit a FSHS in the 
course of their disease (Van Wijngaarden and Bethlem, 1973), but 
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the history and physical examination rarely brings FSHD into the 
differential diagnostic considerations. The two patients of Van 
Wijngaarden and Bethlem (1973) had extraocular weakness as well, 
which excludes FSHD . For similar reasons oculopharyngeal myopathy 
and all other myopathies with extraocular weakness are excluded 
from the differential diagnosis of FSHD . Mobius ' syndrome shows 
other cranial nerve palsies besides facial weakness and skeletal 
deformities in most cases (Henderson, 1939; 
1971). Patients with myotonic dystrophy 
syndrome. Most of these patients have 
Hanson and Rowland, 
may exhibit a FSH 
additional features 
pointing at the proper diagnosis. Serratrice et al. (1969) 
reported on a patient with phosphofructokinase deficiency, who 
had a SP syndrome. He had a history of exercise intolerance. but 
no history of muscle cramps. His deltoid and sternocleidomastoid 
muscles were quite atrophic. These findings should suggest 
another diagnosis than FSHD. The muscle biopsy with biochemical 
and analysis yielded the proper diagnosis. Patients with systemic 
carnitine deficiency (Karpati et al., 1975; Carroll et al., 1980) 
and with muscle carnitine deficiency may exhibit a FSH syndrome. 
Although the clinical presentation may vary considerably, most 
patients demonstrate additional symptoms and signs that exclude 
FSHD. 
3.2. Scapuloperoneal muscular dystrophy 
The question whether scapuloperoneal muscular dystrophy 
(SPD) exists represents a semantic problem. If SPD is defined as 
an autosomal dominantly inheriting primary myopathy with 
involvement of the shoulder girdle and foot extensor muscles. but 
without facial weakness in any patient of the family (Rowland, 
1977). then SPD has never been properly described as will be 
demonstrated below. If one accepts, however, that the definition 
of SPD may include occasional involvement of the facial muscles, 
it is obvious that there is no clear distinction between FSHD and 
SPD, since facial weakness is absent in approximately 20% of the 
affected cases in families with FSHD and foot ex tensor weakness 
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frequently is an early finding. It is probable that the seeming 
distinction between the two conditions could arise when the 
adjective facioscapulohumeral was taken literally as the main 
sites of muscle involvement. 
The adjective scapuloperoneal (SP) was coined by Davidenkow 
(1926) to describe a syndrome that apparently occurred in Russ ia 
only at that time, but has never been observed since. SP 
amyotrophy (Davidenkow, 1939) was said to be an autosomal 
dominant disorder with muscular weakness in a SP distribution and 
sensory disturbances located distally in the extremities. After a 
long discussion, and in spite of the absence of post-mortem 
studies, this syndrome was thought to constitute a separate 
nosological entity standing between FSHD and peroneal muscular 
atrophy . Davidenkow's syndrome, as it was called, will be 
discussed in detail in section 3.6 •• 
Seitz (1957) described a 48-year old Turkish male who 
developed a slowly progressive shoulder girdle weakness since the 
age of 30. By the 45th year the foot extensors became involved. 
Sensory examination was normal. His family was said to be healthy 
but was not examined. EMG and the muscle biopsy findings were 
compatible with a myopathy . Seitz reviewed the literature on this 
syndrome and rejected the sometimes discrete sensory 
disturbances in Davidenkow's cases as criteria for a nosological 
classification because of the subjective nature of the sensory 
examination. He concluded that Davidenkow's cases must have been 
myopathic disorders like his own case, and so the term SP 
muscular dystrophy was born. His conclusion elicited a chain of 
confused and confusing reactions. Some of the confusion can be 
clarified if the chronological sequence of the articles can be 
abandoned . Therefore, the reports on cases with autosomal 
dominant inheritance wil l be discussed first and then those on 
sporadic cases. 
Serratrice et al. (1979) described 14 cases with SP 
myopathy. Seven patients had an onset of symptoms in the shoulder 
girdle muscles, seven in the foot extensors. Two of the four 
sporadic cases and six of the ten hereditary cases had facial 
involvement. Only in one family the facial muscles were spared in 
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all cases (a father and a daughter); the other family members 
were not commented upon. This study lacked family examination 
anyway . It is the more amazing that they reached the same 
conclusion as Ricker and Mer tens did one year earlier (1968) 
namely, that a SP syndrome might be a stage in the development of 
FSHD. 
A similar conclusion was drawn by Kazakow et al. (1975) 
about the famous family K. This family was reported initially by 
Oransky in 1927. All members had shoulder girdle weakness and the 
four affected persons that were examined all had foot extensor 
weakness . Three of them had facial involvement as well. 
Conventional electro- diagnostic examination favoured a myopathy. 
The pattern of inheritance was clearly autosomal dominant. 
Oransky (1927) could not classify this syndrome . He thought it an 
unusual combination of what he called "the proximal scapulo-
humeral or Erb ' s type" and "the distal or Naville's type of 
muscular dystrophy". It is not clear whether he was aware of 
Landouzy and Dejerine ' s publications. In any case, he did not 
mention them. This family was also examined by Davidenkow (1939) 
who found a di screte sensory loss in two cases . Kazakow et al . 
(1975) reexamined this family and found no sensory abnormalities, 
normal peripheral nerve conduction velocities, and a myopathic 
pattern on EMG examination. In his opinion this family suffered 
from FHSD. 
Thomas et al . (1975) reported six patients. In all instances 
the disease started in the foot extensors . Its myopathic nature 
was suggested on EMG examination and muscle biopsy. In two cases 
(mother and daughter) , autosomal dominant inheritance was likely . 
The age of onset was 18 years . Both patients lacked facial 
weakness or cardiac abnormalities. In two other cases there was a 
suggestion of heredity based on anamnestic data, while two other 
cases seemed to be sporadic . The age of onset in those four cases 
varied from 28 to 57 years . One of them had facial weakness : 
three of them (40 , 48 and 57 years old) had cardiac abnormalities 
that could have been caused by ischaemia or by cardiomyopathy. 
Unfortunately , this important distinction could not be made on 
the available data. As the family data also were inadequate, this 
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report was not very helpful in the discussion on SPD. 
The patients reported by MUnzer (1927) , Seitz (1957), 
Hausmanova-Petrusewicz and Zielinska (1962) , Lovelace and Menken 
(1969), and by Steidl and Urbanek (1971) were all considered 
sporadic cases, but in no instance were the families examined. In 
the case of Delwaide and Schoenen (1976), two brothers and two 
nephews were found to be healthy but the parents could not be 
examined. Accordingly, by lack of adequate family examination , 
the existence of sporadic SPD is still an open question. 
Still it is amazing how much attention is paid to unanswered 
questions. Brooke (1977) mitigates the fact that a separate 
section of his book is devoted to SPD by the statement that "in 
approximately one half of the patients there is also associated 
facial weakness and in this instance the differential diagnosis 
(with FSHD) may not only be difficult but irrelevant". The 
recognition of a SP syndrome "lies only in . the fact that other 
illnesses may mimic SPD". Since one half of the patients have 
facial weakness it seems that the term FSH syndrome would do 
equally well. Bethlem (1977) appears rather non-committal about 
autosomal dominant SP myopathy. He wrote that " some authors 
consider this myopathy a variant of FSHD " . He stated that muscle 
biopsy may show moth- eaten or lobulated fibres , a fact never 
reported before and given without reference. Whatever h i s 
opinion, this comment demonstrates once more t hat there is no 
distinction between FSHD and SPD. 
The inference seems fairly well justified that the case for 
autosomal dominant or sporadic SPD as a clinical entity does not 
rest on solid evidence in as much as a proper clinical and 
genetic description has failed to be brought forward. 
3.3. Congenital myopathies 
There are several congenital neuromuscular disorders that 
may present with a FSH syndrome. Because congenital or infantile 
FSHD appears to start with facial diplegia, only Mobius ' syndrome 
seems to be a serious candidate in the differential diagnosis. 
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Both disorders do not present with hypotonia (Hanson and Rowland , 
1971). Mobius' syndrome is characterized by external rectus 
weakness in most cases, is not progressive, and is sometimes 
accompanied by skeletal deformities such as clubfeet or extra 
digits. Congenital or infantile FSHD is a progressive disorder, 
without extraocular muscle weakness and with a positive family 
history in most cases. 
Patients with congenital myotonic dystrophy display facial 
diplegia but the generalized hypotonia , the examination of the 
mother and her family, the laboratory findings, and the clinical 
course did rule out FSHD in most cases so far (Harper, 1979). 
Since Van Wijngaarden en Bethlem (1973) described patients 
with myotubular myopathy, central core disease, and nemaline 
myopathy under the heading of FSH syndrome of early onset, these 
conditions appear regularly on the list of differential diagnosis 
to FSHD (Carroll, 1979). This is why they will be discussed , 
although in most patients with these disorders there are ample 
findings, additional to facial and scapular weakness, to exclude 
the diagnosis FSHD. The three disorders mentioned above are often 
included i n a larger group of diseases arbitrarily called 
"congenital myopathies". These congenital myopathies share a 
particular abnormality on histological, histochemical and 
ultrastructural examination of muscle biopsies . This group 
probably represents heterogeneous diseases and the specifity of 
the various morphological abnormalities is doubted (Brooke, 1977; 
Bethlem et al., 1978). The pathogenetic mechanisms which produce 
the lesions are unknown. Attempts have been made to outline some 
kind of general picture for this group of diseases (Bethlem, 
1977) but, apart from hypotonia af ter birth ("floppy infants") 
wi th delayed motor milestones and type 1 fibre predominance in 
many cases, most other presumed features have too many 
exceptions. Stil l, congenital skeletal abnormalities should raise 
the clinician ' s suspicion with respect to this group of diseases. 
Since myo tubular myopathy, central core disease, and nemaline 
myopathy are most consistently mentioned in relation with the FSH 
syndrome, they will be discussed in more detail. 
Most cases of myotubular or centronuclear myopathy presented 
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as floppy infants. Sometimes the onset of the disease was later 
in childhood and occasionally in adult life (Goulon et al., 
1976). Autosomal dominant (Me Leod et al., 1972), autosomal 
recessive and X-linked recessive modes of inheritance were 
suggested (Van WiJngaarden et al., 1969) . Muscular weakness was 
mainly proximal. Ptosis, extraocular muscle weakness and facial 
weakness were present in about half the cases (Bethlem, 1977). 
Extraocular weakness rules out FSHD. In the rare cases when 
facial and scapular weakness are the main features of the 
clinical picture, the findings on 
differentiate this disorder from FSHD. 
muscle biopsy will 
These findings include 
myotube-like fibres, increased amount of internal nuclei, type 1 
predominance and, occasionally type 1 atrophy. 
Central core disease was first described by Shy and Magee 
(1956) as a congenital autosomal dominant non- progressive 
myopathy. Autosomal recessive (Dubowitz and Platts, 1965) and 
sporadic cases have been reported subsequently (Bethlem and 
Posthumus Meyjes, 1960; W.K . Engel et al., 1961; Bethlem et al. , 
1971; Morgan-Hughes et al., 1973). The main clinical features 
include congenital hypotonia, delayed motor milestones, and a 
mild non-progressive weakness affecting mainly the proximal 
muscles, the legs being more involved than the arms. 
Occasionally, mild weakness of the fae and neck is present 
leading to the designation FSH syndrome. Ho wever, skeletal 
deformities are not uncommon, giving clues to the proper 
diagnosis (Telerman- Toppet et al., 1973). In most cases, type 1 
fibre predominance is found. The condition is named after the 
cores that are almost exclusively present in type 1 fibres . 
Although central core disease is a non-progressive condition 
in most cases, Bethlem et al. (1971) described an eight-year old 
boy with a progressive weakness since his first year of life 
leading to a severe FSH syndrome with almost complete facial 
diplegia and protrusion of the lips. In the muscle biopsy, cores 
were present in approximately 10% of the type 1 fibres . Bethlem 
et al. (1966) also reported cores in a familial non- progressive 
myopathy with muscle cramps after exercise . Therefore, he 
preferred (1977; 1978) to make a distinction between central core 
- 70 -
aisease and diseases with co~es. Since the o~igin and the 
significance of the co~es a~e unclea~, it is unce~tain how many 
diffe~ent diseases a~e included unde~ t he heading cent~al co~e 
disease . 
The te~m nemaline o~ ~od myopathy denotes a congenital 
myopathy with ~od-like st~uctu~es in the muscle fib~es (Shy et 
al., 1963). The patients p~esent with gene~alized hypotonia afte~ 
bi~th, delayed moto~ milestones and muscula~ weakness of the 
t~unk, the shoulde~s, and the pelvic gi~dle . Facial and bulba~ 
weakness is often p~esent leading to difficulties in swallowing 
and sucking and, occasionally, to ~espi~ato~y dysfunction. 
Skeletal abno~malities, such as an elongated face, a high a~ched 
palate , p~ognatism and kyphoscoliosis a~e p~esent in a 
conside~able numbe~ of cases . All these featu~es ~ende~ a 
diagnosis of FSHD unlikely. In most instances the diso~de~ is 
non-p~og~essive. Occasionally a seve~e cou~se may lead to death 
f~om ~espi~ato~y complications . Many ~epo~ts conce~ned spo~adic 
cases, but autosomal dominant and autosomal ~ecessive modes of 
inhe~itance have been desc~ibed (A~ts, 1976; A~ts et al, 1978). 
Of pa~ticula~ inte~est to the subject unde~ study is a 
condition that has been desc~ibed as late onset ~od disease (W .K. 
Engel and Resnick, 1966). In most instances the p~oximal muscles 
we~e mo~e i nvolved that the distal ones, but B~ooke (1977) 
emphasized the clinical p~esentation as a scapulope~oneal 
synd~ome, with foot d~op as an ea~ly sign. He did not comment on 
the facial and bulba~ muscles. As the pathogenesis of ~ods is 
unce~tain and ~ods have been desc~ibed in many othe~ non-
neu~omuscula~ conditions, the nosological place of late onset ~od 
disease and its ~elation with nemaline myopathy ~emains obscu~e. 
In summa~y, the p~esentation of the congenital myopathies 
appa~ently ~a~ely ~aises diagnostic suspicion with ~espect to 
FSHD, as this has neve~ been ~epo~ted . In those cases whe~e 
facial and shoulde~ gi~dle weakness a~e the main clinical 
findings, additional featu~es often point to the co~~ect 
diagnos i s and the muscle biopsy findings will be decisive. 
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3.4. Polymyositis 
Polymyositis is a non-hereditary myopathy of unknown cause 
with a non-infective inflammatory reaction found in biopsied 
muscles. The disorder may run an acute, subacute, or chronic 
course with a varying degree of severity. The problem of the 
classification of the inf'lammatory myopathies and the etiology 
and pathogenesis of polymyositis and dermatomyositis will not be 
discussed. Bohan and Peter (1975), in their excellent review on 
this subject, used four criteria for the diagnosis polymyositis. 
They included the clinical picture , the serum muscle enzyme 
activities, the EMG findings, and the muscle pathology. The 
diagnosis was considered definite if those four criteria were 
met, probable if three, and possible if two criteria were 
present . 
2~!~!~~!_£!~~~£~ 
As an initial symptom, muscle pain or tenderness is present 
in 58% of all cases (Barwick and Walton, 1963) . Muscle weakness 
is mostly symmetrical and i nvolves the proximal limb and the 
girdle muscles in 98% of the cases; the neck flexors and 
pharyngeal muscles are affected in approximately two-thirds of 
the patients (Pearson, 1966) . In more advanced cases (one third 
of all), the distal muscles of the extremities are affected but 
this is rarely the main site of weakness (Wal ton and Adams , 
1958) . Involvement of the extraocular muscles i s extremely rare . 
Facial weakness is reported to develop on the course of the 
disease in 11% of the cases (Barwick and Walton, 1963), but 
facial weakness is rarely an initial sign. This may be the reason 
why very few cases of polymyositis have been reported under the 
heading FSH syndrome. In fact , t he interest in polymyosi t is , with 
regard to the differential diagnosis of FSHD, was only raised 
when muscle biopsies of some cases of FSHD demonstrated extensive 
inflammatory changes (Munsat et al. , 1972) . A rapid course of 
weeks or months, dysphagia, early involvement of the neck 
flexors, and a negative family history , are more compatible with 
polymyositis than with FSHD. Muscle pains play no decisive role 
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as they might occur in both conditions. Only in a few subacute or 
chronic cases one might find no clues pointing to the proper 
diagnosis (Brooke, 1977). 
~~~~~-~~~~~~-~~~~~~~ 
Serum creatine kinase (CK) activity is raised in 64% of the 
cases at the time of presentation (De Vere and Bradley, 1975) and 
is the most useful enzyme to test . The degree of elevation does 
not correlate with the degree of weakness and disability. The 
raised CK activity is an indication for the activity of the 
disease although the CK activitity may be within normal limits in 
patients with a clinical exacerbation of the disease (Brooke, 
1977) . Since serum CK levels in FSHD are normal or only slightly 
raised, one might encounter numerous circumstances in which 
determination of serum CK activity is not helpful for the 
differential diagnosis. 
EMG 
EMG examination in polymositis may reveal increased 
insertional activity and abnormal spontaneous activity such as 
fibrillations , positive sharp waves and bizarre high-frequency 
discharges (pseudomyotonic discharges) (Mechler, 1974) . The motor 
unit action potentials are often short , small, and polyphasic. If 
this complete picture is present , it renders a strong argument 
for the diagnosis polymyositis . But in those cases where 
spontaneous activity cannot be found, FSHD appears equally 
possible . 
~~~~!~-~!~E~l 
The muscle biopsy in polymyositis may show atrophy of both 
fibre types. Perifascicular atrophy in particular suggests 
dermatomyositis, and is thought to reflect ischaemic changes 
secondary to vasculitis. An increased number of fibres with 
internal nuclei is noted, and structural changes such as necrotic 
fibres with phagocytosis, and basophilic fibres with vesicular 
nuclei and prominent nucleoli are often found . Vacuolar 
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degeneration is frequently observed resulting in a practically 
non-staining fibre in routine stains, such as the haematoxilin 
and eosin stain and Gomori's trichrome stain. This is thought to 
be rather characteristic for polymyositis and may be observed in 
50% of the biopsies (Dubowitz and Brooke, 1973). Moth-eaten 
fibres are present in approximately 45% of the cases. An increase 
in endomysial and, later, perimysial connective tissue is 
frequently <35%) noted . Approximately 70% of the cases 
demonstrate some degree of interstitial or perivascular 
mononuclear infiltrations (Dubowitz and Brooke, 1973) . Most 
authors find the inflammatory infiltration or the perifascicular 
atrophy requisite to the histopathological diagnosis . DeVere and 
Bradley , (1975) found the full range of these specific 
pathological abnormalities in 46% of their cases only. Pearson 
(1966) reported the muscle biopsy to be without abnormalities in 
10-15% of his cases. 
The rather ex~ensive inflammatory infiltrations that have 
been described in patients with FSHD (Munsat et al ., 1972) might 
raise a serious problem for the differential diagnosis. Munsat 
suggested that these infiltrations occurred mainly in the initial 
stages of FSHD, but this has never been substantiated. 
Papapetropoulos and Bradley (1974) extended the discussion t o the 
infiltrations sometimes noted in other forms of hereditary 
myopathy and suggested that the inflammatory infiltrations could 
reflect a secondary immunological reaction to the underlying 
muscle degeneration (Currie, 1970, 1971; Caspary et al., 1971) . 
Treatment with prednisone did not influence the clinical course 
in these cases (Munsat and Bradley, 1977). Therefore , a positive 
response to corticosteroids is suggested by some authors as 
another criterion to the diagnosis of polymyositis . 
Dubowi tz and Brooke (1973) stated that fibre hypertrophy 
never was present in cases of polymyositis and suggested that 
this finding, when present, could differentiate FSHD from 
polymyositis. Munsat et al., (1972) did not comment on fibre 
hypertrophy in their cases . Schimrigk (1974), who did note fibre 
hypertrophy in his case, might have used this finding as an 
argument to arrive at a diagnosis. He reported a 36-year old 
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woman with a FSH syndrome, probably of longer duration, who 
complained of a tight, painful feeling in the muscles of her 
calfs. These muscles were not weak. EMG was not reported. Because 
a triceps surae biopsy demonstrated widespread inflammatory 
infiltrations, fibrosis, fibre necrosis, and a varying fibre 
diameter with hypertrophic fibres, the diagnosis FSHD was not 
made, even though the family history suggested a hereditary 
condition. 
A similar problem arose in the case described by Bates et 
al. (1973) . This concerned a 62- year old man with a two year 
history of progressive weakness in the legs, followed by weakness 
and atrophy of the hands and the shoulder girdle muscles. The 
patient denied muscle pains and dysphagia. On clinical 
examination, he also had weakness of the neck flexors. His lower 
facial muscles were affected, but his family denied any change in 
facial expression since his childhood. There was no family 
history of neuromuscular diseases. His relatives were not 
examined. 
Serum CK activity was markedly raised. EMG showed short, 
small polyphasic motor unit action potentials and fibrillations 
on the left deltoid muscle. The motor nerve conduction velocities 
in the left forearm were normaL Biopsy of the right deltoid 
muscle revealed a marked variation in fibre size, with numerous 
atrophic but also a few hypertrophic fibres. Some of the atrophic 
fibres were arranged in small groups, but most of them were 
randomly distributed . Foci of necrosis, phagocytosis and 
regeneration were prominent, and there was significant endomysial 
fibrosis. Several foci of interstitial and perivascular 
infiltration were noted. The condition in this patient was 
diagnosed as polymyositis and he was started on prednisone. This 
resulted in a significant subjective and objective improvement. 
This patient, with a possibly lifelong weakness of the lower 
facial muscles, fits well in the tentative category of FSHD with 
late onset, as outlined by Brooke (1977). These patients are said 
to have significant inflammatory changes in their muscle 
biopsies, but they do not do so well on corticosteroides. 
Examination of the family might have given the answer. 
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Although polymyositis, presenting with a FSH syndrome, 
appears to be a rare occurrence, the 11-year old girl reported by 
Rothstein et al. (1970; 1971) qualifies for this diagnosis. In a 
couple of days she developed muscle pains and tenderness with 
weakness of the facial , shoulder girdle , and upper arm muscles . 
The raised serum CK activity (eight times the upper limit of 
normal), the EMG findings, and the muscle biopsy were all 
compatible with the diagnosis of polymyositis . Hypertrophic 
fibres were not reported. Examination of the parents and three 
siblings was normal. On prednisone, 7 0 mg . daily, only a slight 
improvement of muscle strength was noted . 
The cases reported by Cumming et al. (1977) demonstrated a 
localized nodular myositis . They subsequently developed a more 
classical picture of polymyositis , as in the case reported by 
Heffner and Barron (1981) . The liberal use of the term FSH 
syndrome for cases with dysphagia and dysarthria will never pose 
a problem of differential diagnosis with respect to FSHD. 
In conclusion, one may confidently infer that polymyositis 
presenting with a FSH syndrome is extremely rare. The clinical 
course and the laboratory findings lead to the proper diagnosis 
in most cases. On the other hand, small mononuclear infiltrations 
are rather non-specific findings in neuromuscular disorders, and 
can be quite extensive in FSHD. Examination of family members is 
helpful in many , and is essential in chronic cases. Hypertrophy 
of fibres in the muscle biopsy might argue against the diagnosis 
of polymyositis . 
3. 5. Myopa thies with abnormal mitochondria 
Myopathies with abnormal mitochondria (or mitochondrial 
myopathies) constitute a widely variable group of diseases, 
having in common that the mitochondria in the muscle fibres are 
abnormal in number, size, shape and/or function . The 
morphological abnormalities are studied by electron microscopy 
but abnormal mitochondria can be suspected at light microscopy if 
so-called "ragged red fibres " are present in the modified 
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trichrome stain, or if an excessive reaction or an abnormal 
distribution is found with the oxidative enzyme stains. In many 
cases there is an intracellular accumulation of lipids . The 
morphological abnormalities of the mitochondria appear non-
specific as they are found in many other and unrelated 
neuromuscular disorders as well. Moreover, abnormal mitochondria 
may also be present in disorders that involve other organ systems 
besides muscles, like Kearns -Shy syndrome or ophthalmoplegia plus 
(Kearns and Sayre, 1958; Shy et al., 1967; Drachman, 1968), 
Alpers syndrome or progressive infantile poliodystrophy (Shapira 
et al., 1975) and others (Bradley et al., 1978). 
Most cases of the mitochondrial myopathies were sporadic, 
but all modes of inheritance have been described. Variations in 
ages of onset have been reported and all kinds of clinical 
presentation have been observed, including the FSH syndrome. In 
many instances additional features were present, like salt 
craving, excessive fa tigabili ty, growth retardation, nerve 
deafness, lactic acidosis, loosely coupled stated of oxidative 
phosphorylation or hypermetabolism of non-thyroid origin. Many of 
these findings are believed to be secondary phenomena. More needs 
to be known about the function and pathology of mitochondria 
before a useful attempt at classification can be made. Awaiting 
this knowledge, we will mention some of the reports of cases that 
presented as FSH syndromes. 
In 1967 Van Wijngaarden et al . described a 15-year old boy 
with a progressive limb-girdle syndrome, who was found to have a 
subsarcolemmal accumulation of pathological mitochondria. 
Biochemical analysis demonstrated a loosely coupled 





and extraocular weakness. 
included this patient in 
Van Wijngaarden and Bethlem 
their discussion of the FSH 
syndrome. As extraocular weakness is no part of FSHD, this 
diagnosis will not be considered in such cases. 
D' Agostino et al. (1968) described two sisters with diffuse 
progressive muscular weakness and growth retardation who were 
found to have enlarged and abundant muscle mitochondria. The 
second patient had " a rather expressionless face", suggesting 
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mild bilateral facial weakness. 
The 13-year old patient described by Sp1ro et al. (1970) had 
a congenital non-progressive myopathy, with weakness of the 
proximal 11mb muscles, and slight weakness of the facial and 
sternocleidomastoid muscles. A remarkable feature was his craving 
for salt . There was no history of periodic paralysis. Stains for 
11p1ds and ox1dat1ve enzyme activity were uniformly increased and 
did not permit fibre type differentiation. The mitochondria were 
morphological normal but their numbers were increased. Studied in 
vitro they showed loose coupling of ox1dat1ve phosphorylation. 
The family described by Hudgson et al. (1972) was quite 
remarkable in that the clinical features of the myopathy in this 
family were very similar to FSHD. The disorder inherited in an 
autosomal dominant way affecting males and females, but 
apparently was transmitted only from mothers to children. The 
penetrance of the condition was high . The expression was quite 
variable. Four patients with a normal physical examination had an 
elevation of the serum CK activity . One of them was found to have 
the same pa tholog1cal and biochemical abnormal1 ties in a muscle 
biopsy as his clinically affected relatives. Therefore, these 
four patients were considered to be affected subclinically . Seven 
members of this family were found to be affected on physical 
examination. The ages at onset varied from six to 50 years. At 
the time of examination the duration of the disease ranged from 
six to 19 years. In two cases weakness was noted initially in the 
shoulder girdle, and 1n the pelvic girdle in four cases. In the 
proband's case, the mode of onset could not be decided . Six 
patients had both pelvic and shoulder girdle weakness, and one 
patient had only slight weakness of the h1pflexors. Four patients 
had facial muscle weakness . In addition, the proband demonstrated 
slight wasting of the tongue with dysarthria and wasting of the 
temporal and masseter muscles. There was another patient who had 
dysarthria but no facial weakness. Five out of six patients, with 
upper limb involvement, had sternocleidomastoid muscle weakness 
and two of them also had weakness of the anterior neck muscles, a 
feature Van W1Jngaarden en Bethlem (1973) thought to be less 
compatible with FSHD. Also the other features, such as onset in 
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the pelvic girdle muscles , involvement of the temporal, masseter 
and lingual muscles and dysarthria, strongly suggest a diagnosis 
other than FSHD. 
The serum CK activity was elevated in five clinically 
affected patients ranging from 69 to 426 IU/L (normal up to 60 
IU/L). Taurine excretion in the urine was elevated in three 
clinically affected and in one subclinically affected patient. 
Taurinuria was also found in the two cases described by 
D'Agostino et al. (1968), and mentioned earlier in this section. 
Although muscle is the main source of taurine, and taurine 
excretion rises in acute muscle damage, the relation between the 
taurinuria and this myopathy remained obscure. 
EMG was performed in four cases, showing a myopathic pattern 
in all muscles examined . In one of these cases spontaneous 
fibrillations and positive sharp waves were found in the extensor 
digi to rum brevis muscle. The motor nerve conduction velocities 
were all normaL 
Muscle biopsies were performed in two affected patients and 
in one man who only had an elevated serum CK activity. The 
pathological changes were the same in all biopsies, although less 
pronounced in the asymptomatic patient. The biopsies demonstrated 
a considerable amount of necrotic fibres, a moderate degree of 
fibr osis and infiltration of the fascicles with fat cells. A 
number of large capillaries were present in the areas of 
regeneration. Throughout the biopsy, many fibres demonstrated an 
excessive amount of lipid and an increased oxidative enzyme 
activity. Both fibre types were involved. 
Ultrastructural studies revealed many giant mitochondria, 
often with concentric cristae and small electron-dense 
inclusions, and sometimes with paracristalline inclusions . Some 
small fibres showed abundant and bizarre mitochondria with 
morphological peculiarities like myelin figures and autophagic 
vacuoles. Many more normal looking fibres contained an excess of 
small lipid droplets or large areas of glycogen granules. A 
remarkable finding was the large number of capillaries in the 
affected fibres . A liver biopsy obtained from the propositus 
showed no structural abnormalities of the mitochondria . 
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Biochemical studies of isolated muscle mitochondria revealed a 
loosely coupled state of oxidative phosphorylation (Worsfold et 
al. , 1973). In addition, there was a greatly increased amount of 
muscle lipid , mainly triglycerides. 
Bradley et al. reported later (1978) on one female patient 
of this family who had died due to a viral pneumonia and cerebral 
venous thrombosis, during which she developed gross lactic 
acidaemia. Post-mortem examination showed that the mitochondrial 
morphological abnormality was restricted to the skeletal muscle. 
Another male of this family, who also had the mitochondrial 
myopathy, developed a cerebellar syndrome. His mother, who had 
been affected and had died since Hudgson's et al. (1972) report, 
had suffered from a transient cerebellar syndrome for several 
years, of which only a slight dysarthria had remained at the time 
of examination. In addition, the skeletal muscle carnitine level 
had been investigated in the proband and was found to be normal. 
The pathological and biochemical abnormalities render the 
condition in this family distinct from FSHD. Especially when the 
family is taken as a whole, the clinical picture is different as 
well , although in a more subtle way. 
One may conclude that mitochondrial myopathies may 
occasionally present as a FSH syndrome. Careful clinical 
examination will make FSHD less likely. Additional laboratory 
investigations will lead to the proper diagnosis. 
3.6. Scapuloperoneal muscular atrophy with sensory disturbances 
(Davidenkow's syndrome) 
In 1939 Davidenkow published the data on one sporadic and 26 
familial cases of a condition he named scapuloperoneal (SP) 
amyotrophy . He made 13 personal observations in five families and 
included in his study the large family previously described by 
Oransky in 1927. The disorder was said to be autosomal dominantly 
inherited, and to begin between the age of 17 and 20 years in 
most cases . In some patients the age at onset was as late as 45 
years . Men and women were equally affected . The clinical 
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expression of the disease was quite variable; abortive cases were 
not uncommon. The muscle weakness could start in the upper or in 
the lower extremities, or become manifest in both simultaneously. 
In fully developed cases the pectoralis, trapezius, rhomboidei 
and serratus anterior muscles were affected bilaterally, with 
sparing of the deltoid and levator scapulae muscles. The muscles 
of the upper arms became involved much later in the course of the 
disease and weakness of the hands and fingers was only 
occasionally observed. The facial muscles often participated in 
the process, although this remained limited to an asymmetric 
involvement of the orbicularis oris muscle in most cases. In the 
legs the foot extensor and peroneal muscles usually were 
affected, while the foot flexors and supinator muscles frequently 
were weak as well, but to a lesser degree. In the majority of the 
cases the atrophy did not extend in a proximal direction and the 
muscles of the pelvic girdle remained intact. Pseudohypertrophy 
of muscles was not observed. So far, the description of the 
clinical picture is identical to FSHD. 
Fasciculations were present in two patients (the father and 
his daughter of family "Su" ). Pes cavus, although minimal,was 
frequently found . Sensory disturbances were absent and consisted 
of hypaesthesia and hypalgesia with a distal distribution in the 
limbs. Complaints of pain and paraesthesias were rare . The 
vibration and position senses were intact in most cases. 
Occasionally, perioral hypaesthesia was found. Electrical 
examination of the affected muscles demonstrated a partial 
reaction of degeneration. Muscle biopsies were not performed. 
The nosological place of this syndrome has been disputed 
extensively. In 1927 Davidenkow thought SP amyotrophy to be a 
variety of Charcot- Marie-Tooth disease or peroneal muscular 
atrophy (PMA). In a subsequent article (1939), he noted that the 
pattern of the muscular atrophy resembled the distribution in 
FSHD but that, on the other hand, he had never observed a SP 
syndrome in all the families with PMA he knew. This last 
observation was later confirmed by Ricker et al. (1968) and by 
Dyck and Lambert (1968). In 1939 the nosological place of SP 
amyotrophy remained undecided. In 1954, still lacking 
- 81 -
pathological studies , Davidenkow wrote: "the so- called 
scapuloperoneal amyotrophy occupies a place exactly between the 
neurogenic (peroneal) amyoptrophy and the facioscapulohumeral 
myopathy " . Confirmation of this syndrome by others is s t ill 
needed . A similar condition has not been reported since. In a fe w 
sentences in an earlier report, Eisenlohr ( 1889) mentioned a 
family that might have fitted Davidenkow's description , but t he 
details were scanty . 
There are a fe w reports about similar conditions that we r e 
apparently not inherited in an autosomal dominant way . The 
sporadic case reported by Meadows and Marsden (1969) was a 21-
year old girl with progressive muscular weakness and atrophy 
located dis t ally in all extremities since she was eight years of 
age . Subsequently she developed bilateral infraspinatus weakness . 
The term SP syndrome is hard to justify in this case, because the 
shoulder girdle muscles were certainly not one of the main sites 
of muscle weakness . Sensory abnormalities were absen t . EMG 
revealed neuropathic features, and the motor nerve conduction 
velocities became progressively slower in the course of the 
disease . Muscle biopsy did not show specific abnormalities, wi t h 
the exception of loss of fibres from intramuscular nerve bundles 
and degenerative changes in some terminal nerve fibres, 
suggesting denerva tion. The initial diagnosis, spinal muscular 
atrophy (SMA), was changed to PMA because of the slowing of the 
motor nerve conduction velocities . The authors suggested that a l l 
Davidenkow's cases probably suffered from PMA, ignoring that 
their case did not fit at all in Davidenkow ' s description. 
In 1975 Schwartz and Swash described a 27-year old male with 
progressive weakness and atrophy of the periscapular , triceps , 
biceps and foot extensor muscles . There was a mild bilateral 
facial weakness as well , making the clinical pictur e of a FSH 
syndrome complete . The neck muscles, the deltoid and the extenso r 
digi to rum brevis muscles were virtually uninvolved . All sensory 
qualities were impaired in a symmetrical glove and s t ocki ng 
distribution. The family was not examined, but was reported to be 
unaffec ted . Muscle biopsy and EMG findings were compatible with a 
neurogenic disorder . The sensory nerve conduction velocities we r e 
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slowed, as was the motor nerve conduction velocity in the median 
nerve. Apart from the hereditary aspect, this case fitted 
Davidenkow ' s description quite well. 
Toghi et al. (1971) reported two sibs, a 14-year old boy and 
a 12-year old girl, with progressive weakness and atrophy in a SP 
distribution with onset at the age of seven, and with sensory 
disturbances of glove and stocking type . Pes cavus and quinovarus 
was present bilaterally. EMG and muscle biopsy suggested a 
neurogenic disorder. The motor nerve conduction velocities of the 
ulnar and peroneal nerves were within normal limits. Sural nerve 
biopsy showed demyelination and degeneration of axons. All 
findings were indicative of a neuropathy. Details of the family 
were lacking. The authors presumed autosomal recessive 
inheritance. 
The patient described by Spalke et al. (1976) will be 
mentioned because she was presented as a case of SP amyotrophy, 
although there were some details that made her case different 
from Davidenkow's description. The authors reported a 41-year old 
woman who was noted to have hanging shoulders at the age of 17 . 
When 31 years old she developed, in a couple of weeks, 
progressive weakness of the right foot and toe extensors, 
accompanied by paraesthesias in her right leg. Two years later 
the left shoulder girdle weakened and atrophied in a few months, 
accompanied by cramp-like pain. This muscle weakness gradually 
progressed to a symmetrical FSH syndrome with ptosis and "bouche 
de tapir". At the time of examination the pain in her left arm 
was still present. There was a stocking and glove distribution of 
impairment of pain, temperature and touch sensation. The 
vibration and position senses were normal. Electrocardiography 
revealed a right bundle branch block. EMG showed a myopathic 
pattern. The motor nerve conduction velocities were within normal 
range. Only the sensory nerve conduction velocity of the left 
median nerve was decreased, and histochemical examination of the 
deltoid and anterioir tibial muscle revealed myopathic features. 
The biopsy of the sural nerve showed no histological or 
ultrastructural abnormalities. The father, grand-father, two 
paternal aunts, and one paternal cousin were reported to have 
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problems of gait, suggesting an aut osomal dominant mode of 
inheritance. They were not examined , however. The authors 
concluded that their case could not be classified. Harding and 
Thomas (1980) described an interesting family in which the femal e 
proband showed all features of Davidenkow's syndrome. Her sis t er 
has distal sensory loss and muscle weakness, compatible with 
Charco t-Mar ie- Too th disease (PMA) , while a deceased brother had 
shown generalized weakness of the upper limbs with normal 
strength in the lower limbs . The diagnosis was supported by EMG 
examination. The parents of these three sibs were allegedly not 
affected . Harding and Thomas (1980) suggested that Daviden~ow ' s 
syndrome might be "a phenotypic manifestation of type I 
hereditary motor and sensory neur opathy" (PMA), but they wer e 
unable to prove the autosomal dominant mode of inheritance. 
The discussion on Davidenkow's syndrome, autosomal domi nant 
SP atrophy with sensory disturbances distal l y on the ex t remities , 
can be summarized best by the observation that since the or i gina l 
publications this syndrome has never been descr ibed. 
The sporadic case described by Schwar tz and Swash (1975) and 
the two possibly autosomal recessive cases reported by Toghi et 
al. (1971), and the cases of Harding and Thomas (1980) canno t be 
considered to suffer from the same di sorder . 
3.7. Spinal muscular atrophies 
The spinal muscular atrophies (SMA) have received tremendous 
interest from neurologists and geneticists in recent years . 
Wohlfart et al. (1955) and Kugelberg and Welander (1956) 
separated hereditary proximal SMA from the l i mb- girdle syndr ome . 
Their description can be summarised as follows: 
1. Onset of symptoms from childhood to adolescence. 
2. Proximal muscular atrophy . 
3. Presence of fasciculations . 
4. No bulbar involvement . 
5. Slowly progressive clinical course . 
6. Neurogenic findings on EMG and muscle biopsy. 
7. Autosomal recessive mode of inheritance. 
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Gradually the syndrome, as outlined above, was expanded . 
Magee and De Jong (1960) were the first to describe autosomal 
dominant inheritance. Tsukagoshi et al. (1965) reported adult 
onset and involvement of the bulbar musculature . Numerous 
additional reports on SMA have been published. Several attempts 
at classification have been made (Namba et al., 1970; Emery, 
1971; Pearn, 1981), using the criteria of the clinical picture, 
the age of onset and the mode of inheritance. In some instances 
SMA is part of a more complex clinical picture (Pearn, 1981). 
Although autosomal recessive inheritance is present in most 
cases, no enzyme deficiency has ever been observed with exception 
of a recent report on a young male with hexoseaminidase A 
deficiency (Johnson et al. , 1982) . 
The diagnosis of SMA is based on the clinical picture, on 
the results of EMG, on the examination of muscle biopsies, and 
sometimes, on the study of muscle innervation as well (Coers et 
al., 1973; Coers and Woolf, 1981) . Determination of the serum CK 
activity plays no significant role in the diagnosis of SMA, as it 
is more commonly only slightly raised, and does not discriminate 
SMA from myopathic conditions. 
The clinical picture is that of muscular atrophy with 
fasciculations in the absence of sensory abnormalities. 
Occasionally extensor plantar responses are found (Bouwsma, 
1978). Such findings will never be present in FSHD. Hypertrophy 
of the calf muscles, foot deformities and muscle contractures are 
frequently noted in SMA and very rarely in FSHD. Namba et al. 
(1970) reported cranial nerve involvement (including facial 
weakness) in 17.8% of his cases with juvenile chronic proximal 
SMA and in 31% of his cases with adult onset chronic proximal 
SMA. The fasciculations of the tongue, the bulbar involvement, 
and the tremor of the hands render a confusion with FSHD 
unlikely , even on clinical grounds alone . 
EMG will show spontaneous activity such as fibrillations or 
fasciculations, and motor unit action potentials of long duration 
and high amplitude, with a reduced interference pattern on 
voluntary contraction (Meadows et al., 1969) . Yet, EMG 
occasionally has been found to be normal or even myopathic, as 
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defined in chapter 2 (Emery, 1971). A myopathic pattern is not in 
frequently found in SP- SMA (Kaeser, 1965 , Mercelis et al., 1980). 
Muscle histology reveals atrophy of groups of fibres (group 
atrophy) . Histochemical studies may show type grouping, a 
phenomenon explained by collateral reinnervation of affected 
fibres by normal motor neurons . Particularly in longstanding 
cases, target fibres may be present . In early stages of 
neurogenic atrophy, small angular fibres may be seen, seat tered 
between normal looking fibres, but small angular fibres may also 
be the only abnormality in FSHD . To make the picture even more 
complicated , myopathic features such as variation in fibre size , 
rounded fibres, central nuclei, basophilic fibres, and even 
necrosis and phagocytosis may be found in cases with neurogenic 
atrophy (Drachman et al., 1967; Gardner- Medwin e t al., 1967; 
Mumenthaler, 1970 ; Namba et al., 1970; Achari et al., 1974) . 
These changes are explained as a result of partial and defective 
reinnervation by neighbouring motor neurons . It should be clear 
that the diagnosis of SMA hinges on the laboratory examinations 
in many cases, but that the same examinations could lead to 
faulty conclusions (Mercelis et al . , 1980). 
The most fruitful classification of the SMA 's at present 
appears to be the one proposed by Emery (1981), which is 
presented in a slightly modified form i n Table 3 . 1 . Although the 
facial muscles may be involved in a considerable amount of the 
cases with proximal SMA, and particularly later in the course of 
the disease, the other clinical features and the laboratory 
examinations virtually never bring FSHD in the differential 
diagnostic considerations, even in cases with autosomal dominant 
inheritance. The same holds true for progressive bulbar paralysis 
of childhood or Fazio-Londe disease (Gomez, 1979 ; Bundey , 1981) . 
All 14 reported cases in the literature had facial weakness, but 
they all had involvement of other cranial nerves as well. 
It appears that in the description of SMA the adjectives FSH 
and SP are used in a literal sense, indicating the main sites of 
involvement. Since both adjectives may cover a part of FSHD , it 
is c l ear that FSH- SMA as well as SP- SMA must be considered in the 
differential diagnosis . The cases reported in the literature 
under these 









3 . 2. Cases 
in the 
with a 
cardiopathy will be discussed separately in the next section. 
Mares et al. ( 1964) described a father, his son and two 
daughters all of whom developed a progressive FSH syndrome with 
facial involvement . The age at onset varied from eight to 20 
years. EMG studies performed in all patients showed a reduced 
int erference pattern with action potentials of increased 
amplitude. 
Table 3.1. Classification of the Spinal Muscular Atrophies . 
(modified after Emery, 1981) 
I. Proximal SMA 
A Infantile, autosomal recessive 
~Intermediate, autosomal recessive 
~Juvenile 1 . autosomal dominant 
2 . autosomal recessive a . Usual form 
(Kugelberg- Welander) 
Q_ Adult 1. autosomal dominant 
2 . autosomal recessive 
3. X-linked recessive 
II. Distal SMA 1 . autosomal dominant 
2. autosomal recessive 
b. Ryukyu form 
c . with microcephaly 
III . Juvenile progressive bulbar palsy, autosomal recessive 
IV. Scapuloperoneal SMA 
A. Juvenile 1 . autosomal dominant 
2 . autosomal recessive 
B. Adult 1. autosomal dominant 
V. Facioscapulohumeral SMA, autosomal dominant 
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Table 3.2. Reports on facioscapulohumeral and scapuloperoneal 
spinal muscular atrophies without a cardiopathy 
(only first authors cited) 
FacioscaEulohumeral SEinal Muscular AtrOQh;t 
1. autosomal dominant: Mares 1964 
Fenichel 1967 
Rick er 1968 
Furakawa 1976 
Furakawa 1981 
2. sporadic cases: Furakawa 1969 
Pate1 1969 
KrUger 1974 
Sca2ulo2eroneal SQinal Muscular Atroph;t 
A. Juvenile onset 
1. autosomal dominant: 
2. (autosomal) recessive: 
3 . sporadic cases: 
B. Adult onset 
1. autosomal dominant: 
2. sporadic cases: 
Feigenbaum (cases 1,2 , 3,6) 
Serratrice (cases 1,2,3) 
Feigenbaum (cases 5,7,8) 
Negri 














Feigenbaum (cases 4,9,10) 1970 
Andre 1972 
Hromada 1973 





Serratrice (cases 4,5) 
Fotopulos 
Takahashi (case 2) 






These findings were not specified per patient or per muscle. 
Muscle biopsies revealed myopathic abnormalities in two cases . 
The authors did not arrive at a definite conclusion about the 
primary site of the lesion. 
Fenichel et al. (1967) reported on a mother and a daughter 
who both developed facial weakness at the age of 13, followed by 
shoulder girdle weakness. The deltoid muscle appeared weaker than 
the pectoralis muscle. No fasciculations were observed . Only in 
the daughter the disease had progressed to pelvic girdle muscle 
involvement. Sensory examination was normal. A first EMG in the 
daugh t er was normal, but a repeated study showed increased 
insertional activity and occasional fasciculations in the deltoid 
and biceps muscles without other neurogenic features . A similar, 
though not specified, result was obtained from the mother . Biopsy 
of the left quadriceps muscle in the daughter revealed a few 
angulated fibr es of both fibre types . The neurogenic basis of the 
disorder wa s "identified primarily by the muscle biopsy". Since 
small angulated fibres are known to occur frequently in FSHD , 
this basis appears very small indeed. 
A similar diagnostic problem is posed by the cases described 
by Ricker et al. (1968) . A father and a son were reported with a 
progressive FSH syndrome with facial involvement since the age of 
23. EMG in the son demonstrated myopathic and neurogenic 
features. A muscle biopsy showed myopathic features and isolated 
small angula ted fibres, so that the diagnosis neurogenic FSH 
syndrome appears quite debatable in these cases. 
Furakawa and Toyokura (1976) reported on a mother , her 
daughter and her son, all of whom had developed a FSH syndrome in 
their second decade of life. The tongue and other bulbar muscles 
apparently were normal. A previous biopsy of the left deltoid 
muscle i n the mother was reported to show myopathic features . EMG 
in all three cases revealed fasciculations, and neurogenic and 
myopathic characteristics. Recently (1981) Furakawa et al. 
r eported briefly on 13 patients out of eight families with FSH-
SMA . Autosomal dominant inheritance was said to be present in 
most cases . Electrocardiographic abnormalities were noted in 
several patients, but this was not specified. Details on these 
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patients are eagerly awaited, especially since the diagnosis in 
the cases mentioned before depends heavily on EMG. As small 
angulated fibres are quite common in muscle biopsies of patients 
with FSHD (Dubowitz and Brooke, 1973) and as neurogenic findings 
on EMG in these patients are not rare (McComas, 1977), 1t is 
reasonable to question the existence of autosomal dominant FSH-
SMA. 
A few reports on sporadic cases with FSH-SMA have been 
published. In older literature this syndrome bears the eponyms of 
Vulpian and Bernardt. The deltoid muscles are said to become 
affected early in these cases, which contrasts with the findings 
in FSHD. 
The first patient described by Furakawa et al. (1969) had 
facial weakness and progressive shoulder girdle weakness since he 
was 18 years old. The second patient had shoulder girdle weakness 
only. Both had fascicula tions and neurogenic findings on EMG. 
Muscle biopsy in the first case showed large groups of small 
fibres. No other members of the families were affected. 
Patel and Swami (1969) reported a teen-age case of SMA with 
shoulder girdle weakness and equivocal facial weakness, without 
further elaboration or discussion. 
The 61-year old man studied by KrUger and Frank (1974) had 
facial weakness and a slight ptosis on the right side since the 
age of 55. The shoulder girdle and upper arm muscles were weak 
and atrophic. The deltoids were spared. Fasciculations were 
present in the upper arms. The pelvic girdle and legs were not 
involved. EMG and muscle biopsy supported the diagnosis 
neurogenic muscular a trophy. His family was said to be free of 
neuromuscular diseases, but was not examined. 
The cases of SP-SMA with juvenile onset and with adult onset 
will be discussed separately, in accordance with the general 
principles of Emery ' s classification. The question remains if 
such a division is justified but, so far, all cases belonging to 
one family had either juvenile or adult onset. Sporadic cases are 
all those cases in which the mode of inheritance was uncertain. 
Feigenbaum's (1970) case 2 was the only one with onset of 
the disease in the shoulder girdle muscles. In all other cases 
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the disease started in the peroneal muscles, and ran an ascending 
course, which is not the usual pattern of FSHD. Another 
remarkable feature of SP- SMA is the high incidence of foot-
deformities such as pes cavus and pes equinovarus. Kaeser (1965, 
1975) and Mercelis et al. (1980) emphasized the often conflicting 
findings on EMG and muscle biopsy regarding the primary site of 
the lesion, and the possibility of finding neurogenic features in 
one part of the body and myopathic features in another part on 
EMG examinations. 
Cases with autosomal dominantly inheriting SP-SMA of 
Juvenile onset have been reported by Feigenbaum and Munsat (1970; 
cases 1,2,3 and 6) and by Serratrice et al. (1976; cases 1,2 and 
3). 
A recessive mode of inheritance could have been present in 
three male cases ( 5 , 7 and 8) reported by Feigenbaum and Munsa t 
(1970). The diagnosis in these cases was supported both by EMG 
and muscle biopsy. 
The male patient reported by Negri et al. (1979) was 
mentally retarded. The two living brothers of this patient had 
distal atrophy of the legs, with fasciculations and neurogenic 
findings on EMG. Neither the parents nor the three sisters had 
complaints. 
The pedigree 
Takahashi et al. 
of the f irs t case (a male) 
1974 revealed consanguinity. 
reported by 
The authors 
suggested autosomal recessive inheritance, although no similar 
cases were reported in the family. The patient had a progressive 
SP syndrome since the age of 12 without facial involvement. E1-1G 
showed myopathic features in the lower legs and neurogenic 
features in the upper arms. Biopsy of the gastrocnemius reveal ed 
myopathic changes, while biopsy of the triceps brachii 
demonstrated group atrophy. 
Mercelis et al. (1980) reported on two brothers with SP- SMA. 
In the elder patient, EMG had shown a myopathic pattern on 
several occasions. The muscle biopsy findings in this case were 
equivocal. His younger brother clearly showed neurogenic features 
on EMG and muscle biopsy. Both had presented with foot extensor 
weakness in the first decade. No definite conclusion on the 
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pattern of heredity could be reached in all these recessive male 
cases. 
Sporadic cases of SP-SMA, both males and females, have been 
reported by Emery et al. (1968), Munsat (1968) , Zellweger and 
McCormick (1968), Schuchmann (1970), Feigenbaum and Munsat (1970, 
cases 4,9 and 10), Andre et al. (1972), Hromada et al. (1973), 
and Serratrice et al. (1976, cases 7 and 8). Serratrice's case 
number 9 had sensor'y disturbances and bilater'al extensor' plantar' 
r'esponses . This case was r'ather' deviant fr'om all other' cases and 
cannot be consider'ed a SP- SMA. 
Auto so mal dominant chr'onic SP- SMA of adult onset was fir'st 
descr'ibed by Kaeser' (1964, 1965, 1975). Twelve per'sons (six 
males, and six females) in five generations wer'e affected. Four' 
patients were examined (1965). The disease started between 30 and 
50 year's. Weakness and atr'ophy of all lower' leg muscles wer'e the 
pr'esenting signs . Initially the intr'insic foot muscles , the 
extensor digitorum - br'evis and the plantar muscles were all 
spar'ed. In the fir'st three gener'a t ions the disease had spread to 
involve the thigh and pelvic girdle muscles. In 1965 the shoulder' 
gir'dle muscles were repor'ted not to be affected in these 
generations. In 1975, however' , Kaeser' stated that these muscles 
wer'e slightly affected, although all these patients had died long 
befor'e 1965. Even the four'th gener'ation was r'epor'ted in 1965 to 
be without shoulder girdle involvement. In this generation, one 
patient had weakness of the palatal and phar'yngeal muscles , 
leading to dysphagia. Autopsy was per'formed in this case. 
Shoulder gir'dle, upper' arm and facial weakness occur'r ed only in 
the fifth generation. One patient in this generation also had 
dysphagia and extr'aocular muscle weakness. The distribution of 
the shoulder' girdle weakness was particular in that the 
ster'nocleidomastoidei, the upper par't of the tr'apezius, the 
r'homboidei, the supraspinatus, the infraspinatus and the triceps 
brachii muscles were severely affected, while the serratus , 
deltoid and biceps muscles remained relatively spared. 
EMG studies revealed somewhat different findings on repeated 
examinations, one time thought to be more compatible with a 
chronic neurogenic lesion, the other time with a myopathic 
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disorder. The motor nerve conduction velocities were normal on 
repeated occasions. Muscle biopsy in one case revealed myopathic 
features (1965) . Autopsy in another case showed group atrophy in 
all muscles examined. The anterior horn cells of the spinal cord 
and the bulbar motor nuclei demonstrated vacuolisation and 
central chromatolysis. The peripheral nerves were all normal 
(1964) . In 1977 Probst et al. published another autopsy report on 
a member of this family. The number of anterior horn cells were 
normal at all levels but the anterior horns showed axonal 
swellings, a:ccumulation of possibly pathological lipofuscin and 
large numbers of intra-axonal corpora amylacea. The anterior 
roots, the peripheral nerves and the intramuscular nerve endings 
appeared without abonormalities. The muscles showed selective 
type 2 atrophy, type grouping and accumulation of neutral fat, 
mainly in the type 1 fibres. All the abnormalities found in 
Kaeser's family suggested anterior horn cell disease, yet they 
are distinct from those to be found in chronic proximal SMA 
(Kugelberg and Welander, 1956) in which the number of anterior 
horn cells is reduced considerably. 
The three sibs, presented by Tsukagoshi et al . (1969) pose a 
problem as to the correct diagnosis. One patient had 
"disturbances of superficial sensations in the distal parts of 
the four limbs". Demyelination was present in a sural nerve 
biopsy in this case. EMG and muscle biopsy in the other patients 
were compatible with a neurogenic lesion. A sural nerve biopsy in 
one of these patients was normal. As the father was "probably 
affected" , autosomal dominant inheritance was suggested. In spite 
of the conflicting findings, the authors considered their cases 
to suffer from SMA. Harding and Thomas (1980) however, considered 
these cases to be examples of Davidenkow ' s syndrome. 
Cases 4 and 5 reported by Serratrice et al . (1970) were also 
autosomal dominant cases with adult onset of SMA, and first 
symptoms in the legs. Details on these patients were not offered. 
The first sporadic case with adult onset SP-SMA was reported 
by Fotopulos and Schulz (1966). This 55-year old woman complained 
of weakness in both legs since she was 44. Her condition had 
progressed to a SP syndrome, with weakness of the neck flexors 
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and the sternocleidomastoidei muscles as well. Fasciculations of 
the thigh muscles were observed on one occasion. Sensory 
examination was normal . The family history was negative for 
neuromuscular disorders . EMG showed a neurogenic pattern in the 
legs and a myopathic pat tern in the shoulder girdle muscles . 
Biopsy of the calf muscles demonstrated myopathic features and 
group atrophy. The authors thought their case an intermediate 
between a myopathic and a neurogenic condition and unclassifiable 
in the current taxonomic schemes. Others, like Kaeser (1975), had 
no hesitation in grouping this case under the neurogenic 
conditions . 
The second case, reported by Takahasi et al. (1974), had a 
SP syndrome with a slowly ascending course . EMG of the arms 
showed myopathic findings, and EMG of the legs both myopathic and 
neurogenic features. Biopsy of the quadriceps muscle revealed 
both myopathic characteristics and a feN groups of small fibres . 
The cases 6 and 10, reported by Serratrice et al. (1976) , 
were apparently sporadic . In the first case the disorder had 
started in the legs; in the second case shoulder girdle onset was 
suggested. Details on these cases were not offered. 
One must conclude that the existence of autosomal dominant 
FSH-SMA has not been firmly established. The cases reported as 
such are not (yet) proven to be non-FSHD. Sporadic cases with SMA 
in a FSH distribution have been reported, but are apparently 
rare. SP-SMA is a well established entity . The ascending course 
which is almost invariably present, the lack of facial weakness 
in the majority of cases and the high frequency of foot 
deformities are relative arguments against the diagnosis FSHD . 
Bulbar weakness excludes FSHD . EMG and muscle biopsy may yield 
both myopathic and neurogenic features, making the proper 
diagnosis difficult in a considerable number of cases. 'Ihese 
findings have been explained as the result of dying back of 
terminal axonal twigs (Jennekens, 1975). 
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3.8 . Facioscapulohumeral and scapuloperoneal syndromes with 
cardiomyopathy 
FSH syndromes with cardiomyopathy can be divided in: 
A. X-linked recessive myopathic conditions with muscle 
contractures, in which the cardiomyopathy presents as a 
progressive 
leading to 
impulse generation and conduction defect, 
persistent atrial paralysis (PAP), with 
ventricular hypertrophy in the elderly patients. 
B. Autosomal dominant myopathic conditions with muscle 
contractures, cardiac impulse conduction defects, and 
cardiomegaly. 
c. Neurogenic conditions with impulse conduction defects and 
cardiac enlargement. 
A. Clinical medicine is long since familiar with 
observations that atrial paralysis may occur as a terminal 
condition in myocardial infarction and in hyperkalemia. It also 
can occur as a transient phenomenon in severe sinus arrythmias, 
in anoxia, drug intoxication and in open heart surgery. A 
prolonged and persistent atrial paralysis (PAP) was described for 
the first time in 1965 in a patient with a FSH syndrome 
( Bloomfield and Sinclair-Smith) . Since then PAP has been 
described in sporadic and familial cardiac disorders, with or 
without myocardial amyloid deposits (Allenworth et al., 1969; 
Nagle et al., 1972) . PAP, in association with a myopathy, was 
reported in three sporadic cases (Bloomfield and Sinclair-Smith, 
1965; Caponetto et al., 1968; Baldwin et al., 1973). They were 
all studied by cardiologists who paid extensive attention to the 
cardiac abnormalities but, regrettably, poorly informed the 
readers about the neuromuscular condition. Because PAP is very 
rare, and all three cases were men with a FSH myopathy, it is 
very likely that these patients were suffering from the same 
condition described later as X-linked recessive scapuloperoneal 
myopathy with cardiomyopathy. Moreover, photographs of these 
three patients suggested that they all had abduction contractures 
of the shoulders and flexion contractures of the elbows. Every 
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author offered a slightly different name for the same syndrome: 
X-linked SP syndrome (Thomas et al., 1972) , X-linked scapulo-
humero-d1stal muscular dystrophy (Rotthauwe et al., 1972) , X-
chromosomaler ben1gner Muskeldystroph1e m1t FrUhkontrakturen 
(Camman et al., 1974), X-linked humeroperoneal neuromuscular 
disease (Waters et al., 1975). It is debatable if the family, 
described by Emery and Dre1fuss (1966) under the name "benign X-
linked muscular dystrophy", should be included. This family 
differed from the others by presenting with a 11mb-girdle 
syndrome instead of a SP syndrome, and by the absence of a 
flex1on limi tation of the neck. Since calf hypertrophy was ~bsent 
and PAP was suggested in two cases, this family is usually 
included in the description of the X-11nked SP syndrome with 
cardiomyopathy (Rowland and Layzer, 1979). Rowland et al. (1974) . 
even suggested the name "Emery-Dre1fuss muscular dystrophy" while 
describing an extensively studied sporadic case. 
The disorder u~ually manifests itself between the age of two 
and ten years, affecting males only. The reported pedigrees are 
compatible with X-linked recessive inheritance. In the family 
reported by Thomas et al. (1972), the disorder was linked w1 th 
deutan colour blindness. The 1ni tial signs were flexion 
contractures of the elbows, accompanied (or followed within a few 
years) by ankle contractures. Upper arm weakness and atrophy was 
an early finding in all families, except 1n the one of Emery and 
Dre ifuss. In this family pelvic-femoral weakness appeared early, 
progressing to a 11mb-girdle syndrome. In the other families the 
upper arm and peroneal weakness was conspicuous, while the 
periscapular muscles were less affected. Several pa t1ents w1 th 
mild facial weakness were present in all families. Accordingly, 
it 1s quite understandable that the sporadic cases were described 
as a FSH svndrome. Lack of muscle hypertrophy and early muscle 
contractures were other features that distinguished t his syndrome 
from benign X- linked recessive muscular dystrophy (Becker type). 
Elbow and ankle contractures were early signs. Limitation of 
flex1on of the neck and bending of the back were present in all 
families, except 1n the one reported by Emery and Dreifuss 
(1966). Abduction contractures of the shoulders were mentioned or 
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were suggested from photographs in all families . Pes cavus was 
frequently encountered . EMG revealed a myopathic pattern in most 
patients. In one patient of Thomas' family and in several 
patients of the two families examined by Waters et al. large 
motor unit action potentials of long duration were found. Motor 
and sensory nerve conduction studies, when made, were normal in 
all cases. Muscle biopsies revealed myopathic changes . Rotthauwe 
et al. (1972) found type 1 predominance in his two biopsies. 
Waters et al . (1975) found type 2 predominance and type 1 
atrophy. Because of the EMG and biopsy findings, these authors 
remained undecided on the primary lesion in their patients. Post-
mortem studies, carried out on one patient of Thomas' family, 
confirmed the myopathic nature of the disorder. The peripheral 
nerves were found to be normaL The spinal cord, unfortunately, 
was not examined . Histological examination of the heart in this 
case showed "extensive fibrous replacement of the myocardium" . 
The cardiological examination in these families remained 
mostly limited to physical examination and an electrocardiogram 
(ECG). Only the report of Waters et al. (1975) on two families 
furnished quite extensive data. The cardiac abnormalities started 
later in life than the myopathy, and consisted of a progressive 
slowing of the pulse generation and conduction, leading to a 
progressive bradycardia. Complaints of dizziness or syncope were 
rare. Most patients were aware of the progressive slowing of 
their pulse. ECG was made of all 15 affected patients. No ECG was 
normal. P-wave abnormalities with a first degree atrio-
ventricular (A-V) block were present in four patients, atrial 
flutter in one, atrial fibrillation in two, a complete A-V block 
in one, atrial fibrillation with complete A-V block in three, and 
PAP with a slow junctional pacemaker in four patients. Emery and 
Dreifuss (1966) and Rotthauwe et al. (1972) reported similar 
findings although several ECG's were normal. In the other 
families (Thomas et al., 1972; Camman et al., 1974), ECG's were 
registered in a limited number of cases. They revealed conduction 
defects but no PAP . 
Five of Water's patients underwent echocardiography and 
cardiac catheterisation. Two patients with normal ventricular 
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rates had a normal ventricular function. Three patients, with 
chronic bradycardia secondary to PAP, had a marked increase in 
the left ventricular end-diastolic volume and left ventricular 
mass. These patients had demonstrated cardiomegaly on physical 
examination. The authors suggested that these findings indicated 
a compensatory physiologic response to the profound bradycardia 
of long duration, and not intrinsic ventricular myocardial 
disease. 
Thomas et al. (1972) did not comment specifically on the 
condition of the atria in their autopsy report. Therefore, the 
selected degeneration and the fibrosis of the atrial myocardium, 
suggested as an explanation for PAP (Waters et al. 1975), still 
need pathological documentation. It is important to secure the 
diagnosis PAP during life by as many criteria as possible. They 
are: 
1. Absence of P-waves on regular, oesophageal and intra-
cardiac ECG's. 
2. Supraventricular type of QRS. 
3. Absence of A-waves on jugular venous pulse on right 
atrial pressure tracings. 
4. Inability to stimulate the atria electrically. 
5. Immobility of the atria on echocardiography, fluoroscopy 
and cineangiography . 
The necessity of cardiac catheterisation is debated. 
However, the inability to stimulate the atria is conclusive. It 
may be hard to make the diagnosis on an ECG alone . 
Most patients die suddenly at an early age. Rotthauwe et al. 
(1972) reported sudden death between 37 and 59 years of age. 
Waters et al. (1975) recommended "on-demand" ventricular 
pacemaker insertion in patients who have ventricular rates below 
50 beats per minute. 
B. The father and his three children reported by Chakrabarti 
and Pearce (1981) suffered from a neuromuscular disorder with 
progressive contractures of the neck and limb muscles. All four 
patients had a SP syndrome with normal facial muscles. 
Histological examination of a muscle biopsy in one child and a 
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normal spinal cord on post-mortem examination of another child 
suggested the myopathic nature of the condition. The mode of 
inheritance appeared to be autosomal dominant with late onset in 
the father, but early onset (before the age of three) in his 
children, which makes this condition distinct from the X-linked 
recessive myopathy described above . The cardiac abnormalities 
were present in the father and in two of the children, and 
included atrial fibrillation, left bundle branch block, absence 
of P waves with a nodal escape rhythm and complete heart block, 
leading to cardiomegaly and heart failure. On the basis of this 
information, the disorder in this family appears to be an 
independent entity . 
c. The patients reported by Mawatari et al. (1973), 
Takahashi et al. (1974) and Jennekens et al . (1975) constitute a 
different group of diseases. Mawatari et al. (1973) examined 
three male patients with a scapulo(humero)peroneal syndrome . The 
age at onset varied between seven and ten years . Two brothers had 
a restriction of neck flexion, ankle contractures and complete A-
V block with bradycardia on EKG examination. The other patient (a 
maternal cousin) had ankle contractures and an incomplete right 
bundle branch block, with left axis deviation on his ECG . Two 
other maternal cousins had peroneal weakness, wi th atrophy and 
ankle contractures. They were not examined cardiologically. Two 
of the mothers of these patients had a first degree A- V block, as 
did the patients' maternal grandmother. The most likely mode of 
inheritance appeared X- linked recessive with slight expression in 
the carriers, but autosomal dominant inheritance with variable 
expression could not be ruled out . EMG and muscle biopsy were 
compatible with a neurogenic condition. The motor nerve 
conduction velocities were normal. 
The last two patients (two brothers) presented by Takahashi 
et al. (1974), under the title "Scapuloperoneal dystrophy 
associated with neurogenic changes" , appeared to be the same as 
the ones reported by Takahashi et al. in 1971. These patients 
developed progressive muscular atrophy when 11 and 12 years old. 
No other members were said to be affected, but they were not 
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examined. Since every mode of inheritance was possible, this was 
not discussed. Contrac tures were not present in these patients. 
Bulbar muscular weakness with facial involvement appeared between 
the 40th and 50th years. Syncopal episodes and palpitations were 
reported after the patients had passed the 35th year . Both 
patients had a complete A-V block with high T-waves and 
bradycardia on their ECG' s . Chest X-rays showed cardiac 
hypertrophy . EMG and muscle biopsy demonstrated both myopathic 
and neurogenic features. One of these patients sustained a 
cerebral infarction. He died four years later. Post-mortem 
examination showed the anterior horn cells of the spinal co~d to 
contain a large number of lipofuscin granules, but the number of 
cells seemed normal at all levels. In the brainstem the facial 
and hypoglossal nuclei were well preserved, except for a few 
atrophic cells. The tongue demonstrated abundant myopathic 
changes without neurogenic features. The hear t revealed many 
atrophic fibres of variable size, located mainly in the 
subendocardial and subpericardial tissue . The authors considered 
a decision as to the primary site of the lesion imposs i ble. They 
regarded the myopathic changes too extensive t o be explained as 
secondary phenomena. The spinal cord was normal and a peripheral 
nerve les ion seemed unlikely, because of the normal sensory 
examination. Unfortunately, no nerve conduction studies were 
undertaken, no nerve biopsy was done, and the nerves were not 
examined at autopsy . A peripheral nerve lesion, t herefore, cannot 
be ruled out. Nonetheless, the authors suggested that dying back 
of terminal axonal twigs might explain the phenomena encountered . 
Jennekens et al. (1975) suggested a similar mechanism to be 
present in two families (26 patients) with an autosomal dominant 
"scapulo-ilio-peroneal syndrome with cardiopathy". Among the 16 
examined patients, the age of onset varied between 17 and 42 
years. The bulbar muscles and the neck flexors were affected in 
approximately a third of all patient s . Occasionally facial 
weakness was noted. Contractures were absent . ECG changes 
developed gradually from nonspecific findings to abnormalities of 
pulse-formation and conduction. PAP was not encountered, 
Radiological examination demonstrated cardiac hypertrophy and 
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left hemidiaphragm elevation in many cases . EMG showed neurogenic 
and myopathic characteristics. Although most muscle biopsies 
demonstrated group atrophy, the myopathic features were quite 
extensive with a remarkable interstitial and perivascular 
inflammatory reaction in four out of eight biopsies. 
Immunological tests were normal and did not support the thesis 
that the i nflammatory reaction could be considered a secondary 
immunological response to the underlying muscle degeneration 
(Papapetropoulos and Bradley 1974). Genetic studies using 19 
genetic markers failed t o demonstrate linkage . 
The findings o n clinical and laboratory examination made the 
families of Mawatar i et al., Takahashi et al., and Jennekens et 
al. not quite comparable . Also, the mode of inheritance was 
different in all families as far as this could be ascertained. 
Possibly all these reports deal with different diseases. 
In summary, X- linked recessive SP myopathy with 
cardiomyopathy appears an independent , well defined, and quite 
consistent entity. The mode of inheritance, and clinical 
features , such as muscle contractures and a progressive cardiac 
conduction defect leading to the rare syndrome of persistent 
atrial par alysis, make this syndrome distinct from FSHD. Although 
the adjective FSH would fit this syndrome equally well, it 
appears appropriate and in accordance with the 11 terature to 
continue to call this syndrome X-linked recessive SP myopathy 
with cardiomyopathy . A similar disorder without documented PAP 
but with an autosomal dominant mode of inheritance has been 
reported. 
Other FSH syndromes with cardiomyopathy have been described. 
Bulbar and facial ···eakness were present only occasionally . All 
modes of inheritance have been suggested. Neurogenic 
abnor malit ies were present in all cases, but in several reports 
the myopathic features were so extensive that the authors could 
not reach a conclus i on about the primary lesion. The findings 
were similar to those found in cases described as chronic adult 
SP- SMA . 
- 101 -
3.9. Summary 
Sporadic cases with FSH myopathy have been repeatedly 
documented (Walton and Gardner-Medwin, 1981). Autosomal dominant 
SP myopathy without involvement of the facial muscles has never 
been reported, autosomal dominant SP myopathy with facial 
weakness is indis tinct from FSHD (Kazakow et al., 1975). The 
families of the sporadic cases with SP myopathy are not examined 
exhaustively, or not at all. Even without this information, it 
appears that there are no good grounds to consider SP myopathy a 
separate and independent entity . 
Many disorders are reported to resemble FSHD at some stages 
of their courses. Yet all these disorders reveal additional, 
though sometimes minimal signs pointing at their proper 
diagnosis. The examination of families renders important clues tQ 
the diagnosis. Autosomal dominant inheritance is suggestive for 
FSHD . In cases where the family cannot be examined, one has to 
rely heavily on laboratory studies such as EMG and muscle biopsy 
and , occasionally, on biochemical studies . But even in autosomal 
dominant cases, additional studies may be necessary to rule out 
neurogenic conditions and rare disorders such as mitochondrial 
myopathies . 
Polymyositis presenting with a FSH- syndrome is rare. The 
correct diagnosis is important because it could involve 
therapeutic measures like corticosteroids. The diagnosis might be 
difficult to make as occasionally extensive inflammatory 
reactions are present in muscle biopsies of patients with FSHD 
(Munsat et al., 1972) . Mitochondrial abnormalities will be 
suspected on histochemical studies of muscle biopsies, although 
the clinical picture may have suggested already that FSHD is a 
less likely diagnosis (Hudgson et al., 1972). The existence of 
autosomal dominant FSH-SMA has not been established beyond doubt. 
The small angulated fibres and the neurogenic features on EMG in 
these cases are reported in FSHD as well. None of the patients 
had group atrophy or target fibres in their muscle biopsies. 
Sporadic cases of FSH SMA have been recognised since the end of 
the nineteenth century . This disorder necessitates labora tory 
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studies in sporadic cases. SP-SMA appears to be a well 
established disorder. The clinical course is an ascending one. 
Laboratory studies may sometimes reveal myopathic features in 
some muscles and neurogenic features in other muscles. 
Fasciculations and foot deformities, if present, are relative 
arguments aga inst FSHD . Autosomal dominant SP amyotrophy with 
sensory disturbance (Davidenkow's syndrome 1927; 1929; 1930; 
1939) has never been observed since the original descriptions . 
Sporadic and possibly autosomal rec;:essive disorders resembling 
Davidenko w' s syndrome have been reported. The sensory 
abnormalities exclude FSHD . X-linked SP syndrome with 
cardiomyopathy differ from FSHD by their mode of inheritance, the 
cardiac conduction disorders, and by the clinical picture of 
muscular atrophy with rather extensive muscle contractures. Both 
myopathic and neurogenic conditions have been reported, but also 
conditions in which the primary lesion could not be decided upon. 
Thi s svndrome might turn out to be heterogeneous. Also a similar 
disorder with autosomal dominant inheritance has been reported 
recently (Chakrabarti and Pearce, 1981) . More important to the 
differential diagnosis of FSHD are the t wo families reported by 
Jennekens et al . (1975) with autosomal dominant neurogenic 
muscular atrophy and progressive cardiac pulse formation and 
conduction defects . Most muscle biopsies showed group atrophy, 
but myopathic changes and inflammatory reactions were extensive 
on occasions that confusion with FSHD seems quite possible, if 
the results of muscle biopsies only are taken into account. Only 
a few of these patients had facial weakness. 
Thus it appears that there is a fairly limited differential 
diagnosis of FSHD . Facial and shoulder girdle weakness, being the 
most conspicuous findings on clinical examination, are in them-
seJ.ves rather unspecific . The term FSH syndrome serves no other 
purpose than to summarize the physical examination of a patient. 
Chaprer4 
Facioscapulohumeral disease: personal 
observations 
4 . 1. Introduction 
The general clinical picture of FSHD is fairly well 
established but the extent and the limits of the disease are no t 
clearly defined . Moreover, several issues , such as possible 
differences between males and females, the poss i bility of 
environmental influences on the mani festation of the disease , the 
problem of genetic heterogeneity and others, are still unsettled. 
In order to study the var ious aspects of FSHD we star t ed 
with the pro bands of 19 families. The terms family and kindred 
will be used as synonyms in this study . The pro bands of the 
families B, C, D, E, F,G , J,K,M , N, P,R and S wer e all known a t the 
Muscle Research Center of the University of Amsterdam (Head Prof. 
Dr . J. Bethlem). The pro bands of the kindreds H, I , L, were seen 
regular l y at the Neuromuscular Clinic of the University Hospi tal 
of Leiden (Head Dr . A.R. Wintzen) . The pro banda of t he families 0 
and Q were known at the Neurological out-pa t ient Department of 
the University of Amsterdam (Head Dr. J. van Manen). The 
Department of Human Genetics of the Free University of Ams t erdam 
(Chairman Prof . Dr . A. W. Eriksson) referred the proband of family 
A to us . This patient was subsequently studied at the Muscle 
Research Center of the University of Amsterdam. 
We reconstructed the pedigrees from a namnestic data, 
checking and expanding this informa t ion through the records of 
the registrar ' s office, to which our genealogist (Mr. L. P. Kuij t) 
had easy access. As many members of t he families as possible were 
visited by the author at their homes and examined as extensively 
as possible, this being the only available method by which to 
determine whether someone is affected or not (Walton and Gardner-
Medwin 1981) . The persons examined are indica t ed i n the 
pedigrees . 
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The support of the family doctors involved in this study was 
uniformly very positive. The patients varied in their degree of 
cooperation: only a few refused to be visited, most patients 
being eager to talk about the disease and about their families. 
The information regarding others, and especially more distant 
relatives, proved to be quite unreliable and confirmed earlier 
experiences of authors such as Tyler and Stephens (1950) . Several 
patients refused a complete physical examination, the reasons for 
such refusal varying . However, all these patients could be 
persuaded to perform several tests of muscle function. 
In a single visit it is impossible to assess what it means 
to each individual pat i ent to have such a disease and, while 
examining the families, all kinds of reactions relating to the 
disease were observed . Some people were anxious to have 
confirmation that they were not affected, others sought the 
denial of an evident diagnosis . One unaffected person had made 
his family believe he had the same disease from which his father 
suffered, and he thought himself unfit to work. Many patients 
dissimulated their disabilities. It was interesting to note that 
a reluctance to a physical examination was never observed in the 
non- affected family members, while this reluctance was present in 
several of the asymptomatic patients. It was also impossible to 
know the real import of questions such as "Do I have the 
disease?" or "Is he or she affected?" . On several occasions it 
was observed that the mechanisms of suppression and distortion of 
facts were quite strong. Also depressions and forced cheerfulness 
testified to the impact of this disease on the patients' 
existence. 
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4.2. The patients 
One hundred and ninety individuals in 19 kindreds were 
examined at their homes (Table 4.1.). One hundred and seven gene 
carriers were identified . One hundred and eighty-nine persons are 
indicated in the pedigrees. The one person, that is not shown, is 
the mother of patient H V 20. 
Table 4 .1. All persons examined in 19 kindreds with FSHD. 
Affected Possibly Not 
Affected Affected Total 
Completely examined: males 46 3 41 90 
females 28 2 31 61 
Partially examined: males 13 2 15 
females 20 4 24 
107 5 78 190 
"Completely examined" means that the strength of all muscles 
or muscle groups described in Table 4.12. was graded. "Partially 
examined" indicates that not all muscles could be graded 
properly. This group includes severely affected patients, who 
refused a complete physical examination, but also obviously 
affected persons who refused to take off their clothes. '!heir 
muscles could be tested to a variable extent. All but one of 
these 33 patients had definite facial weakness. Testing of the 
facial muscles was never refused. The one patient without facial 
weakness was among a group of patients who were examined 
completely but in whom the grade of muscle strength was not 
recorded; therefore they were included in the group of "partially 
examined" patients . Six partially examined persons refused to 
take off some of their clothes, but they could be examined 
sufficiently so as to convince the examiner that they were not 
affected. 
Three males (A IV 13, K V 23, K V 24) and two females (K V 
2, P II 1) were considered "possibly affected" . Physical 
examination did not reveal muscular weakness or a distinct 
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atrophy, but the history (patient P II 1, see section 4 . 22.) or 
the habitus of the patients (for instance an increased lumbar 
lordosis, a protruding belly , sloping shoulders, protruding 
scapulae or an increased distance between the medial borders of 
the scapulae with endorotation of the arms) was sufficient t<o 
raise the examiner's suspicion. 
Table 4.2 . gives all "possibly affected" persons in the 
kindreds. Persons not examined or deceased were designated 
"possibly affected" if the several sources of information within 
the families were not conforming . 
Table 4.3 . shows the number of all known patients. The not 
examined and the deceased patients all were recognisably 
affected. 
Table 4 .2. All "possibly affected" persons in 19 kindreds with 
FSHD. 
Examined Not Deceased Total 
Examined 
Males 3 2 5 10 
Females 2 6 8 16 
5 8 13 26 




patients . Table 4 . 4. 
decade. 
Examined Not Deceased Total 
Examined 
59 7 29 95 
48 16 22 86 
107 23 51 181 
represents 
gives the 
the ages of the examined 107 
numbers of patients per age-
The average duration of the disease at the time of 
e xamination {27 .9 years) is based on anamnestic data of the 73 
symptomatic patients and represented in Figure 4.2 •• The average 
duration in males was 27.8 years and in females 29 . 9 years . 
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FIGURE4.1 : AGES IN YEARS OF 107PATIENTS WITH FSHD(59MALES. 48FEMALES) 
• FEMALE 
0 MALE 
FIGJRE4.2:DURATION OFTI-EDEASE IN YEARSI46MALES, 27FEMA1£S) 
2 6 10 :a4 44 52 56 
• FEMALE 
0 MALE 
Table 4.4. Number of patients per age-decade. 
Decade 1 2 3 4 5 6 7 8 9 
Males 1 8 10 12 8 12 6 2 0 
Females 0 3 8 9 5 9 9 3 2 





In order to study phenomena such as penetrance and age of 
onset , we considered separately those sibships of which it could 
be reasonably assumed that all affected individuals had been 
identified. All these sibships had one definitely affected 
parent, with the exception of sibship P III . P II 1 must possess 
the abnormal gene, but she was completely healthy, when examined 
at the age of 68 years. The sibships were examined as extensively 
as possible . Because several authors (Tyler and Stephens 1950, 
Becker 1953) claimed that it was impossible to make the diagnosis 
before the age of seven, sibships consisting entirely of children 
in their first decade were excluded, with the exception of 
patient J VI 3, who was a nine-year old asymptomatic case . The 
sibships involved, indicated by their eldest representative, were 
A III 1, A V 4, A V 8, A V 14, B III 1, B IV 1, C III 1, D III 
1 0 , E II I 1 , E IV 1 , E V 1, F IV 1 , G III 17 , H IV 3, H V 7 , H V 
• • 82 
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16, H V 20, H VI 1, I V 6, I V 25, I VI 10, I VI 21, J III 1, J 
IV 1, J IV 27, J IV 38, J V 6, J V 15, J V 19, J V 23, J VI 3, K 
III 12, K III 18, K IV 1, K IV 15, L IV 8, L IV 40, L V 6, L V 
10, LV 14, LV 83, M III 8, N IV 14, 0 III 6, P III 1, P IV 1, Q 
III 1, S III 1 and S IV 4. Only kindred R yielded no useful 
sibships as no sibship could be examined entirely . Sibship 0 III 
6 consisted of the proband only. Also the probands in the other 
sibships (eleven males and four females) have to be excluded 
because of the bias of ascertainment. The same bias is present in 
the affected parents and grandparents of the probands as they are 
obligatory gene carriers. The numbers of individuals in these 49 
sibships are shown in Table 4.5 •• 
Table 4.5. Fbrty-nine sibships with FSHD in 17 kindreds. 
Males Females Total 
Pro bands 10 4 14 
Obligatory gene carr>iers 3 3 6 
Affected sibs 44 41 85 
Not affected sibs 37 43 80 
94 91 185 
Figur>e 4.3. gives the distribution of the ages of all sibs 
involved, without the pr>obands and the obligatory gene carrier's. 
The ages r>ecorded are the ages at the time of this study if they 
were alive, or> the ages at their death. 
AGURE4.3: .AGES IN YEARS AT EXAMINATION OR OF DEATH OF 165 SIBS(81MALES. 84 FEMALES) IN 49 
SIBHIPS(17KINDREDS) IPROBANDS AND OBUGATORY GENE CARRIERS EXCLUDED) 
MALES 
FEMALES 0 NOT AFFECTED 
C AFFECTED ASYMPTOMATIC 












Tabl e 4 . 6 . Number o f s i bs per age-decade 
(probands and o bliga t ory gene carriers excluded) 
Malee Pemalea 8oth sexes 
Not Not Not 
Affected Affected Total Affected Affected Total Arreeted Af f eete<S 
aympto asympto sympto asympto sympto asympto 
mat le :aat1c mat le ID& tie matte mat1c 
0 I I 2 0 0 I I 0 I 2 
3 4 6 13 0 3 3 6 3 7 9 
6 3 10 19 3 5 13 21 9 8 23 
5 I 7 13 7 3 8 18 12 4 15 
5 I I 7 4 I 5 10 9 2 6 
9 I 5 15 2 3 7 12 11 4 12 
3 1 5 9 2 5 4 11 5 6 9 
I 0 2 3 2 0 2 - 3 
0 4 











Table 4. 6 . g ives the n umbers of the patients with symptoms, 
of those without symptoms, and t he numbers of the unaffected sibs 
per age-decade . J oint and muscle pains and inabil ity to whistle 
were not accepted as diagnostic symptoms. Inability to whistle 
was never a spontaneous complaint . Onl y patients without 
compla i n ts r elated to muscl e weakness are included in the 
asympto matic group. There was only one affected female in the 
ninth de cade: she is no t considered in this tabl e because the 
i nfo r mation is too limited to draw any conclusions for this 
decade . 
The r elative frequencie s of the symp tomatic, the 
asymptomati c , a nd the not aff ected s i bs are given in the Figures 
4 . 4 . a nd 4. 5 . • These diagrams will be referred to later in the 























FIGURE44: PERCENTAGE OF AFFECTED AND NON·AFFECTED SIBS PER AGE GROUP 
(164 5185, BOTH SEXES) 
AGE IN YEARS 
0 NOT AFFECTED 
~~~~~~AFFECTED, ASYMPTOMATIC 
~AFFECTED, SYMPTOMATIC 
FIGURE4.5: PERCENTAGES OF AFFECTED AND NON ·AFFECTED 
SIBS PER AGE GROUP(164 SIBS: 81MALES,83FEMALES) 
MALES 
AGE IN YEARS 




4 . 3 . The kindreds 
The pedigrees are shown in the following pages. Details 
about the ancestors and other parts of the family, not studied by 
us, will be mentioned briefly if relevant. The living members of 
the families will be discussed only if they demonstrated 
remarkable features. 
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LEGENDA 
2 m• Affected male; sib number2; generation number3 
0 Not affected female 
~ Possibly affected male 
0 Sex unknown 
m Twomales 
Q Childless marriage 
9 Offspring not explored 
0 ;0 Consanguineous marriage 
db Di- zygotic twins 
/ Proband . 
S Single 
A Asymptomatic 
tJ Completely examined by the author 
6 Partially examined by the author 
[5 Examined by others 
* Year of birth 
t Year of death 
J2f. Male deceased at the age of 2 years 
2 
2m Male deceased at the age of 2 months 
2d Male deceased at the age of 2 days 






Kindred A: This kindred was ascertained through the proband V 14, 
who sought genetical advice. A definite diagnosis could not be 
made in his son (VI 13). II 1 was said to have had shoulder 
girdle weakness. Nothing is known about her two brothers and two 
sisters. III 1 suffered from severe pelvic girdle weakness. Her 
brother III 5 had died in his teens and her sister III 7 had 
emigrated to the USA: patient IV 3 thought they both had been 
affected. This could not be confirmed since no one else in the 
fourth generation had known these persons. Patient IV 10 was 
quite remarkable because he had severe neck extensor weakness; he 
could not keep his head constantly upright, which is definitely 
exceptional in FSHD . There was only one abortive case in his 







Kindred B: Patient II 1 died at the age of 59 after "a heart 
attack which was related to her thyroid disease" . Details were 
not available. According to her children and to III 13, her t wo 
brothers and her parents were not affected. III 1 and III 6 had 
been examined ten years previously . At that time no facial 
weakness was noted ; this was clearly present when they were 
examined by us . 
c 
I 
Kindred C: I 2 was an Indonesian woman. No thing is known about 
her family. It was said she could not walk proper ly at advanced 
age, but II 6 was not sure she was affected. I 1 was a tall and 
strong professional soldier. The proband's brothers and sisters 





Kindred D: The proband's father (II 5) claimed to be the first 
one in his family with muscle disease . No one else of his 
generation could be examined. Biopsy of the right deltoid muscle 
of the proband (III 11) revealed no abnormalities. EMG of the 
shoulder girdle muscles showed a myopathic pattern in the left 
deltoid muscle only. II 5 had chronic heart failure, generalized 
atherosclerotic vascular disease, and anticoagulation therapy for 
an aorta bifurcation prosthesis. A muscle biopsy was not 
performed. The diagnosis in this family therefore, is largely 







Kindred E: Patient II 2 was said to be the only one of his 
generation who was affected. His first symptoms became apparent 
around the age of 25 and were those of foot extensor weakness. 
His parents had no complaints of muscle weakness. His daughter 
(III 1) also noted symptoms of foot extensor weakness first. She 
was 38 years at that time and had never been able to whistle. Two 
years later she noted shoulder girdle weakness. Her sister had no 
symptoms but turned out to be affected. In her son (IV 1) the 
disease manifested by symptoms of shoulder girdle weakness at the 






Kindred F: The information given in this pedigree is based on the 
family records of the probrand (III 3), and could not be checked, 
because the ancestors came from several small towns in Germany, 
close to the Dutch border. I 1 was said to have been a strong 
man, member of the German Imperial Guard . I 2 "missed a muscle in 
her shoulder" but details are lacking, nor is anything known 
about her sister and parents. II 4 also missed some muscles in 
her shoulder, which was noted on an examination for tuberculosis. 
She had difficulties walking when she became older. Her son is 
positive that she had the disease and suggested that II 6 was 
affected as well. The proband (III 3) had a slightly progressive 
costal gibbus and an impressive thoracic kyphoscoliosis. He could 
stand upright with an increased lumbar lordosis and flexed hip 
and knees, but he walked progressively bent forwards since his 
fifties. On examination he had a waddling gait with a bilateral 
foot drop and his upper trunk bent to an angle of 45 degrees. He 
had to hold on to chairs and tables in his house, and to a stick 
while outside. All his life he had ridden a bicycle and, when 
this became more difficult, he persuaded his wife to ride a 
tandem. This most remarkable man, who loved outdoor-life, still 
drove a car in his seventies and each year spent long summer 
holidays with his wife camping, sleeping in a tent, in the south 





Kindred G: I 1 was a Belgian male who changed his name after his 
emigration to Indonesia . I 2 was an Indonesian orphan. The family 
is divided about her being affected or not. The larges t part of 
the family still lives in Indonesia or Malaysia. They are all 
said to be without complaints. Patient II 6 was reluctant to be 
examined. She had racial weakness and was unable to raise her 
a r ms more than 90 degrees , also showing a right- sided foot 
extensor weakness . 
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Kindred H: Only the proband (V 16) was so severely affected that 
he had sought referral to a neurologist. As a child of eight 
years he was unable t o raise his arms above his head. He noted 
foot extensor weakness at the age of 20 and pelvic girdle 
weakness when 24 years old. His father (IV 5) developed shoulder 
girdle we akness at the age of 15. This progressed till he was 21 
years old. Then the progression stopped, and on examination at 
the age of 61 he still had only shoulder girdle and upper arm 
weakness . There were several abortive cases in this family. IV 7 
was minimally affected and will be discussed in detail in section 
4. 22 . V 8 had suffered from a radicular Sl syndrome on the left 
due to slipped disc, which left him with a dis t inct paresis and 
atrophy of t he left triceps surae muscle . 
Remarkably , in this family facial weakness was generally 
minimal. IV 5, IV 7 and V 8 had no facial weakness at all . That 
this was not a rule without exception was demonstrated by III 11 
whom we met but who was not examined by us: he showed severe 





Kindred I : Many members of this family had been rose-growers 
living in the same village for centuries. Various degrees of 
severity were reported in the descendants of I 1. Among the 
members examined, one abortive case (V 6) was found. 
- 120 -
J 
Kindred J: Several members of this kindred have been seen by 
other physicians in the past. Within this family large 
differences in the degree of involvement were noted. Asymptomatic 
patients of older age (IV 8, 54 years; IV 12, 47 years) and 






• .., 3 ..... 
Kindred K: The proband (IV 2) told, when examined in the 
neuromuscular clinic, that only his half-uncle (III 20) was said 
to suffer from the same disorder. When visited at his home, his 
mother was found hanging out the clothes to dry on very low line, 
walking with a waddling gait and bilateral footdrop. For years 
she considered herself to suffer from rheumatism. Her sister (III 
16) and her sister's son (IV 15) had no complaints and were 
minimally affected. III 20 refused a complete physical 
examination since he was very disappointed in his physicians for 
various reasons . His sister III 18 denied the obvious signs of 
her weakness and explained the weakness of her arms by fatigue . 
Neither would cooperate by permitting their children to be 
examined. All but one of the children of II 3 were definite that 
their mother was not affected. III 20 and III 19 said that III 24 




Kindred L: Descendants of I 1 were living in the same town. 
Their r elationship was confirmed by tracing their common ancestor 
thr ough the records of the registrar's office. The fami l y was 
uncertai n if II 1 was affected. There were many abortive cases in 
his offspring. Only III 2, IV 8 and IV 12 were symptomatic. Some 
of t he descendants of I I 2 could be examined . IV 42 , IV 44 and I V 





Kindred M: The proband of this kindr·ed will be discussed in 
detail in section 4.19. on the infantile onset of FSHD . His 
father (II 3) demonstrated the normal pattern of FSHD. All his 
uncles appeared healthy. His grandmother (I 2) could not be 
examined, but was said to be without symptoms relating to FSHD. 






Kindred N: The proband (III 10) of this kindred demonstrated two 
notable features. Firstly, his calf muscles were rather bulky and 
slightly pare tic (grade 4). Although he had been very muscular 
when he was young the question of pseudohypertrophy was raised. 
This will be discussed later. Fasciculations had been noted in 
the shoulder girdle muscles on a previous examination. We 
observed no myotonia nor fasciculations. Secondly, a biopsy of 
the left biceps muscle revealed a great variation in fibre 
diameter, more than 20% central nuclei, many ring fibres and 
sarcoplasmic masses, and many moth- eaten fibres. Patient III 12 
was a more usual case of FSHD with no special features. A muscle 
biopsy in this case revealed no abnormalities. III 15 was said to 








Kindred 0: Pro band III 6 had had a muscle biopsy . This biopsy 
could not be reviewed but was said to have demonstrated myopathic 
features. His half-sister III 8 had a wry mouth. She could not be 
examined. II 2 demonstrated facial weakness on a photograph at 
the age of three. It was suggested by the patient that the facial 
weakness might have been congenital but this could not be 
substantiated. She developed shoulder girdle weakness at the age 
of 14 and foot extensor weakness when 24 years old. Subsequently, 
ankle contractures became apparent and, at the time of 
examination, she was moderately affected . Her father (I 1) had 
died at the age of 34 of pneumonia . The family was not sure 
whether he was affected or not, but his sister had had "a wry 
face" and his mother a "crooked shoulder". No detail s on other 








Kindred P: This kindred was particular in that II 1 was 
asymptomatic and without unequivocal physical findings suggestive 
of FSHD. She will be discussed in detail in the section on 
penetrance. Her father was known to have had a muscle disease. 
She is considered a carrier of the gene, which has not come to 
expression (yet). III 2 and IV 1 had no facial weakness, while 
the proband (III 1) had facial weakness with a protruding, 
immobile upper lip. III 1 showed myopathic features on EMG: he 
had normal motor nerve conduction velocities . Biopsy of his right 
biceps revealed small angulated fibres and type 2 predominance. 
III 2 showed neurogenic features on EMG: biopsy of the right 
deltoid muscle revealed no abnormalities. 
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Kindred Q: Proband III 5 was seen at the age of four at the 
neurological clinic because of shoulder girdle weakness. In his 
twenties or thirties he developed foot extensor weakness, but no 
further extension was noted on examination at the age of 52 . At 
that time he had minimal facial weakness. Sensory examination had 
always been normal in the past . Diabetes mellitus was noted when 
he was 43 years old. Several years later, at the age of 50, he 
developed a mixed polyneuropathy. EMG of the lower legs, with 
slowing of the nerve conduction velocities, supported this 
d iagnosis. EMG of the proximal arm muscles revealed a myopathic 
pattern. A muscle biopsy was refused. His sister (III 1) was 
noted to have facial weakness at the age of five. She developed 
shoulder girdle weakness when eight years old and was unable to 
walk unsupported at the age of 21. Her non-identical twin sister, 
III 2 , noted shoulder girdle weakness when 20 years old and foot 
extensor weakness at the age of 48. When she was examined at the 
age of 72, she was unable to walk outside but she walked unaided 
at home . In both, sensory examination revealed no abnormalities. 
Both sisters refused a muscle biopsy. The father of these 
patients (II 5) had clearly been affected. He was said to have 
been able to walk for hours at the age of 60 years . He lived to 
be 86 years old and only in the last years of his life he was 
unable to stand up by himself . This family has been included in 
this study largely on the basis of clinical criteria like facial 
onset, the pattern of weakness on examination, and the course of 
the disease, and on the basis of the genetic criterion of 






Kindred R: Proband II 6 was said to be the only one in his family 
Only one of his four children, III 13, was 
asymptomatic but physical examination 
girdle weakness and atrophy. The facial 
muscles were not involved in this case . Photographs of the 
proband's mother were suggestive of facial weakness. 
with muscle disease. 




Kindred S: This pedigree is characterized by a considerable 
number of asymptomatic cases . The pro band III 6 and her eldest 
sister III 2 both had slight ankle contractures and a rather 
severe facial weakness. A visit at home revealed that their 
mother (II 1) had facial weakness as well: she could not be 
examined in detail. A photograph of I 2 also suggested facial 
weakness. III 2, an intelligent woman and good observer , 
suggested on relevant grounds that other members of the family 
might be affected as well . These persons could not be examined . 
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4. 4. Symptoms 
Among the 107 affected persons, 73 were symptomatic (46 
males and 27 females). The presenting symptoms are given in Table 
4.7 • • It is important to note that symptoms suggestive of pelvic 
girdle onset were not observed. In the majority of cases (82%) 
the presenting symptoms were those of shoulder girdle weakness. 
Only seven patients (10%) remembered events indicating early 
facial weakness (Table 4 . 8.). Most people could not answer 
Table 4. 7. Presenting symptoms in 73 symptomatic cases of FSHD. 
Facial Shoulder girdle Foot ex tensor Total 
·eakness weakness weakness 
Males 2 ( 4%) 42 (91%) 2 ( 4%) 46 (lOO%) 
Females 5 (18%) 18 (67%) 4 (15%) 27 (lOO%) 
7 (10%) 60 (82%) 6 ( 8%) 73 (lOO%) 
Table 4.8 . Observations indicating facial weakness being the 
presenting symptom of FSHD. 
Patient Sex Age of 
observation 
F IV 1 F 7 Noticed mouth asymmetry in mirror 
herself. 
I VI 11 F 6 Orbicularis oculi weakness noted 
by ophthalmologist consulted for 
spectacles. 
I VI 21 F 6 Unable to blow up balloons . 
J V 16 M 5 Unable to blow up a balloon in a 
competition. 
K IV 2 M 6 unable to close his eyes while 
asleep. 
o. II 2 F 3 Weakness of the orbicularis oris 
noted by family. 
Q III 1 F 5 Her teacher observed that "she 
could not really smile". 
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questions about blowing up balloons or drinking through a straw 
because, as they said, they had never tried it. Inability to 
whistle is probably strongly suggestive of facial weakness , but 
the precise significance of this symptom is not clear. We 
observed inability to whistle in several elderly non-neurological 
patients who had no facial paresis and who could pout their lips . 
On the other hand, all medical students in a class of 50 and all 
unaffected persons in the families studied could whistle . Twenty-
seven males (59%) and 18 females (67%) i.e . 45 (62%) symptomatic 
patients had never been able to whistle (Table 4 . 9 . ) . At the time 
of examination 33 males (72%) and 23 (85%) females i . e . 56 (77%) 
symptomatic patients were unable to whistle. Ten other males and 
four females could whistle softly and with a t wisted, asymmetric 
mouth. When the asymptomatic patients were asked about these 
symptoms it was found that one out of 13 males (8%) and eight out 
of 21 females (38%) had never been able to whistle. Although the 
average age of the symptomatic patients (45.3 years) was slightly 
higher than that of the asymptomatic patients (36.3 years), no 
conclusions can be drawn from these figures about the onset and 
progression of the disease in the asymptomatic cases since both 
are quite variable and independent of each other, as can be 
concluded from the symptomatic cases. Still it is noted that 54 
of 107 patients (51%) never had been able to whistle, and that 67 
of the 107 patients (63%) were unable to whistle at the time of 
examination. Although inability to whistle as a symptom 
Table 4.9 . Inability to whistle as a symptom of . facial weakness. 
Syrrptonatic pitients Asymp~matic patients 
Males Females 'lbtal Males Fenales 'lbtal 
Never been able to whistle n 18 45 1 8 9 
Lost the ability to l'hlistle 6 5 11 0 2 2 
Could whistle with: 
moderate facial weakness 4 2 6 2 5 7 
mlld facial weakness 6 2 8 8 5 13 
oo facial weakness 3 0 3 2 1 3 
'lbtal 46 27 73 13 21 34 
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of facial weakness may yield false positive findings and a 
substantial number of false negative findings it still may give 
an important hint as to who might be affected. Another, though 
rarer, symptom which we found more reliable is the inability to 
close the eyes completely while asleep : this always indicates 
weakness of the orbicularis oculi muscles. We never observed 
false positive findings . 
Initial complaints relating to shoulder girdle weakness were 
inability to keep the arms sustained above shoulder level in 
various tasks. Pain in the shoulder region was not accepted as a 
diagnostic symptom of FSHD because it did not appear specific for 
it. However 21 symptomatic patients (28%) and three asymptomatic 
patients (9%) Le. a total of 24 patients (22%), had suffered 
episodes of shoulder pains. One asymptomatic patient (L V 9) 
related pains in his right shoulder to his heavy work in the 
harbour of Rotterdam. The right shoulder girdle was more affected 
than the left on physical examination. In another asymptomatic 
patient (H IV 3) the pains in her left shoulder had been 
diagnosed as "frozen shoulder". She indeed had slight limitation 
of passive movement in the shoulder joint . The third asymptomatic 
patient (H V 20) had noted several episodes of shoulder pains, 
lasting hours. In four patients (D II 5 , F IV 1, G III 19, S IV 
4) the pains were thought to be related to the onset of the 
disease. Three patients(E III 1, I VI 23, J IV 27) had noticed 
episodes of shoulder pains lasting several days, followed by an 
exacerbation of- the shoulder girdle weakness . Nine patients (A V 
10, B III 6, C III 1, I VI 10, I VI 11, L IV 45, L V 80, N III 
10, S III 2) were positive about a relation between shoulder 
pains and physical exertion in which the arms are used. Two 
patients (K III 12 and Q III 2) frequently had muscle and joint 
pains not clearly related to exercise. Three patients of old age 
(J III 1, J III 3, Q III 1), wheelchair-bound and dependent on 
nursing care, complained of severe muscle and joint pains upon 
being turned in bed, dressed, or lifted . Only in the last cases 
the explanation offered by Ketenjian (1978), who claims that 
stretching of tendons and weakened muscles causes pain, seems 
appropriate. 
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Six patients (Table 4.7.) presented symptoms related to the 
lower legs. Two men (B III 1, L IV 12) and one woman (E III 1) 
claimed they had foot extensor weakness only: they were not 
examined at that time. The son of E III 1 is positive that his 
mother had shoulder girdle weakness as well at that time, but she 
denied this. Three other women (L IV 42, L IV 44, S III 6) had 
both ankle contractures and foot extensor weakness at the time of 
first complaints. The ankle contractures contributed strongly to 
an early referral. When examined they all demonstrated shoulder 
girdle weakness as well. 
4.5. Precipitating factors 
Specific events precipitating the onset of the disease were 
not reported, nor was it possible to identify any. One patient (J 
VI 4) strongly believed that heavy labour and the preferred use 
of his right arm resulted in the severe atrophy and paresis of 
the right arm which was distinctly more seriously affected than 
the left. 
Two patients (A V 14, F III 3) confirmed to notion that 
immobilisation in plaster casts has an adverse affect on the 
progression of the disease. Both had sustained a humerus 
fracture, and on mobilisation they noted a loss of muscle mass 
and strength in the upper arm that could not be regained by 
exercise. It is conceivable that immobilisation could elicit a 
first sign of the disease. 
4.6. Presenting signs 
Records on the clinical conditions made within a couple of 
years after the onset of symptoms were available only in a few 
cases. We saw only four patients (all males) within five years 
after the onset of their symptoms (Figure 4.2.). Assuming that 
sooner or later, with progression of the disease, the 
asymptomatic patients might become symptomatic, it was felt that 
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studying the signs in the asymptomatic patients could provide 
insight into the presentation of FSHD. Knowledge of the 
presentation is important in the discussion of the differential 
diagnosis . Table 4. 10. shows the signs in the 34 asymptomatic 
patients. Facial weakness was the only sign in eight patients but 
in three women the shoulder girdle muscles could not be inspected 
for atrophy. Facial weakness was absent in two males and one 
female, i.e. in approximately 9% of the asymptomatic cases, which 
suggests that the majority of patients with FSHD will have facial 
weakness at the time of first symptoms. 
Any combination of shoulder girdle weakness with facial, 
foot extensor or pelvic girdle weakness was observed. Foot 
extensor weakness was invariably minimal. Otherwise, obviously it 
would have led to complaints. Pelvic girdle weakness was present 
in two cases. Although unlikely, it is conceivable that pelvic 
girdle weakness could give rise to presenting symptoms in FSHD. 
In those cases, shoulder girdle weakness might be expected as 
well, but the correct diagnosis might be difficult if the family 
history is lacking. The frequency (12%) of pelvifemoral onset 
among the 95 cases of Chung and Morton (1959) is inconceivably 
high and raises suspicion that other disorders , such as spinal 
muscular a trophies, might have been included in their material , 
which could account for their remarks on genetical heterogeneity 
of the disorder under study. 
table 4.10. The signs in 34 asymptomatic patients with FSHD. 
F s FS SE FSE FSP FSEP Total 
Males ~ 1 7 1 2 1 13 
Females 7 1 7 0 5 1 21 
8 2 14 1 7 1 1 34 
F: Facial weakness; S: shoulder girdle weakness; E: foot extensor 
weakness; P: Pelvic girdle weakness. 
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4 . 7. The facial muscles 
The facial muscles were examined as suggested by Kendall et 
al. (1971). No grading system was used for facial weakness . 
Facial weakness was the sole finding in eight cases (Table 
4.10 . ) , and was present in 101 (94%) out of the 107 patients . 
This percentage is higher than Becker ' s 81% (1953) and Chung and 
Morton ' s 83% (1959) . Facial weakness was absent in three of the 
34 asymptomatic cases (9%) and in three of the 73 symptomatic 
patients (4%) . These percentages suggest that facial weakness can 
arise later in the course of the disease and are not contrary to 
the observation that B III 1 and B III 6 had no facial weakness 
t en years ago (according to their physician at that time) but 
did, when examined by us . 
A remarkable f i nding i s 
of the fac i al musc l es 
orbicularis oculi muscle 
the frequent asymmetric involvement 
(Tabl e 4.11 . ). Occasionally, the 
was weaker on one side and the 
orbicular i s oris muscle weaker on the opposite side: this is 
ref'err ed to as " crossed asymme t ry" in Table 4. 11 . Fifty- four 
patient s had facial asymmetry which is 57% of all patients in 
whom the symmetry was judged and recorded. There was no 
preference f'or the right or left side, nor f'or males or f'emales . 
It is not clear why and ho w fac i al asymmetry should develop . The 
jaws are often used asymmetrically in chewing and biting but 
these muscles are spared in FSHD. Several facial expressions 
requir e an asymmetr ic use of muscles but it is hard to understand 
how this could lead to asymmetric weakness and atrophy . 
Table 4. 11. Facial weakness in lOl pat ients with FSHD. 
Predominantly Predominantly Asymmetry Symnetric Weakness 'lbtal 
riePt-sided lef't-sided crossed weakness rot 
weakness weakness or rot specified 
specified 
Males 13 (24%) 11 (20%) 6 (11%) 18 (33%) 6 (11%) 54 (lOO%) 
Fellales 9 (19%) 7 (15%) 8 (17%) 22 (47%) 1 ( 2%) 47 (lOO%) 
22 (22%) 18 (18%) 14 (14%) 40 (40%) 7 ( 7%) 101 (100%) 
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Three or more generations of abortive cases do occur (Pamboukis, 
1931; our family S) but facial weakness without a clear autosomal 
dominant pattern of inheritance is not enough to make the 
diagnosis FSHD. We observed, in two years time, five (two males, 
three females) unrelated persons with weakness of the orbicularis 
oris muscle, who were referred to us for neurological problems 
not related to neuromuscular diseases . Both the men were aware of 
it because they never could whistle well, and they claimed it had 
not been progressive since their early youth. However, one of the 
males claimed his sister had a similar paresis. Neuromuscular 
disorders in any of the five families were reportedly not 
present, but these families could not be studied. Speculations 
that these five patients might be part of a large source of 
asymptomatic families with FSHD cannot be denied with certainty, 
although another explanation, such as congenital aplasia of the 
orbicularis oris muscle, seems more appropriate in these 
patients , as is properly illustrated in Mumenthaler's Atlas 
(1982). 
4.8. The shoulder girdle, pelvic girdle and limb muscles 
In 74 patients (46 males and 28 females; see Table 4.1) all 
muscles, indicated in Table 4.12 . , could be examined using 
methods as described by Kendall et al. (1971) and as published in 
the Medical Research Council (MRC) memorandum No. 45. All muscles 
were graded for their strength from 0 to 5 according to the MRC 
scale. The gradings of each muscle for all patients were added. 
The maximum score that could be reached for each pair of the same 
muscles on the right and on the left side was 740. Table 12 shows 
the percentages of the maximum score observed for each muscle 
pair. It is appreciated that grading of muscles around the 
shoulder joint may be difficult if the fixation of the scapula 
has weakened or is lost. In those instances, fixation was 
attempted by the examiner ' s hand . The teres major muscle was 
tested in two ways, by adduction of the upper arms and by having 
the arms internally rotated. Both tests are combined effort of 
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several muscles and the total score has to be interpreted with 
caution. 
The group of 33 partially examined patients (see Table 1) 
included several seriously affected persons . The scores in Table 
12, therefore, do not reflect the severity of the disease in the 
total group of patients . FOur patients with facial weakness only 
were included in the group of completely examined patients. 
The muscles were arranged in an ascending order of their 
scores . The truncal muscles could not be graded according to the 
MRC system. Their place in Table 12 will be discussed in section 
4 . 9. Assuming a steady progression of the muscular weakness once 
a muscle has become affected, this transverse section gives a 
rough estimate regarding the order in which the muscles become 
involved in FSHD. The individual differences which are known to 
occur, are expected to level out in this large sample. Therefore, 
one should not adhere to this order rigidly, but it should be 
noted that the sequence of this transverse section is in 
agreement with the general picture of spread of disease based on 
anamnestic data ( longitudinal section). Since we did not perform 
a longitudinal study , these data are the best available. 
For the purpose of this study the muscles were grouped. Each 
group suggests a stage in the course of this disease. Each stage 
is marked by the onset of recognisable symptoms and signs . It is 
suggested in Table 4 . 1 2., that the scapular fixators, the 
latissimus dorsi, and the pectoralis major muscles are among the 
first to become affected. Involvement of these muscles and 
involvement of the facial muscles constitute the first stage of 
the disease. The onset of the second stage is marked by the 
involvement of the anterior tibial muscles . The peroneal muscles 
become affected later in this stage. In the shoulder region other 
muscles such as the infraspinatus, the supraspinatus, the teres 
major and , finally, also the deltoid muscles become involved . In 
the upper arms the triceps appears to be involved first, followed 
by the biceps. The lower arm muscles are notably spared in this 
stage. The brachioradialis muscles become involved in the third 
stage of the disease in this material, which is in contrast to 
the findings of Tyler and Stephens (1950), who noted an 
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Table 4.12 . Mean scores of strength of muscles in 74 patients 




Stage 1 Pectoralis major (sternocostal head) 
Serratus anterior 
Pectoralis major (clavicular head) 
Latissimus dorsi 






Stage 2 Peroneus longus and brevis 
Extensor hallucis longus 
Extensor digitorum longus 
Extensor -digitorum brevis 
Biceps brachii 
Deltoid (medial belly) 




Glutaeus medius and minimums 
Quadriceps femoris 
Stage 3 Upper trapezius 
Adductors 
+ Wrist extensors 
Neck flexors 
Glutaeus maximus 






Intrinsic hand muscles 
Neck extensors 
Stage 5 Ambulatory indoors, unable to climb stairs . 
In wheelchair while outside . 









































early involvement of these muscles in their patients 
The third stage of the disease is marked by the start of 
involvement of the pelvic girdle and thigh muscles. Late in this 
stage the upper trapezius muscles, the neck fle xors and the wrist 
extensors become involved. The relatively late involvement of the 
neck flexors in these patients is in agreement with observations 
made by Van Wijngaarden and Bethlem (1973) . 
The fourth stage is essentially characterized by progressive 
pelvic girdle weakness, leading to progressive disability. We 
would like to mark the onset of stage 4 with the loss of ability 
to climb stairs. Also in this stage there is further extension of 
the disease to the lower arms . Finally , the triceps surae and the 
neck extensors become involved. 
We marked the onset of the fifth stage at the moment the 
patient became dependent on a wheelchair for all outdoor 
activities . The last stage, stage 6, covers the period a patient 
is wheelchair-ridden at home too ; this always implies dependence 
on nursing care. 
In our material the deltoid muscle did not appear so 
uniformly spared as is suggested in the literature (Brooke 1977). 
Table 4.13. shows that 40 patients of the 74 that could be 
examined completely , demonstrated weakness of the deltoid 
muscles . Distinct atrophy was present in 25 pat i ents (34%). The 
pattern of atrophy was quite different from patient to patient, 
and different patterns were found within families . There is no 
good explanation for the partial atrophy of this muscle . 
Hypertrophy of the deltoid muscle was never observed. 
Recent publications about thoracoscapular fusion (Cope land 
and Howard, 1978) and scapular fixation (Ketenjian, 1978) in FSHD 
have directed special interest towards the del to id muscles . We 
repeatedly observed in mildly affected patients that the scapulae 
rose higher if abduction of the arms was resisted by the 
examiner. This suggests that the rise of the scapulae into the 
normal position of the trapezius muscles on abduc tion of the arms 
is, indeed, the result of the relatively strong deltoid muscles, 
pulling on the scapulae that have lost their muscular fixation to 
the chest. 
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There was only one patient in this material in whom scapular 
fixation was attempted (K IV 2). The sutures broke after several 
months. He was not operated upon again . 
4.13. Deltoid muscle involvement in 74 patients with FSHD. 
Vhole Proxillal Anterior Posterior ParesiS No 'lbtal 
nuscle atrophy belly belly ro atrophy 
atrophy all bellies atrophy atrothy atrophy rorrml 
function 
Males 4 8 0 2 8 24 46 
Fermles 1 5 1 4 7 10 28 
5 (7%) 13 (18%) . 1 (1%) 6 (8%) .15 (20%) 34 (46%) 74 (lOO%) 
4.9 . The truncal muscles 
The MRC scale does not provide adequate grading for the 
truncal muscles . The only test for the abdominal muscles used in 
this study consisted of asking the patient to try to come to a 
sitting position, while lying supine, without the use of the 
arms. Table 4.14 . shows that 43 patients (58%) had abdominal 
muscle weakness . Seven patients had abdominal muscle weakness 
without foot extensor weakness , while the opposite was found in 
two patients. Abdominal muscle weakness thus appears to be a 
fairly early sign in FSHD. Under the same conditions as applied 
for the interpretation of Table 4. 12 . , abdominal muscle weakness 
might be placed on the border between the first and second stage . 
A protruding abdomen, which is a rather subjective finding on the 
examiner ' s part, was scored separately . Forty-one patients with 
abdominal muscle weakness on the test had a protruding abdomen . 
Two pa t1ents with a protruding abdomen had no abdominal muscle 
weakness while tested. 
Lumbar hyperlordosis is also a rather subjective finding. 
Since it probably reflects a compensatory mechanism for the 
pelvic tilt due to both an increasing abdominal muscle weakness 
and a hip extensor weakness, one might expect to note an 
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increased l umbar lordosis at the beginning of the t hird s tage 
when a certain degree of abdominal weakness has dev eloped a nd 
pel vic girdle weakness becomes apparent (Table 4 .14 . ) . It is 
possibl e that the strength of the il i opsoas muscle was recorded 
l ower in a few cases because an i ncrease of the lumbar 
due to a lack of compensatory mechanisms of the 




would not have a great influence on the sequence of muscle 
involvement , as suggested i n Table 12 . 
Table 4 . 14 . Involvement of truncal muscl es as compared to pelvi c 
gird~ e and foot extensor involvement in 74 pa t ients 
with FSHD . 
Abdomi nal Foot ex tensor Pelvic Lumbar All 
muscle weakness girdle hyper- patient s 
weakness weakness lordosis 
Males 29 23 19 18 46 
Females 14 15 10 9 28 
43 (58%) 38 (51%) 29 (39%) 27 (36%) 74 ( lOO%) 
4 . 10. Asymmetry of muscle involvement 
Becker (1953) noted that the shoulder girdle muscles on the 
right side were significantly (P2 = 0.03 sign test) more sever ely 
affected than those on the left s i de in his pa t ients . We 
considered asymmetry to be present i f the strengt h of similar 
musc l es on the right and left side differed one degree or more on 
the MRC scale, if either side was graded 4+ and the other 4- o n 
the MRC scal e, or if there was a distinct difference in muscle 
atrophy . A preference for right- sided shoulder girdle or arm 
weakness was observed in 39 patients (Table 4 . 15.) . In 17 the 
l eft side was more involved. Twelve patient s had some muscles o n 
the right side and others on the left side tha t wer e more 
invo l ved than the corresponding muscles on the opposite side. The 
preference for the right shoulder or arm was statis t ically 
significant (P1 = 0 . 00 5 sign test) . No such preference was found 
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in 72 patients with pelvic girdle or lower extremity involvement . 
In 13 of these patients the right leg or the right side of the 
pelvis showed more involvements and 16 patients were more 
affected on the left side. An alternating picture was present in 
one patient , 19 patients had a symme t rical clinical picture, and 
in 23 patients definite data on laterality were lacking. 
Table 4.15 . Preference of side of shoulder girdle involvement in 
107 patients with FSHD. 
Right Left Alter- Symmet- Facial Limited Total 
side side nating rical weakness data 
only 
Males 24 10 8 8 1 8 59 
Females 15 7 4 9 4 9 48 
39 17 12 17 5 17 107 
We scored arbitrarily right arm and left leg preference each 
+ 1, and left arm and right leg preference each - 1. Symmetric 
involvement, no involvement or alternating involvement of several 
corresponding muscles on similar girdles or extremities were 
scored o. Adequate data for scoring were present in 77 patients 
(see Table 4. !6 . ) . The total score of all individuals was +22, 
which proved to be statistically significant when compared to the 
Table 4.16 . Scores of laterality of muscle involvement in 77 
patients 
Arms 
Scores - 1 0 +1 
L -1 1 5 7 13 
E 0 11 16 21 48 
G +1 3 7 6 16 
s 
15 28 34 77 
variance of scores between the individuals (P2 ~ 0.01 Student ' s 
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test), indicating that the preference of involvement of the right 
shoulder and upper extremity was not related to a preference for 
the right side of the body. 
Variance analysis of the score per kindred demonstrated a 
significant influence of the kindred on the score (P = 0.02 
Fisher ' s F-test) and no significant influence of the individuals 
(P = 0.2 Fisher's F-test). 
The results so far were rather surprising and we had no 
information on handedness of the patients at the end of our 
investigation. Therefore, we sent questionnaires to all patients, 
asking them if they considered themselves right- or left-handed. 
In addition we asked them which hand was used for writing, 
throwing a ball, dealing cards, brushing teeth, and eating soup . 
Forty- three patients of the 56 patients with asymmetry of 
shoulder girdle or arm involvement responded (Table 4.17.) . All 
patients had a clear preference for one arm: no ambidexterity was 
reported. The association between the side of most involvement 
and handedness was tested in a four-fold contingency table 
yielding a one-sided tail probability of 0 . 01. 
Table 4.17. Preferred side of shoulder and arm weakness and 
handedness in 43 patients. 




Left 3 1 4 
Right 8 31 39 
Total 11 32 43 
Because we used several statistical tests on the item of 
laterality, a correction had to be made for the critical level of 
the tail probabilities. The main factor determining this level 
for a total of mutually independent tests is the number of tests 
involved. We therefore fixed our probability of an error of the 
first kind at 0.0125 for each of the four tests performed. This 
requirement was not met by the test on the influence of the 
kindreds only. We therefore would like to conclude that the right 
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shoulder girdle and arm were significantly more often more 
seriously involved than the left; this asymmetry was not related 
to body side but was associated significantly with handedness. 
4. 11. Reflexes 
The myotatic reflexes were spared in all cases with the 
disease limited to the shoulder girdle muscles (stage 1). With 
further spread the myotatic reflexes were lower and ultimately 
absent. Absent myotatic reflexes were not necessarily related to .. 
severe involvement. Asymmetry in myotatic reflexes was often but 
not always related to asymmetry of muscle involvement. 
The myotatic reflexes of the legs tended to be spared longer 
than those of the upper arms. The Achilles' tendon reflex 
disappeared in several cases without signs of involvement of the 
calf muscles, whil; the opposite, i . e . foot flexor weakness with 
positive ankle jerks, was never observed. The knee jerk was often 
preserved till late in the course of the disease, but any 
suggestion of an order of disappearance of the myotatic reflexes 
was opposed by numerous observations to the contrary. The plantar 
responses never were pathological . 
4.12. Muscle contractures 
Muscle contractures were indeed quite rare in our material, 
with the exception of ankle contractures, which were found in ten 
patients (one male, nine females) out of 102 (10%) that could be 
examined for this feature. In three female patients (L IV 42, L 
IV 44, S III 6) ankle contractures gave rise to the first 
symptoms. In three other females (L IV 45, 0 II 6, S III 2) ankle 
contractures developed in the course of lower leg involvement. 
The male patient (M III 8) and three females (E III 1, J III 3, Q 
III 1) were all in an advanced stage of the disease and 
completely dependent on wheelchairs . Achilles ' tendon elongation 
has been performed in two patients (L IV 44, Q III 1), both with 
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poor results and no subjective improvement of the patients' 
conditions. 
A pronation contracture of both lower arms was present in E 
III 1. Patient M III 8 had a flexion contracture of his right 
arm, limitations of movement of both wrists, and flexion 
contractures of both hips and knees, in addition to the 
abovementioned ankle contractures. 
The left sternocleidomastoid muscle was transected in 
patient L IV 42 at the age of 12 years because of a progressive 
torticollis . At the time of examination she was unable to bend 
her head completely laterally to the right. The left 
sternocleidomastoid muscle was absent, but the left trapezius and 
scaleni muscles appeared tight and contracted. Rotation to the 
right was minimally impaired. Anteflexion and retroflexion of her 
head were unimpaired . 
4.13. Hypertrophy of muscles 
Hypertrophy of muscles was rarely observed. One patient (M 
II 3) had hypertrophy of the infraspinatus muscles. Two patients 
(A V 10 and S II I 6) had a remarkable hypertrophy of the extensor 
digitorum brevis muscles as described by Brooke (1977). These 
muscles tend to be spared for a long time and were found to be 
absent only in the severely affected patients confined to bed and 
wheelchair. Hypertrophy of these muscles apeared to be a 
transient phenomenon in the course of FSHD in some patients and a 
compensatory mechanism for a footdrop. 
Hypertrophy of the calf muscles was observed in two male 
patients (M III 8 and N III 10). In the former, the calf muscles 
were firm on palpation and severely paretic (grade 2). This 
patient will be discussed in detail in the section on the 
infantile form of FSHD . The latter had been a very muscular man, 
as could be judged from photographs, and in contrast to the foot 
extensors the calf muscles were very well developed, but slightly 
paretic (grade 4) at the time of examination. In both instances 
hypertrophy of the calf muscles was not present in other patients 
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in these families . Both cases meet the requirements of the 
clinical definition of pseudohypertrophy of muscles Le. 
hypertrophy with weakness. 
4 . 14 . Skeletal abnormalities 
In 81 patients (49 males and 32 females) the backs could be 
examined properly. A scoliosis was observed in 18 males (37%) and 
eight (25%) females, i . e. in 26 (32%) patients . Only one patient 
(M Ill 8) had a severe and progressive kyphoscoliosis that 
compromised respiratory functions. He had several other no table 
findings and his case will be discussed in section 4.19 on the 
infantile form of FSHD. In all other patients the scoliosis was 
quite mild and most patients were not aware of it. An increased 
thoracic kyphosis was present in five males (10%) and in four 
females (12.5%) i . e. in nine (11%) out of 81 patients. 
A progressive costal gibbus was present in the patient with 
severe scoliosis mentioned above (M Ill 8) and in another male 
patient with a mild scoliosis (F Ill 3). Both had an increased 
thoracic kyphosis. The latter patient had no respiratory 
complaints. 
Pectus excavatum was not observed as frequently as reported 
by Tyler and Stephens (1950). We observed this in four patients 
(three males, D II 5, DIll 11, J V 18, and one female, L IV 42). 
Foot deformities have never been observed. 
4 . 15. The cardiac muscle 
Cardiac complaints 
study. Patient C II 6 
myocardial infarction at 
were very rare in the patients under 
had angina pextoris and suffered a 
the age of 47 years. In another patient 
(J Ill 3) chronic heart failure was diagnosed at the age of 78 
years. She suffered a small myocardial infarction when 81 years 
old . A third patient (D II 5) had coronary and peripheral 
atherosclerotic disease and chronic heart failure. An aorta 
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bifurcation prosthesis had been implanted and he was treated with 
diuretics, digoxine and acenocoumarol. Patient G III 19 had a 
congenital valvular disease and underwent a commissurotomy at the 
age of 14: she was free of symptoms at the time of examination. 
One patient (L IV 44) underwent a cardiologic examination in the 
course of establishing the diagnosis. The electrocardiogram and 
phonocardiogram were within normal limits. Two of the deceased 
patients (B II 1, J III 6) were said to have died from a heart 
attack. 
It appears that cardiac disease in these patients with FSHD 
was rather a result of a vascular disorder than of a 
cardiomyopathy •. 
4.16. Concomitant diseases 
Concomitant diseases in our material appeared to be a matter 
of coincidence. Strumectomy had been performed in one patient. 
Another deceased patient was said to have suffered from thyroid 
d isease. Other operations, not mentioned in Table 4 . 18, were 
gastrectomy (1) , appendectomy (2), hysterectomy (1), 
cholecytectomy (1), scapular fixation (1), and Achilles ' tendon 
elongation (2) . The patient with late onset hydrocephalus 
underwent ventricular drainage. The eye was removed in the 
patient with the retinoblastoma. A brother of this patient had a 
retinoblastoma as well; he had no muscular weakness. Retinitis 
pigmentosa was present in two sisters . with FSHD. A third sister 
with FSHD was ophthalmologically normal. 
Intermittent low back pa in as a sole symptom was present in 
four patients. None of them had a severe hyperlordosis. An 
episode of sciatic pain was reported in two patients. 
Psoriasis was found in three patients with FSHD in one 
family, but it was also present in non-affected members. 
Severe depressions were reported in three instances. Two 
patients related their depressions to the neuromuscular disease. 
The third patient was an asymptomatic case. 
Psychotic episodes have been reported in two patients . 
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Mental retardation has not been observed in this patient-
material. 
Table 4 . 18 . Concomitant diseases in 107 patients with FSHD. 





























The problem of the age of onset has been discussed in 
Chapter 2. We divided the patients in symptomatic and 
asymptomatic ones (abortive cases) . The symptomatic patients 
could give more or less precise information on the onset of 
muscle weakness. Most of the asymptomatic patients were not aware 
having the disease. A few of them (E V 1, L V 84, P IV 1) were 
brought to the attention of a physic~.an by their concerned 
parents and were made aware of their condition. A similar problem 
is observed regarding facial weakness. Most patients were not 
aware of it at the time of examination. Questions about the 
inability to whistle suggest that facial weakness might be the 
earliest symptom in the majority of cases. Reporting facial onset 
depends to a great extent upon an attentive family. 
The ages of onset in the symptomatic group of patients are 
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presented in Figures 4.6. and 4. 7 •• The mean age of onset of the 
disease was 17.0 years, if all symptoms were considered (Table 
4.19.). The differences between the onset in males (15.8 years) 
and females (19.0 years) was statistically not significant (P2 = 
0.1 Student's t-test). As facial weakness remained unnoticed in 
the majority of cases, the age of first complaints of any muscle, 
other than the facial muscles, probably is a more comparable 
situation in the course of this disease. If symptoms of facial 
weakness were excluded, the mean age of first symptoms was 17 . 8 
years for all patients. Then the difference between males (16.1 
years) and females (20.6 years) was statistically significant (P2 
= 0.02 Student's t-test). The last figures do not reflect an 
early stage of detection. 
FIGURE 4.6: AGES AT ONSET OF SYMPTOMS IN 73 PATIENTS(46 MALE$.27 FEMALES) 
• FEMALE 
0 MALE 
14 18 22 26 ~· 4 46 
FIGURE 4.7: PGE AT ONSET OF SYMPTOMS( FACIAL SYMPTOMS EXCLUDED) IN 46MALES, 27 FEMALES 




34 •• 42 
Table 4.19. Mean age at onset in 73 symptomatic patients 
Males Females All pat ients 
Facial symptoms included 15.8 (SD6 . 5) 19.0 (SD11. 6) 17 .o (SD8.8) 
Facial symptoms excluded 16.1 (SD6.2) 20 . 6 (SD10 . 2) 17.8 (SD8.1) 
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The age of first complaints of all symptomatic patients, 
given in cumula t ive percentages, is represented in Figure 4 . 8 •• 
It shows that at the age of 20 years at least 89% of the males 
and 63% of the females, that will be symptomatic, can be 
diagnosed . At the age of 30 years, these percentages are 98 and 
81 respectively. For genetic counseling one is particularly 
int erested i n the asymptomatic cases. Figure 4.5, which reports 
only the 49 extensively studied sibsh i ps , suggests that in all 
decades bu t the first, the expected 50% affected persons can be 
diagnosed by clinical exami nation; however, the standard error in 
the estimated probability of mi ssing a gene carrier in the second 
decade is ra t her large (0.229), due to the limited number of 














FIGURE 4.8: cumulative percentages of ages of first complaints 
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Regression analysis offers another way to also include the 
asymptomatic patients in the study of the age of onset . Such an 
analysis was performed on the segregation data of the cohort ages 
in 84 patients and 80 healthy sibs in 49 sibships (Table 4 . 6 . ) . 
If it assumed that a linear relation exists between the age and 
percentage of affected cases , one finds that at the age of 32 
years all cases can be diagnosed by clinical examination (Figure 
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FIGURE4.9 : PERCENTAGES DETECTABLE GENE CARRIERS AT DIFFERENT AGES, 
CALCULATED FROM REGRESSION ANALYSIS 
4 . 9.). At the ages of ten, 20 and 30 years these percentages are 
89 .7, 94.3 and 99.0 respectively , with a standard error of 9.5% , 
7 . 3% and 5 .6% respectively. Fifty percent of the cases can be 
diagnosed at the age of -75 years. This would be the mean age at 
onset . The reason for this strange figure lies in the fact that 
already in the second decade all expected cases could be 
diagnosed. Clearly , such an analysis is a theoretical one and not 
much in agreement with reality. 
If regression analysis is performed under the assumption 
that the relation between the age and percentage of affected 
cases is represented by an S-shaped curve or ogive, the mean age 
at onset is found to be - 9.3 years (Figure 4.9 . ) . This figure 
appears not to be i n contradiction with the statement that a 
congenital manifestation is within the possibilities of FSHD . 
According to these calculations, it is possible to diagnose 72.0% 
of the cases at the age of ten years, 81.2% at the age of 20 and 
88 . 3% at the age of 30 years, with a standard error of 38 . 3%, 
16.9% and 18 . 1% respectively. The assumption of an ogive is 
probably more in agreement with the reality since the curves of 
the ages at onset based on symptoms (Figure 4 . 8 . ) appeared to be 
ogives. Regression analysis has not been performed for males and 
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females separately because the sex differences in this material 
were not statistically significant (see section 4. 23. on sex-
influences). 
Variance analysis on the ages of onset revealed no 
significant correlation between the ages of onset among sibships 
(P = 0.2 Fisher ' s F-test) or among kindreds (P = 0.2 Fisher's F-
test). These figures led to an intraclass correlation of 
individuals belonging to the same kindred of 0. 06806 and to an 
intraclass correlation of individuals belonging to the same 
sibship of 0.24875. From these estimates non-genetic factors 
appear to play a large role in the age of onset of the disease. 
4 .18 . Abortive cases 
Abortive cases are defined as asymptomatic cases. The 
distinction between symptomatic and asymptomatic patients serves 
only the practical purpose of studying FSHD. Symptoms of shoulder 
pain were not accepted as specific for FSHD. Inability to whistle 
is a fairly reliable sign of facial weakness. It suggests early 
onset of the disease. But it was never brought out as a 
complaint , and since it could not help to establish the onset of 
the disease more precisely, it was disregarded as a criterion on 
which to base the decision whether a patient was symptomatic or 
not. It turned out that only a fair degree of girdle or extremity 
muscle weakness led to complaints. Patients with complaints 
constitute the symptomatic group and by reciprocity the patients 
without complaints of muscle weakness form the asymptomatic 
group. 
There were 34 (32%) asymptomatic patients among 107 studied 
(Table 4.20 . ) . The ages are presented in Figure 4.10 •• If we 
consider the 49 sibships that were extensively studied, the 
percentage of abortive cases was 30% . 
The differences between the absolute numbers of males and 
females was statistically not significant but, 1f percentages 
were considered, the difference between asymptomatic males and 
females among all patients studied was statistically significant 
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(P = 0.016 Student's t-test). 
Table 4.20. Asymptomatic patients with FSnD. 
Males Females Total 
All cases considered 13 (22%) 21 (44%) 34 (32%) 
(107 cases in 19 kindreds) 
49 sibships considered 12 (21%) 20 (42%) 32 (30%) 
(105 cases in 17 kindreds) 
FIGURE4.10 IIGES IN YEARS OF 34 ASYMTOMATIC PATIENTS(13 MALES 21 FEMALES) 
• FEMALE 
0 MALE 
• 38 n • 46 .r-. I. n I 54 58 62 66 
The differences between the percentages of males and females 
remained more or less the same for many years (Table 4. 21.) . 
Since the natural history of the asymptomatic cases is not known , 
one cannot conclude that such findings indicate that women tend 
to remain asymptomatic for a longer per i od of time than men. 
Table 4. 21 . Percentages of asymptomatic patients at differ ent 
ages . 
All cases > 20 years > 30 years 
Males 22% (13/59) 16% ( 8/50) 10% ( 4/40) 
Females 44% (21/48) 40% (18/45) 35% (13/37) 
Total 32% (34/107) 27% (26/95) 22% (1 7/37) 
Variance analysis of the cohort data of the 49 extensively 
studied sibships yielded no significant influence (P 0 . 1 
Fisher ' s F-test) of sex and no influence (P = 0.2 Fisher ' s F-
test) of the decades on the frequency of abortive cases . 
Regression analysis demonstrated no significant (P > 0. 05) 
decrease or increase of the number of abortive cases per decade . 
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There are two possible explanations for this finding: some 
patients wi ll remain asymptomatic all their lives or, at each 
age , some previously asymptomatic patients may become 
symptomatic , while other gene carriers will develop the first 
detectable signs and will become asymptomatically affected. The 
latter mechanism is probably not of great importance , since at 
most decades the expected 50% of affected sibs could be found 
(Figure 4 . 4 . ). 
It is important to note that asymptomatic patients may be 
found up to the seventh decade. It should be clear that one can 
never rely o n family da t a if all cases in a family have to be 
detected . 
Th e degree of muscle involvement in the asymptomatic cases 
was qui te vari able (see Table 4.10 . ) . The cl i nical picture in 
t hese cases has been discussed in section 4.6 . on the presenting 
s y ndromes . The impressi on existed that a certain, unquantifiable, 
degree of dissimura tio n was present in several cases. Denying 
seemed definitely pres ent in the two cases with pelvic girdle 
weakness . The man (B IV 4) was unable to run properly and the 
woman (H IV 3) even refused to accept any other explanation than 
her mild o besi t y for her difficulties in climbing stairs . 
4 . 19. Infantile onset and onset in early childhood 
Infantile o nset , i.e. onset within the first t wo years of 
l i fe , was not observed i n our patients . Also Mobius' syndrome was 
never me ntioned . Pat i ent 0 II 2 demonstrated a distinct asymmetry 
of the orbicular is o ris muscle on a photograph taken at the age 
of three years . Her mo t her had said that this sign was present at 
birth but this could not be confirmed. In her case the disease 
was slo wly pr ogr essiv e, wi th the onset of shoulder girdle 
weakness at the age of 14 years (see kindred 0) . 
Ther e wer e several patients in this study who had onset of 
the disease before the age of seven years (Table 8) . Patient Q 
III 5 was presented at the neurological clinic of the "Wilhelmina 
Gasthuis" i n Amsterdam at the age of four years. Shoulder girdle 
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weakness was noted several months earlier. In his case the 
disease ran a rather mild course which is reported in more detail 
in the description of his kindred. Patient Q III 1 was observed 
to have facial weakness at the age of five, and shoulder girdle 
weakness when eight years old. 
Another patient that deserves particular attention is M III 
8. His parents appeared unrelated. Pregnancy and delivery were 
unremarkable. His mother thought he was slow in motor develop-
ment, yet he stood unsupported at 15 months and walked with 17 
months. His facial expression was unobtrusive at that time. At 
the age of four years he was noted to have a waddling gait and to 
have difficulties in running. At the same time, shoulder girdle 
weakness became apparent . When he was examined at the age of nine 
years he had a mild to moderate facial weakness, but a severe 
paresis of the neck flexors, the shoulder girdle and the upper 
arm muscles, while the distal arm and intrinsic hand muscles were 
only minimally to mildly involved. He had pelvic girdle, quadri-
ceps and foot extensor weakness. The quadriceps femoris and 
triceps surae appeared to be hypertrophic. Myotonia or fascicula-
tions were not observed. 
The disease progressed rapidly. He was completely dependent 
on an electric wheelchair since he was 11 years old. When he was 
examined at the age of 19 he had a moderate to severe facial 
weakness. The extraocular, the masseter, the temporalis, the 
lingual and the pharyngeal muscles were unaffected. His wheel-
chair was slightly tilted backwards to prevent head and truncal 
collapse. He had developed a rather severe thoracolumbar kypho-
scoliosis and a pectus excavatum. The use of his right hand was 
very limited. He steered his wheelchair using the right wrist. 
With his left hand he controlled several electronical devices and 
a typewriter. His pelvic girdle and upper leg muscles were all 
graded 1 or 0. He had a severe paresis of his triceps surae 
muscles (grade 3), which still appeared to be hypertrophic amidst 
the general atrophy, and a bilateral foot extensor paralysis. 
Both extensor digitorum brevis muscles could be felt to contract 
without a visible movement. There was a generalized areflexia. 
He had a flexion contracture of his right elbow. All 
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movements of both his wr-ists wer-e limited and he had bil ater-al 
hip, knee and ankle flexion contr-actur-es. 
At the age of nine year-s ser-um CK activity was 1265 U/ L. EMG 
at that time demonstr-ated a myopathic patter-n. The conduction 
velocity of the right peroneal nerve was 53 m/sec. Biopsy of the 
left quadriceps femoris muscle showed myopathic features only. 
The father (M II 3) had never- been able to whistle. When he 
was eight year-s old he developed a progressive shoulder- girdle 
weakness. Foot extensor weakness was noted at the age of 20 years 
and pelvic girdle weakness at the age of 33 years. At the age of 
43 he displayed an average case of FSHD in stage 3. All his 
brothers were examined and appeared unaffected. His mother 'could 
not be examined. She was said to have no muscle weakness. The 
mother of the proband had no symptoms and her family history was 
unremarkable. 
The case of M III 8 is certainly unusual for FSHD. The 
hypertrophy of the calf muscles is rather exceptional. The high 
levels of CK activity might reflect the rate of progression of 
his disease and the contractures could have been the result of 
his confinement to bed and wheelchair. The facial weakness had 
initially been mild, which is different from the cases with the 
infantile form of FSHD described by Brooke (1977) who all had 
early and severe facial weakness . Most, but not all, of Brooke's 
patients had a parent who was minimally affected, which is also 
different from this case. Still there are no good grounds to 
r-eject this case as an unusual expression of a quite variable 
disease . Also the other patients described in this section 
testify to the variability of the expression of FSHD . These 
patients and the other patients mentioned in Table 8 demonstrate 
clearly that FSHD can manifest before the age of seven years, as 
was stated by Landouzy and Dejerine (1885) but denied by Tyler 
and Stephens (1950) and Becker (1953), and that an early 
manifestation does not necessarily imply the presence of the 
syndrome with severe facial weakness described by Brooke (1977). 
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4.20. The clinical course and disability 
The course of the disease in our patients will be assessed 
in two ways. Firstly , we will look at the onset of symptoms. They 
certainly do not reflect early detectable weakness as is stated 
in 2. 2., but they represent a kind of longitudinal section 
through our patient-material. Secondly, we will attempt a 
transverse section and describe the clinical picture at the time 
of examination. 
Table 4.22. gives the onset of symptoms in 73 patients. The 
mean age of first symptoms, facial symptoms excluded (Table 
4.19.), was 16.r years in males and 20 .6 years in females and 
17.8 years for all patients. These figures are lower than the 
mean age of shoulder girdle weakness because a small group of 
patients first noted foot extensor weakness (group ESP) . It is 
suggested that the shoulder girdle weakness in the ESP group was 
very slowly progressive, while the onset of foot extensor 
weakness did not differ significantly from the average for the 
whole group of patients: if these patients were examined early, 
they all showed shoulder girdle weakness as well. Symptoms of 
pelvic girdle weakness also developed quite la te in the ESP 
group , so that this group of patients probably reflects a slow 
progression of the disease . The five patients in this group (B 
III 1, E Ill 1, L IV 12, L IV 42, L IV 44) came from three 
fami lies. In two patients ankle contractures were present at the 
first examination. In all these families other patterns of spread 
of disease have been observed. 
The last group, indicated wi th a question mark, represents 
all patients who could not give precise ages of the onset of all 
symptoms. One female (S III 6) had foot extensor weakness and 
tight heel cords at the age of 14. She noted shoulder girdle 
weakness when 19 years old but she was unable to tell when 
symptoms of pelvic girdle weakness were noted first. All other 
patients in this group had presented with shoulder girdle 
weakness. Two of them could indicate the onset of foot extensor 
weakness and five patients remembered the onset of pelvic girdle 
weakness. Most of these patients though could indicate the Table 
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4.22. Mean age of fir s t symptoms in 73 patients . 
Sequence Sex Number Mean age at onse t Mean age at 
of muscle of of symptoms time of 
invo l vement patients s E p examination 
M 12 16 . 2 32 . 3 
s F 3 18 . 7 30 . 3 
Tota l 15 16 . 7 31. 9 
M 6 16 . 2 27 32 . 8 
SE F 4 23 32 41.5 
Total 10 18 . 7 29 36 • .3 
M 15 14 . 9 22 . 8 33.4 47 . 5 
SEP F 5 21 33.4 43 . 6 57 . 2 
Total 20 16.5 25 . 5 36 . 0 49 . 9 
M 2 17 . 5 34 47 
SP F 2 14 27 28 . 5 
To tal 4 15. 8 30 . 5 37 . 8 
SPE F 2 19 37 23 46 
M 2 45 25 53 . 5 59 
ESP F 3 41.7 33.7 45 . 7 52 
To tal 5 43 30.2 48 . 8 54 . 8 
M 9 15 . 8 ? 43 . 7 (131/3) 50 . 2 
? F 8 17 . 6 25 (75/3 ) 40 . 5 ( 81/2) 61.9 
To tal 17 16 . 6 42 . 4 (212/5) 55 . 7 
=========== =====· ===== === ===== f= ========== p============= ======= 
M 46 17 24 . 1 36 . 7 42 . 6 
All groups F 27 21.7 32.0 38.3 49 . 7 
To tal 73 18.7 27 . 5 37 . 3 45 . 3 
S : shoulder gir dle muscles ; E: foo t extensor muscles; P : pelvic 
girdle mus cles ; ? : sequence unknown (see t ext) ; M: males F : 
females. 
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sequence of muscle involvement . 
Table 4. 22. suggests that, for the group as a whole, foot 
extensor weakness might be present nine years after the onset of 
symptoms and that again ten years later symptoms of pelvic girdle 
weakness might be expected. Such global statements should be 
handl ed with extreme caution because the onset of symptoms of 
foot extensor weakness varied from 0 to 28 years and the onset of 
pelvic girdle weakness from 0 to 33 years after the onset of 
shoulder girdle weakness, and some patients even presented with 
foot extensor weakness. Moreover, other patients will never 
develop more than shoulder girdle weakness, and some will remain 
asymptomatic. Patients H IV 5 and I V 7 had been symptomatic for 
46 and 39 years respectively. At the time of examination the 
disease was still limited to the upper extremities. 
In order to compare the clinical pictures in our patients we 
staged their condition as outlined in Table 4.12. The stages were 
chosen so that all partially examined patients could be 
classified as well. Stage 1 also comprises patients with the 
disease limited to their facial muscles . The four patients with 
pelvic girdle weakness but no foot extensor weakness were 
classified in stage 3. The different stages reflect an increasing 
severity of the disease and the criteria for each stage are 
chosen so as to represent an increasing disability as well. Table 
4.23. shows, as could be expected , an increasing severity with 
age . A similar tendency, although less distinct , is shown in 
Table 4. 2 4 where the stage of the disease is compared to its 
duration in 73 symptomatic patients. A comparison of the two 
tables shows that the bulk of the patients of stage 1 in table 
4 . 23. is formed by the 24 asymptomatic patients, of which eight 
patients had facial weakness only. 
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Table 4.23. Stage of the disease related to age at examination 
in 107 patients. 
Stage 0-9 10-19 20-29 30- 39 40-49 50-59 60-69 70- 79 80- 89 'Ibtal 
1 1 9 11 7 2 1 4 35 
2 1 2 2 3 7 3 18 
3 5 12 7 10 5 1 40 
4 1 1 2 4 
5 . 2 1 1 4 
6 1 1 1 1 2 6 
1 11 18 21 13 21 ' 15 5 2 107 
Table 4.24. Stage of the disease related to its duration in 73 
symptomatic patients 
Stage 0-9 10-19 20-29 30-39 40- 49 50::-59 60-69 Total 
1 5 2 2 1 1 11 
2 2 3 3 1 1 10 
3 3 9 12 8 6 38 
4 2 2 4 
5 1 2 1 4 
6 l 1 1 1 2 6 
10 15 19 13 11 3 2 73 
Stage 3 includes many patients with a clinical picture 
ranging from minimal pelvic girdle weakness, detectable only at 
examination, to such a degree of weakness that climbing stairs 
was just possible with extreme effort. The average duration of 
this stage is probably longer than the previous ones, since this 
stage involved the largest number of patients, but no adequate 
data were available to assess this problem. 
It is clear though, that the majority of the symptomatic 
patients (81%) are within the first three stages of the disease, 
but table 4.23 demonstrates that six out of seven patients (86%) 
over 70 years of age are within stage 4 or even higher. Since, as 
will be demonstrated later, the age of death is probably not 
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affected by the disease, and since the average expected life span 
in the Dutch population is 72 years in men and 78 years in women, 
a distinct degree of disability might be anticipated at an older 
age . If disability is judged by complete inability t o walk , only 
six patients qualified for this criterion. Ten patient s (9%) 
needed a wheelchair when outside their houses. Four of six 
patients in stage 6 were in a nursing home. Two were nursed a t 
their homes by their husbands with the aid of district- nurses . 
All patients in stage 1 to 5 were living with their fami lies. 
Fifty-two male patients were between the ages of 18 and 65 
years. Five patients were still at school or university . Eleven 
of the 47 patients (23%) were unemployed . Their di sabilities were 
the major reason fo r unemployment in all patients. 
Table 4.25. shows the s t age of the disease related to sex. 
None of the stages revealed a significant difference between t he 
numbers or percentages of males and femaies. If we adopt Becker's 
(1953) criterion for severity, i . e. the presence of pelvic girdle 
involvement, we will find 31 males (53%) and 23 females (48%) 
severely affected. 
We assigned a score 1 to each patient in stage 1 and score 2 
to each patient in stage 2 and so on. All 107 patients were 
scored. All scores added per sex yielded no significant 
difference between the sexes (P2 = 0.6 Student 's t - tes t ). Also , 
if all patients in stage 4, 5 and 6 are considered toge ther , no 
significant difference is found between t he sexes (P2 = 0.124 
Student's t - test). 
Table 4.25 . Stage of the disease related to sex in 107 patient s . 
Stage 1 2 3 4 5 6 'lbtal 
Males 18 (31%) 10 (17%) 26 (44%) 2 (3%) 1 (2%) 2 (3%) 59 (lOO%) 
Ferrales 17 (35%) 8 (17%) 14 (29%) 2 (4%) 3 (6%) 4 (8%) 48 (lOO%) 
'Ibtal 35 (33%) 18 (17%) 40 (37%) 4 (4%) 4 (4%) 6 (6%) 107 (100%) 
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4 . 21. Death 
The age at death of affected individuals with symptoms was 
known in 16 males and 12 females . The average age at death in 
males was 64 . 2 years. Affected women lived to an average age of 
70.5 years. The majority of these patients lived the greatest 
part of their lives in the first half of this century and died 
after the second World War. The average year of death in males 
was 1963 and females 1957. According to the Dutch National Office 
of Statistics the average age at death in the Dutch population 
for males in 1963 was 65.5 years and for females in 1957 was 67 . 3 
years. Table 4 . 6. shows that equal, though limited numbers of 
affected and healthy sibs, live up to old age and that there are 
no apparent differences between males and females. These findings 
suggest in different ways that there is a little or no influence 
of the disease on the age of death. 
Only in a few instances were the precise causes of death 
known to the families . Two patients (one male, one female) had 
died of what was said to be a heart attack. Two patients had died 
of pneumonia. A relation between the disease and respiration was 
never suggested . Other causes mentioned were drowning (1), 
complications of alcohol abuse (2), uremia (1), and abdominal 
malignancy ( 1) • 
4.22. Penetrance 
The penetrance of FSHD is said to be complete (Tyler and 
Stephens 1950; Becker 1953) . Table 4.5. shows that 85 affected 
and 80 non-affected sibs are involved in the 49 extensively 
studied sibships after corrections have been made for the 
probanda and the obligatory gene carriers. These numbers do not 
differ significantly from the expected 1 : 1 ratio and suggest 
complete penetrance . 
Yet we made two observations that were of interest with 
regard to the problem of penetrance. Patient H IV 7 (56 years 
old) was judged a questionable case when first examined . He was 
restudied after his son H V 20 was found to be clearly affected . 
His scapulae were somewhat prominent but all shoulder girdle 
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muscles were found to be of good strength. He could whistle and 
had no facial weakness . His foot extensor muscles were graded 4+ 
and his extensor hallucis longus muscles 4 . The remaining 
examination revealed no abnormalities. Because of this minimal 
foot extensor weakness, he was classified as an abortive case . 
His wife was examined as well . She revealed no abnormalities . 
The other observation was made on P II 1 (68 years old) . She 
claimed she never could whistle well. People had made remarks 
about her shoulders when she was young and she had never been 
able to ride a bicycle properly . Yet no definitely abnormal 
findings were present on physical examination . Her father was 
said to have suffered from muscular dystrophy and a photograph 
showed him walking with a steppage gait . Her chi ldren were 
clearly affected . She could not be classified as an asymptomatic 
case, because she demonstrated no abnormalities on physical 
examination. She is therefore classified as possibly affected. 
Still there is little doubt that she is a non-penetrant gene 
carrier . 
Experiences like the ones above demonstrate the potential 
biases of the examiner . One wonders how these patients would have 
been classified if they had had no offspring or if their childr en 
were too young to show signs . It is known from the examination of 
children that there is a phase in the development of FSHD in 
which the diagnosis cannot be made with certainty and , since the 
decision on who is a gene carrier and who is not hinges on the 
physical examination, it is suggested that the penetrance of FSHD 
might not be complete, although it must be almost complete 
because of the observed 1 : 1 ratio. 
The S-shaped curve for the age of onset calculated wi th 
regression analysis (Figure 4.9.) suggests that at the age of 57 
years 2 . 5% of the gene carriers have not come to clinical 
expression yet . Although it is in the nature of such a curve 
never to cross the 100% line, calculations such as these support 
the suggestion that there is a chance that a small percentage of 
the gene carriers may not come to expression in a lifetime. 
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4.23. Sex-influences 
Influences of the sex have been implicated concer-ning the 
sever-ity of the disease (Becker-, 1953) and the age of onset 
(Chung and Morton, 1959). We looked at several potentially 
impor-tant differ-ences between the male and female patients. 
1. Of the 19 pr-obands, 15 were males and four- females, a 
difference which was statistically significant (P2 = 0 . 0117 
Student's t - test). 
2. The mean age of onset, based on symptoms, was 15.8 years in 
males and 19.0 years in females. This difference was 
statistically not significant (P2 = 0.1 Student ' s t - test). 
3. Twenty-two percent of the male patients and 44% of the female 
patients were abor-tive cases. This differ-ence was 
statistically significant (P2 = 0. 016 Student's t-test) . 
4. If the sever-ity of the disease was judged by pelvic girdle 
involvement no impor-tant sex-difference was demonstrable. If 
patients in stage 4, 5 and 6 were considered together-, the 
difference in scor-es of severity 
involved was statistically not 
Student's t-test). 
between males and females 
significant (P2 0.124 
If the issue of sex-influences on the disease as a whole is 
considered, we have to corr-ect for the number- of tests performed 
in or-der- to fix our pr-obability of an er-r-or- of the first kind at 
0.05. Since the main factor determining the critical level of the 
tail pr-obabilities for the total of mutually independent tests is 
the number- of tests involved, we required each of the four tests 
to have a P value smaller than 0.0125 in order to be significant. 
This requirement was only met by the test on the number- of 
pro bands. 
The differences between males and females were mostly found 
in those items that include an important subjective element. It 
is possible that men by their- nature and professional tasks 
become awar-e of this disor-der earlier- than the female sex, and 
that for similar r-easons they seek pr-ofessional advice mor-e 
easily. 
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4.24. Genetic heterogeneity 
Several suggestions have been made in the literature that 
FSHD might be genetically heterogeneous (Chung and Morton, 1959; 
Kazakov et al. 1974). Regression analysis of the ages of affected 
sibs (figure 4.9), and anamnestic data of our patients suggested 
that congenital and infantile manifestation are very well within 
the possibilities of FSHD. 
Kazakov et al. (1974) stated that the spread of muscle 
involvement to the lower extremities a l ways occurred in a similar 
manner in one family i.e. either to the foot extensors first and 
then to t he pelvic girdle muscles, or the other way round . We 
observed shoulder girdle weakness and pelvic girdle weakness 
without foot extensor weakness in six patients (A IV 4, F IV 1, G 
III 20, I VI 11, I VI 12, J V 16). Two other patients (J IV 10, L 
IV 45) were positive that the muscle weakness first had spread to 
t he pelvic girdle and late r to the foot extensors . The reverse 
sequence of spread was observed in other patients in all these 
families. Therefore we could not substantiate Kazakov' s sugges -
tion, based on the clinical course, that FSHD is genetically 
hetereogeneous. 
Chung and Morton (1959) using 18 characters, calculated an 
interpedigree correlation of 0.747 for their patient- material 
collected from the literature. Such a figure suggests that 
multiple alleles or different loci are involved. The authors 
could not exclude a systematic bias of the various examiners in 
reporting the onset of symptoms. Also a pelvifemoral onset in 
11 .6% of their cases suggests heterogeneous material according to 
our experience. Variance analysis of the ages of onset in our 
patients (see section 4.17 . ) yielded an intraclass correlation of 
individuals belonging to the same sibship of 0.24875. Such a 
figure argues against heterogeneity. 
In summary, no arg uments for genetic heterogeneity were 
found in our patient- material. 
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4. 25. Environmental influences 
Influence of non- genetic factors on the expression of the 
disease could not be proven in our material . The presence of such 
factors affecting the age of onset has been suggested by finding 
an intraclass correlation of individuals belonging to the same 
sibship of 0 . 24875 , but genetic factors leading to such a figure 
could not be excluded. 
The asymmetry of muscle involvement (see section 4 . 10 . ) 
could very well be due to environmental factors, although ~gain, 
genetic influences of some kind could not be excluded. 
Studies of genetic markers showed that patients Q III 1 and 
Q III 2 were non-identical twins. 
4.26. Fitness 
To study fitness, we only considered those children of one 
affected parent, that were older than 25 years (see Table 4.26) . 
Among 107 affected sibs 25 (23. 4%) remained single, two were 
infertile and 80 fertile sibs had 255 children, which was an 
average of 3.19 children per sib. We also considered 65 non-
affected sibs. Fourteen were single (21.5%), two were infertile 
and the 49 fertile sibs had 150 children, an average of 3. 05 
children per sib. The relative fitness in the patients with FSHD 
is therefore 1. 04, which is a normal fitness compared to their 
non-affected sibs. Also the chances to remain single appeared not 
to be increased in the group of affected sibs, compared to their 
non-affected sibs. 
If the fitness was normal in the past, one would expect to 
find some very large kindreds. These have not been identified and 
they were also not suggested by genealogical investigations. This 
apparent inconsistency is not well explained. 
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Table 4.26. Fitness in patients with FSHD. 
Single Infertile Fertile No. of Average 
children 
Affected 25 2 80 255 3.19 
Not affected 14 2 49 150 3.06 
4.27 . Genealogical examination 
Extensive genealogical investigations were undertaken in all 
families described. Information obtained from family members was 
often of great help. Most of the data could be checked with the 
aid of the records of the registrar's office. In two of the 
families (I and L) these data also served to confirm the already 
suspected relation of various parts of the kindreds. Two families 
(C and G) were of Indonesian origin through the maternal line. 
There was little information on the paternal line in family C. 
The paternal line of family G came from Belgium 
traced further. According to both families, 
inherited through the maternal, Indonesian line . 
family F came from Germany . We obtained 
and could not be 
the disease was 
The ancestors of 
quite detailed 
information on the family from the proband but we were unable to 
confirm all his data. Six and occasionally seven generations of 
ancestors could be traced in the other 16 families. In general, 
the lists of ancestors were reconstructed until around 1800 AD. 
None of the 17 kindreds appeared to have a common ancestor. They 
also could not be traced to a common region. The chances that the 
families were related more distantly seemed small. Such findings 
suggest that mutations are the main factor in the emergence of 
new kindreds with FSHD . However, it should be realised that the 
first reported cases in a kindred are not necessarily de novo 
mutations. One or more generations of abortive cases do occur in 
FSHD (Pamboukis, 1931), the patients may have had ancestors with 
late onset of the disease and incomplete penetrance might play a 
role in some kindreds. The same arguments apply to all sporadic 
cases: only follow-up studies may elucidate whether they are non-
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hereditary cases or mutations . 
4 . 28 . Prevalence 
Figures about the prevalence of FSHD in the Netherlands 
cannot be more than a rough estimate. The pedigrees shown still 
might hide several cases. If approximately one-third of the 
patients are asymptomatic it is possible that asymptomatic 
families might be hidden in a population (Pamboukis, 1931). But 
even symptomatic patients often do not seek referral to a 
specialized centre. For instance in Family H only the proband (H 
V 16) was k no wn t o us. 
Fo rty-three patients out of 11 kindreds living in the 
province of North- Holland are included in the present study. We 
know of another famiy in this area with at least seven affected 
members . All but one refused examination and are not discussed 
here . Genealogical examination, going back an average of 180 
years , revealed no relation between these families, although they 
lived in a small area of 2600 square kilometers . At the end of 
this study, the population of the province of North-Holland was 
2 . 299 . 175 . Th i s would yield a prevalence of approximately 1 
patient per 46 . 000 individuals . Assuming similar prevalences in 
other parts of this country one would expect at least 300 cases 
of FSHD in t h e Netherlands . From the information of other 
neuromuscular clinics known to us , this figure is probably on the 
conservative side. No second proband was found in the 12 kindreds 
in Nor t h-Holland . If we assume that the chance for finding no 
second pro band in 12 kindreds is greater than 0 . 05, than the 
chance for finding no second proband in one kindred is greater 
than 0 . 775 , and t he chance for finding a second proband in one 
kindred smaller than 0 . 225 . According to the Poisson distribution 
the chance of fi nding a second proband in one kindred with this 
d i sease is about I X , in which X represents the probability of 
ascertaining a kindred . Therefore it is estimated that less than 
45% of the kindreds in North-Holland have been found . The 
ascertainment probability ( n ) is estimated to be smaller than 
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0.108, which is in agreement with other reports (Morton et al., 
1959). These estimates suggest that the true prevalence of FSHD 
is greater than 1 per 21.000 individuals in our population, a 
figure which is close to the one reported by Becker (1953) . 
Because several families had moved in recent times we were 
unable to estimate directly the number of new cases in a 
population within a certain period of time (incidence). Although 
the average Dutchman is expected to live 75 . 8 years in 1982, so 
that the average patient with FSHD in the province of North-
Holland is expected to live approximately 59 years with this 
disease, we did not try to estimate the incidence indirectly 
since this involved too many uncertainties. Similarly , because 
several famil~es had moved, because of possible illegitimacy, and 
because of reasons outlined in the previous section, we were 
unable to estimate reliably the number of mutations by the direct 
method (Morton et al., 1959) . The indirect method appeared not 
applicable since we observed a normal fitness in our material. 
Even if we assume a reduced fitness of patients with FSHD , the 
estimation of the incidence rate is too uncertain to try to 




As many patients as possible were studied with the use of 
routine laboratory procedures in order to establish the diagnosis 
in the kindreds as firmly as possible. These procedures included 
the examination of the serum creatine kinase (CK) activity, 
needle electromyography (EMG) of several muscles, and biopsies 
of muscles for histological and histochemical staining. Open 
biopsies (25) as well as needle biopsies (5) (Edwards 1980) were 
performed. In several possibly informative kindreds blood and 
saliva were collected for linkage studies. 
5.2. Serum creatine kinase activity 
Using automated sample analysers serum creatine kinase (CK) 
activity was determined in 77 patients with FSHD, and in 39 non-
affected sibs (19 males, 20 females), all with one affected 
parent. The average CK activity in the latter group was 27.9 U/1 
for both sexes (see Table 5.1 . ). 
Table 5.1. Average serum creatine kinase (CK) activity in 39 non-
affected sibs; values in U/1 
Number Average CK activity Range Upper limit 
of patients of normal 
Mal es 19 21.7 2 - 44 50 
Females 20 33 . 8 0 - 364 35 
Total 39 27.9 0 - 364 
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Two unaffected females had elevated CK activi ties. One 
patient revealed several bruises on physical examination for 
which she had no good explanation. Her serum CK activity was 364 
U/1. Serum CK-MB activity was not detectable in her case. The 
other patient had a serum CK activity of 53 U/1. If the former 
patient is disregarded , the average serum CK activity for females 
would be 16.4 U/1 (range 0 - 53) and, for all non- affected sibs 
19.1 U/1. 
The average serum CK activity was 84 . 5 U/1 in 77 affected 
sibs (Table 5.2.), and the average value in males (106 . 4 U/1) was 
approximately double that in females (53 . 6 U/1) . The asymptomatic 
patients had a lower level than the symptomatic patients . Twenty-
eight patients (15 males, 13 females) had normal CK levels (36% ). 
Normal values were predominantly found in the more advanced 
stages of the disease . 
Table 5 .2. Serum creatine kinase (CK) activity in 77 patients 
with FSHD ; values in U/1 
Symptomatic asymptomatic all patients 
patients patients 
Males No . 40 5 45 
Average CK 107.7 96.8 106 .4 
Female No. 21 11 32 
Average CK 56 . 4 48 . 2 53 . 6 
Total No. 61 16 77 
Average CK 90.0 63 . 4 84.5 
Table 5.3. shows the relation between serum CK activity and age. 
Patient M III 8 had a serum CK activity of 1265 U/1 at the age of 
nine years. He was already severely affected at that t ime . The 
high CK level is felt to reflect the high rate of progression in 
his case . The ne xt highest value was 214 U/1. All other values 
were below 200 U/1 . The decline of the serum CK act i v ity with age 
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is statistically significant (P 0.0001 Rank Regression 
Analysis). A similar decline is observed if the relation between 
the CK activity and the duration of the disease is considered 
(Table 5.4). This decline with duration is also statistically 
significant (P = 0.001, Rank Regression Analysis). 
The relation between the serum CK activity and the stage of 
the disease is demonstrated in Table 5. 5. If patient M III 8 is 
disregarded, because of the unusual rapid progression of the 
disease, the average serum CK-activity in stage 4 would be 38 . 0 
U/1 . The low level of CK activity in stages 5 and 6 could reflect 
both the diminished muscle mass and the immobility of the 
patients in this stage. 
Table 5.3. Relation between serum creatine kinase (CK) activity 
and age in years in 77 patients with FSHD; values in U/1 
Age ln yeare 0 - 9 10 - 19 20 - 29 30 - 39 40 - 49 50 - 59 60 - 69 70 - 19 so - 89 
Malea Ko I * 9 11 5 9 ' 2 -Average CK 1265 71.0 112. 0 87 . 6 118.' 52.1 31.0 42.0 -
Pemalea No - 3 7 7 ' 5 5 - 1 Average ClC - 115. 0 51.0 59· 7 32.5 51.6 38.6 - 14 
Total No I 7 16 18 9 I' 9 2 I 
Average CK 1265 89·9 85.3 76.8 80 . 2 51.9 35.2 42.0 u 
Table 5.4. Relation between serum creatine kinase (CK) activity 
and duration of the disease in years in 61 symptomatic patients 
with FSHD; values in U/1 . 
Duration 0 - 9 10 - 19 20 - 29 30 - 39 40 - 49 50 - 59 
Males No 6 11 7 10 5 1 
Average CK 279 . 7 93.8 112.1 54 . 0 28 . 6 55.0 
Females No 5 6 6 1 3 -
Average CK 85 .0 57 . 7 43.3 23 . 0 36 . 3 -
Total No 11 17 13 11 8 1 
Average CK 192. 1 81.1 80 .4 51.2 31.4 55 . 0 
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Table 5 . 5 Serum creatine kinase (CK) activity related to the 
stage of the disease in 77 patients with FSHD; values in U/1 
stage 1 stage 2 stage 3 stage 4 stage 5 stage 6 
No of patients 20 14 33 4 3 3 
Average of CK 64 . 6 72 . 2 75-9 344.8 25.3 25 -3 
Range of CK 10 - 168 23 - 176 11 - 214 23 - 1265 25 - 26 14 - 44 
In summary, only a general statement can be made: serum CK 
activity is only slighty raised in FSHD, in most cases does not 
exceed four times the upper limit of normal, and declines with 
age and duration of the disease . 
Serum CK-MB isoenzyme activity was measured in 16 patients 
by ion-exchange column chromotography (Mercer, 1974). It turned 
out that slightly elevated CK values yielded no detectable CK-MB 
fractions. In 11 patients (eight males and three females) with CK 
values above 100 U/1 the average CK-MB fraction was 4 . 4% (range 0 
- 6.2%) of the total CK activity. Values were considered normal 
up to 3%. These observations support previous reports (Klapdor et 
al.,1977) that the CK-MB fraction rarely exceeds 6% of the total 
serum CK activity in patients with neuromuscular disorders . The 
origin of the elevation of the serum CK-MB fraction in patients 
with FSHD is not quite clear . Silverman et al. (1976) and Zweig 
et al. (1980) suggested that the MB isoenzyme is of skeletal 
origin. It certainly cannot be concluded that the cardiac muscle 
is involved in FSHD . 
Serum CK activity was also examined in four si bs younger 
than ten years. All had normal values. Only one sib (A VII3), 
five years old, was suspected to be affected on clinical grounds. 
He had a CK value of 25 U/1. These persons have not been restu-
died to establish the predictive value of serum CK examination. 
Wal ton and Gardner - Medwin (1981) apparently observed no predic-
tive value of the serum CK levels in healthy children of parents 
with FSHD. 
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5.3. Genetic Linkage 
Genes are considered to be linked if their loci lie in 
proximity to each other on the same chromosome. The closer the 
distance between the loci, the smaller the chance that crossing-
over between the two homologous chromosomes occurs during gameto-
genesis . The distance between the loci is expressed in centimor-
gans . One centimorgan means a recombination frequency of 1% . 
Large families, in which many generations can be examined are 
most informative in linkage studies. Also the loci that are 
studied need to show sufficient heterogeneity in the population. 
Rarely are all these requirements met. In practice one has to 
rely on the combined information of several smaller families . 
Statis t ical analysis of data, mostly performed with the aid of a 
computer program, gives the probability of linkage at a given 
fraction of recombination (e) . These probabilities are expressed 
in logarithms and are called led- scores (logarithm of odds) . The 
logarithmic form allows the addition of the results of various 
studi es. If the lod-scores are +3 or higher , linkage is assumed. 
If the scores are -2 or lower, linkage at the given genetic 
dis tance i s highly improbable. No definite conclusion can be 
reached if the scores are between - 2 and +3. 
We studied possible linkage of the locus of the gene for 
FSHD with 35 d i fferent marker genes. The ten most informative and 
cooperative fami lies (kindred A - J) participated in this study . 
We collected blood and saliva from 62 affected and 58 non-affec-
ced members , including 17 non-affected parents. 
The blood groups ABO, MNS, P, Rhesus (RH), Kell (K), 
Lutheran (LU), Duffy (FY) and Kidd (JK) were determined. Phospho-
glucomutase (PGMl), 6 phosphogluconate dehydrogenase (PDG), 
adenylate kinase (AKl) , esterase D (ESD), glutamate-pyruvate-
t ransaminase (GPT), superoxide dismutase (SODl), phosphoglycolate 
phosphatase (PGP), glyoxalase (GLO), NADPH-diaphorase (DIA2), 
acid phosphatase (ACPl) adenosine deaminase (ADA), were investi-
gated in lysates of erythrocytes . Pseudo - cholinesterase 
(CHE2), a !-antitrypsin (PI), haptoglobin (HP), group-specific 
component (GC), complement factor (C3), transferrin (TF) and the 
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Table 5.6 Lod-scores for l inkage between the loci for FSHD and 
several genetic markers at di fferen t recombination fractions (9). 
AOO MNS p RH K LU Pt' JK 
0.01 - 8. 468 - 9. 469 0.167 - 23 .456 -6.773 0.029 -7.513 - 1.083 
0. 10 - 2.316 - 0.762 0.182 - 5.916 -3.124 0.016 - 2.665 -0.508 
0. 20 - 0.887 0.700 0. 1ll1 - 1.891 -1.795 0.007 -1.151 -0.232 
0.30 - 0.387 0. 734 0 .071 - 0.494 -0.988 0.004 -0.455 -0.089 
0. 40 - 0.181 0.276 0.021 - 0.082 -0. 426 0.001 -0.147 -0.016 
PGD PGMl AK1 ESD GPT GLO ACPl ADA 
0.01 - 2.548 - 4.742 - 1.222 - 8.843 - 7.372 - 12.622 -7.389 -7.764 
0. 10 - 0.825 - 1.379 - 0.321 - 2.611 -1.542 - 3.861 -1.745 - 2.920 
0.20 - 0.247 - 0.544 - 0.124 - 1.085 -0.318 - 1.626 -0.540 -1.920 
0.30 - 0.048 - 0.193 - 0.043 - 0.390 0.004 - 0.631 -0.194 -1.469 
0.40 0.004 - 0.039 - 0.009 - 0.095 -0.009 - 0. 168 -0.097 -0.633 
PI HP GC C3 TF AM KM GM 
o.o1 -15.577 - 3.600 - 9.613 - 0.848 0.068 - 0.606 - 2. 285 - 2.716 
0. 10 - 5. 715 - 1.542 - 2.328 - 0.507 o.on - 0.282 -0.956 1.277 
0.20 - 2.500 - o. 779 - 0.731 - 0.258 0.074 - 0.048 -0.341 1.428 
0.30 - 1. 108 - 0.319 - 0.156 - 0.108 0.056 0.016 -0.043 0.889 
0.40 - 0.292 - 0.077 0.001 - 0.027 0.023 0.013 0.053 0.252 
HLA- A B c D AMYl 
0.01 - 16.964 - 22.767 - 18 .346 - 13.725 - 2.763 
0. 10 - 4. 120 - 6. 721 - 5. 179 - 3.892 -0.835 
0. 20 - 1.253 - 2.575 - 1. 764 - 1.347 -0.345 
0.30 - 0.185 - 0. 747 - 0.348 - 0.301 -0.126 
0. 40 0.126 - 0.019 0.127 0.057 -0.029 
- 174 -
immunoglobulin marker genes AM, KM and GM were studied . Human 
Leucocyte Antigens (HLA) were typed, and in saliva Amylase (Amy 
1) and the proline-rich saliva proteins (PR, PA and DB) were 
determined . Statistical analysis was carried out with the use of 
the LIPED program (Ott, 1974). 
The scores obtained are represented in Table 5.6. SOD1, 
DIA2, CHE2, PR, PA, and DB were not informative in these 
kindreds: their scores were 0 and have been omitted. None of the 
marker genes studied gave a clear indication for linkage with 
FSHD. For the polymorphic marker genes ABO, RH, K, FY, ESD, GLO, 
ADA, GC, PJ and HLA linkage with FSHD at a recombination fraction 
of 0.10 could be excluded. The highest score obtained was 1 . 428 
for GM at a 0 . 20. This score, together with the score of 1.277 
at a recombination fraction of 0 . 10, suggests that there is a 
possibility that the genes for FSHD and for GM are linked, 
assuming only one locus for FSHD . More data on independent 
families will be required to confirm or refute this possibility. 
Recent studies proved that the locus for the GM system, which 
codes for the constant region of the heavy chains of IgG 
immunoglobulins, is situated on the short arm of chromosome 14 
(Croce et al., 1979; Shander et al., 1980; Cook et al., 1981). 
Linkage is known to exist between the GM locus, and PI locus 
which codes for a 1-antitrypsine. A peak lod-score of 20.75 is 
found for a GM- PI recombination fraction estimate of 0 . 26 (Gedde-
Dahl et al., 1981). Since the scores for PI and FSHD were all 
negative in our material, the gene for FSHD - if it were to be 
found linked with GM - would have to be on the other side of GM . 
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5. 4. Electrophysiological studies 
Concentric needle electromyography (EMG) was performed in 31 
patients ( 17 males, 14 females). In all patients at least five 
relevant muscles were sampled. These muscles were the left del-
toid, the right biceps brachii, the right quadriceps femoris, the 
left gastrocnemius and the right extensor digitorum brevis in 26 
patients. In five patients several other muscles were chosen. In 
16 patients more than five muscles were sampled. 
In all patients the motor nerve conduction velocity was 
measured in the right peroneal nerve. In nine patients additional 
motor nerves were studied. 
Table 5.7 shows that four patients (two males, two females) 
had normal electromyograms. One of the males had undergone 
another EMG two years prior to our examination, which was said to 
show myopathic patterns at that time. We do not feel a need to 
introduce new terms, as has been argued in Chapter 2, and will 
continue to use the terms myopathic patterns and myopathic EMG in 
those cases where a mixed or interference pattern of brief, small 
and often polyphasic action potentials is found . We are well 
aware that certain neurogenic lesions could lead to similar 
findings (W.K. Engel, 1975). 
Table 5. 7 Electrophysiological studies in 31 patients with FSHD 
Males Females Total 
Patients with normal studies 2 2 4 
EMG Patients with myopathic 
features only 11 12 23 
Patients with myopathic and 
neurogenic features 4 0 4 
Motor conduction velocity of the >-- 40 m/sec 15 12 '21 
right peroneal nerve < 40 m/sec 2 2 4 
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EMG of some or all muscles studied revealed a myopathic 
pattern and no neurogenic findings in 23 patients (Table 5.7). 
Four male patients, all of different families, had a myopathic 
pattern on EMG of several proximal upper extremity muscles, while 
EMG of leg muscles demonstrated neurogenic charac teris tics. One 
of these patients (Q III 5) had diabetes mellitus and clinical 
findings of a polyneuropathy, which had not been present in the 
past. The polyneuropathy could account for the neurogenic 
findings on EMG of his lower extremities. His sisters both had a 
typical picture of FSHD and a normal sensory examination (see 
kindred Q) . The right quadri~eps femoris muscle in patient C II 6 
showed spontaneous fibrillation potentials and a mixed to inter-
ference pattern on maximal voluntary muscle contraction with 
polyphasic action potentials, and individual action potentials of 
long duration and amplitudes of 1000 microvolts. The motor nerve 
conduction velocities were within normal limits. EMG in patient N 
III 10 revealed spontaneous fibrillation potentials in the right 
tibialis anterior muscle with a single to mixed pattern on maxi-
mal contraction, polyphasic potentials and amplitudes up to 1000 
microvolts . The left gastrocnemius muscle and the right extensor 
digitorum brevis muscle showed a mixed pattern with many 
polyphasic potentials. The duration of the potentials was not 
quantified, but the pattern was interpreted as compatible with a 
neurogenic lesion. The motor nerve conduction velocity of the 
right peroneal nerve was normal. Also in patient P III 2 (38 
years old) a mixed pattern, with many polyphasic potentials and 
potentials of long duration and increased amplitude was recorded 
in the right serratus anterior muscle (2000 microvolts) and in 
the right extensor digitorum brevis muscle (2000 microvolts). The 
left anterior tibial muscle revealed a single pattern on maximal 
contraction with polyphasic potentials of long duration and 
amplitudes of 1000 microvolts, while the right anterior tibial 
muscle showed a myopathic pattern with potentials of 200-300 
microvolts. Fibrillation potentials were observed in the right 
serratus anterior muscle in this patient. 
EMG of the orbicularis oris and orbicularis oculi muscles 
were performed in two patients (A IV and I VI 11), showing 
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myopathic features in both . 
High frequency (pseudomyotonic) discharges were recorded in 
patients M III 8 (gastrocnemius), P III 1 (tibialis anterior), 
and S III 6 (quadriceps femoris). 
The motor nerve conduction velocity of the right deep 
peroneal nerve exceeded 39 m/sec in 27 patients. Patient Q III 5 
had a polyneuropathy and a conduction velocity of 30 m/sec. No 
proper response could be elicited in what was left of the 
extensor digitorum brevis muscle in patient A IV 3. Two patients 
(F III 3 and N III 12) showed a conduction velocity of 39 m/sec. 
The meaning of these values is debatable. At the time of 
examination the patients were 70 and 50 years old respectively . 
Two patients (J III K, 78 years old, and J IV 10, 46 years old) 
demonstrated conduction velocities of 31 m/sec and 23 m/sec 
respectively . Repeated examination with control of the 
temperature of the extremities yielded values of 45 m/sec in both 
patients. 
The conduction of other motor nerves tested in nine patients 
yielded no abnormalities, with the exception of a slight 
reduction of the conduction velocity in the right (39 m/sec) and 
in the left (38 m/sec) posterior tibial nerves in patient P III 
2 . The motor conduction velocities in the peroneal nerves in this 
case were normal. A previous examination had shown a reduced 
motor nerve conduction velocity in the right median nerve. 
Repeated examination revealed normal values. 
Our observations strongly suggest that, if properly 
executed, measurements of motor nerve conduction velocities in 
FSHD will reveal no abnormalities. 
It can be concluded that routine EMG in FSHD shows myopathic 
features in the majority of cases. Occasionally (in 10% of our 
cases, i . e. in three out of 30 cases), neurogenic features such 
as abundant fibrillat ion potentials, in combination with - often 
polyphasic - potentials of increased duration and amplitude, may 
be observed in some of the muscles sampled. The neurogenic 
features may be present in the upper as well as in the lower 
extremities. 
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5.5. Muscle biopsies 
Muscle biopsies have been performed in patients of all 
kindreds, with the exception of kindred Q (see description of the 
kindred in chapter IV). In patient 0 III 6 the biopsy was said to 
have been compatible with a myopathy, but the slides could not be 
reviewed. Patient H V 16 had undergone a biopsy of the right 
quadriceps femoris . Only paraffin embedded slides had been made . 
These wer e reexamined and showed an increased variation of fibre 
diameter with hypertrophic fibres (up to 140 micron in diameter) 
and an advanced endomysial fibrosis and fatty infiltration. Prior 
to his examination at the neuromuscular clinic of the University 
of Amsterdam patient F III 3 had undergone biopsies of the lef t 
pectoralis major and the left anterior tibial muscles. These 
biopsies were reported to have been compatible with a myopathy. 
We studied 30 muscle biopsies obtained from 28 patients . 
Histological as well as histochemical preparations have been made 
in all instances. Haematoxylin and eosin (HE), NADH-tetrazolium 
reductase (NADH-TR) and myofibillar adenosine triphosphatase 
(ATP-ase) stains have been made in all cases. Modified Gomori ' s 
trichrome, periodic acid Schiff, lactic dehydrogenase and 
succinic dehydrogenase stains were available in most instances . 
Occasionally acid phosphatase, oil red 0, and other stains have 
been used. 
Six of the 30 biopsies (20%) revealed no abnormalities 
(Table 5. 8). Therefore the diagnosis of FSHD in kindred D rests 
on non-morphological criteria (see description of this kindred) . 
A similar situation was present in kindred Q, in which no patient 
had a muscle biopsy. Early in the course of the disease a normal 
biopsy is particularly found in muscles that are not (yet) 
involved on clinical examination such as the del to id of 
quadriceps femoris muscles. They confirm the experience of 
physical examination that muscle involvement may be localized in 
FSHD. 
Twenty-four biopsies from 23 patients revealed 
abnormalities. F IVl had two biopsies . The biopsies have been 
examined using the criteria outlined in Table 5.9 . Figure 5.1 
represents the percentages of the abnormalities found. 
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Table 5. 8. Muscle biops i es withou t abno r maliti es i n pa t ients wit h 
FSHD 
s III 11 : R. del t o id 
G II I 20 : L. del toid 
H V 20 : R. del t o i d 
I VI 11: R. quadriceps femoris 
N III 1 2 : L. quadriceps f emoris 
p III 2 : L. t r i ceps br a ch11 
FIGURE 5.1 : FINDINGS IN 24 MUSCLE BIOPSIES OF 23 PATIENTS WITH FSHD 
VAR.lATlON OF FIBRE DIAMETER 
FIBRE HYPERTROPHY ( >100 MICRONS) 





ENOOMYSIAL FAT INFILTRATION 
CENTRAL NUCLEI 
RING FIBRES 
TYPE 1 PREDOMINANCE 
TYPE1 ATROPHY 
TYPE 2 PREDOMINANCE 
POOR FIBRE TYPE DIFFERENTIATION 
MOTH · EATEN FIBRES 
• SEVERE. VERY MANY 
~ MODERATE. MANY 
[i;g MILD. A FEW 
!··;:.··. ! 
percentages or cases 
Patient AIV3 AV14 BIIIl BIII6 CII6 
Site of biopsyl QL QL TAL TAL QL 
Variati~ of fibre 
diarrete +++ + +++ +++ +++ 
F'1bre hypertropl'l}! 
(>lOO u) - - - + ++ 
Small angulated fibres2 - + - - -
Necrosis d~neration2 - - - + -
Regeneration2 - - - ++ -
~ 
Cellular infiltrations' - - - - + 
F'1brosis - - ++ +++ +++ 
Fat (endacys1a1)2 ++ - ++ +++ +++ 
Central nuclei3 - - ++ - ++ 
Ring f1bres2 - - - - -
Type 1 predan1nance 4 - - - - + 
Type 1 atrophy4 - + - - -
Type 2 predom1nance 4 - - - - -
Un1t'orm enzyme activ1t~ ~- - + + -
Jlbth-eaten f1bres2 +++ + + - ++ 
(G) (G) 
1~ Q: quadriceps femoris; TA: tibialis anterior; 
T: triceps brachii; D: deltiodeus; B: biceps brachli; 
R: right; L: left. 
2. - absent; +: mild, a few; ++: m:x:lerate, many; 
+++: severe, very many. 
Table 5.9. Resul 
CIIIl EIVl FIII3 PIVl GIII 
TAR QR QL QL 'm QR 
++ + ++ - + +++ 
++ + - - - -
- - - - - -
+ + + - - -
+ + - - - + 
++ ++ + - - -
+ + +++ - - +++ 
- - +++ - - +++ 
+ - - - - -
- - + - - -
+ - - - - -
- - - - - -
- - - - - -
- - - - - + 
+ - +++ + - + 
(G) (G) 
r 2~ muscle biopsies in 23 patients with FSHD. 
1111 JIVlO KIV2 LIV~2 LIV~~ LIV~~ LV84 MIII8 NIIIlO Pllil RII6 SIII2 SIII6 
L QL QR QR BL QR QR QL BL BR QL TAR DR 
+ + - ++ ++ + + +++ +++ +++ + +++ ++ 
- - - + - - - - - - + -
- + + - - +(G) - - + +(G) - -
- - + + - - ++ - + - - + 
- - - + - - + - - - - -
+ - - + - - + + - + - -
- - - + + - ++ +++ - - ++ +++ 
- - - - - - ++ +++ - - ++ +++ 
- - - - - - ++ +++ - - - -
- - - - - - - ++ - - + -
- - + - + - - - - - - -
- - - + - - - - - - - -
- + - - - - - - + + - -
- - - - - - - - - - + -
- - - - - - + +++ - - ++ -
(G) 
3. - absent; 3-10%; ++: 10-20%; +++: 20% or more 
4. absent; +: present. 
G indicates: observed in groups. 
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Figure 5. 2. Patient LV84 : small angulated fibres . Routine ATP-
ase x 400. 
Figures 5 . 3 . and 5.4 . Patient LV84 : small groups of atrophic 
fibres. HE X 400. 
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Figure 5. 5. Patient A V14: atrophic type 1 fibres. NADH-TR x 400. 
Figure 5.6 . Patient F III 3 : groups of moth-eaten fibres. NADH-TR 
X 400 . 
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Figure 5. 7. Patient N III 10: sarcoplasmi c masses and ring 
f i br es . HE X 1000 . 
Figure 5. 8 . Patient N III 10 : moth- eaten fibres in clusters. 
NADH- TR X 1000 . 
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An increased variation of fibre diameter was present in most 
cases (92%). Fibres were measured using a calibrated ocular . 
Hypertrophic fibres, i.e. fibres with a diameter exceeding 100 
microns were found in one-third (33%) of the cases . Small 
angulated fibres were present in six biopsies (25%) (Figure 5.2) . 
In four of these biopsies the small fibres occurred in small 
clusters of three or four cells (Figures 5.3 and 5.4). Larger 
groups of a trophic cells were not observed in these biopsies. 
Signs of degeneration such as necrosis and phagocytosis were 
present in eight biopsies (33%) . The biopsy with the most 
necrotic fibres was the one of patient M III 8, who indeed 
exhibited .the most rapid progression of the disease of all 
patients. Signs of regeneration, such as basophilic fibres with 
vesicular nuclei and prominent nucleoli, were remarkably 
inconspicuous. Small cellular infiltrations, occasionally rather 
frequently present, were never as extensive as reported in the 
literature (Munsat et al., 1972). No relation was apparent with 
complaints of muscle pains, but the pain was invariably located 
in the shoulder region, where a biopsy was rarely taken. 
Endomysia! fibrosis (58%) and fatty infiltration (42%) were 
rather common in this material. Most of these patients were seen 
in a rather advanced stage of the disease . Ring fibres were 
observed in three patients (12.5%). sarcoplasmic masses were 
present in the biopsy of patient N III 10 . Fibre splitting was 
observed in three biopsies (J IV 10, K IV 2 and S III 2). 
The histochemical stains were used for fibre typing, for the 
study of the organisation of the fibres in the biopsy, and for 
the identification of morphological peculiarities such as moth-
eaten fibres. Predominance of fibre type 1 was observed in four 
biopsies (17%). Selective atrophy of type 1 fibres was observed 
in two biopsies (8%). Figure 5.5. shows the NADH- TR stain of the 
biopsy in patient A V 14. The atrophic fibres are type 1 fibres, 
as was affirmed by the ATP-ase stain. Predominance of fibre type 
2 was present in three (12.5%) biopsies. 
Poor fibre type differentiation (Dubowitz and Brooke, 1973) 
was observed in four biopsies. This phenomenon is often reported 
in Duchenne muscular dystrophy but it is ill-explained. Van 
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Wijngaarden and Bethlem (1973) observed uniform enzyme activity 
in 27 out of 32 biopsies of patients with benign infantile spinal 
muscular atrophy . They suggested that uniform enzyme activity 
might be the result of the neurogenic lesion in these patients. 
The uniform enzyme activity in these two conditions might not be 
the result of the same mechanism . In two of our biopsies (G III 
' 17 and S III 2) vague suggestions of fibre type differentiation 
were present in other than ATP-ase and NADH-TR stains. 
Moth-eaten fibres have been observed in 11 biopsies (46%). 
This frequency is remarkable and in agreement with previous 
observations (Bethlem at al. 1973). They varied from small 
fibres, scattered through the biopsy, to large fibres in 
clusters. In five biopsies they occurred in groups (Figure 5 . 6.) . 
The reasons for this arrangement are obscure. A vasogenic lesion 
might be an explanation although morphological abnormalities of 
the small vessel wal ls have not been observed. However 
perivascular cellular infiltrations were present in four of those 
five biopsies. Another explanation for the grouped arrangement 
can be found in postulating a neurogenic lesion. The aberrant 
myofibrils and the sarcoplasmic collections in the moth-eaten 
fibres have been elegantly demonstrated by Bethlem et al. (1973): 
they resemble at an ultras true tural level the ring fibres with 
the sarcoplasmic masses known from histological examinations. 
Patient N III 10 demonstrated both features (Figures 5. 7. and 
5.8 . ). 
In summary, judged by pathological criteria, it can be said 
that both the nature and the degree of muscle involvement may be 
quite variable. Most abnormal! ties suggested a myopathic 
condition. The low degree of necrosis and the even lower degree 
of regeneration were remarkable and compatible with t he slowly 
progressive course of the disease . The amount of cellular 
infiltrations was impressive at times, but infiltrations were not 
present in all biopsies. 
Definite neurogenic findings such as type grouping, distinct 
group atrophy, and target fibres, have never been observed, but 
several features such as small groups of atrophic fibres, small 
angulated fibres, and clusters of moth-eaten fibres suggest that 
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neurogenic factors might play a role in FSHD. One or more of 
these features were present in 11 (46%) out of 24 abnormal 
biopsies. 
5. 6. Discussion 
Physical examination and family studies (Chapter 4) 
suggested that the patients in kindreds A-S suffered from the 
same disorder. Linkage studies (5. 3.) did not give evidence for 
linkage between the locus for the gene of FSHD , and the loci of 
any of the 35 genetic markers used . 
The serum creatine kinase (CK) activity revealed a rather 
uniform pattern in these patients (5 . 2). Elevation of the CK 
activity rarely exceeded four times the upper limit of normal. 
Normal values were obtained in approximately one third of our 
patients, and particularly in the more advanced stages of the 
disease. Determinat ion of the CK activity might be helpful in the 
occasional case when physical examination leaves doubts whether 
someone is affected or not. A marked CK elevation does not rule 
out FSHD but suggests also to consider disorders such as 
polymyositis. In most instances determination of the serum CK 
activity is not very helpful in the differential diagnosis of 
FSHD, because all disorders to be considered are able to give CK 
elevations similar as in FSHD. 
In several instances needle EMG (5.4.) and histological and 
histochemical examination of muscle biopsies (5 . 5.) revealed 
features considered to be of neurogenic origin. We will discuss 
the results in each kindred in order to demonstrate that the 
neurogenic abnormalities occur in some members of the families 
and not in others of the same families. It is inferred that 
neurogenic features in EMG and muscle biopsy are part and parcel 
of this disease . 
Kindred A demonstrates the importance of histochemical 
staining in muscle biopsies. Groups of small fibres in the HE 
stain proved to be moth-eaten fibres in A IV 3 . In patient A V 14 
the small fibres represented selective type 1 atrophy. In both 
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patients EMG showed myopathic features. Myotonia was not 
observed. 
Patients B III 1, and B III 6 both showed myopathic features 
on EMG. Poor fibre type differentiation was present in the 
biopsies of the anterior tibial muscles in both these patients. 
This might be related to the site of the biopsy, as patient S III 
2 presented a similar picture . In the other cases, where the 
anterior tibial muscle was biopsied ( C III 1), type 1 
predominance was found', a feature reported to occur frequently in 
biopsies of these muscles (Mercelis et al., 1981). 
Both patients in family C showed moth-eaten fibres in groups 
and no small angulated fibres. In patient C III 1 EMG was 
performed in another hospital and reported to be without 
abnormalities: he was not reexamined. Patient C II 6 had 
neurogenic features on EMG of his quadriceps femoris muscle. 
In patient D III 11 EMG showed myopat~ic features. Biopsy of 
his deltoid muscle revealed no abnormalities. 
Myopathic features were present both on EMG and in the 
biopsy of patient E IV 1. 
Patient F III 3 demonstrated many moth-eaten fibres in 
groups (Figure 5. 6.), myopathic features on EMG and a reduced 
conduction velocity of his right peroneal nerve (39 m/sec). EMG 
in his daughter (F IV 1) revealed no abnormalities. 
The two brothers in family G were studied in more detail. 
Both had myopathic features on EMG. G III 17 showed myopathic 
features on histological examination of the biopsy of the right 
quadriceps femoris muscle: histochemistry revealed poor fibre 
type differentiation. The biopsy in his brother G III 20 was 
normal. 
EMG and histological examination in patient H V 16 suggested 
a myopathy. The EMG and muscle biopsy in his cousin (H V 20) 
revealed no abnormalities. Patient I VI II had myopathic features 
on EMG and muscle biopsy similar to patient J IV 10. 
In patient K IV 2 both angulated fibres and fibre splitting 
were present in the biopsy of his right quadriceps muscle. EMG 
revealed no abnormalities. 
In family L, EMG studies suggested a myopathic condition in 
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L IV 44, L IV 45 and L V 84, while the muscle biopsy revealed 
myopathic abnormalities in patients L IV 42, L IV 44 and L IV 45 . 
Patient L V 84 demonstrated numerous small angulated fibres , 
occasionally occurring in a small group (figures 5.2 ., 5. 3. , and 
5.4.). 
In patient M Ill 8, both EMG and muscle biopsy suggested a 
myopathic condition. 
The motor conduction velocty of the right peroneal nerve in 
patient N Ill 12 was 39 m/sec. EMG revealed myopathic features . A 
biopsy of the left quadriceps femoris muscle was normal. Her 
br other, patient N Ill 10, was observed by others to show 
fascicula tions in several shoulder girdle muscles. When he was 
examined by us , neither fasciculations nor myotonia were 
observed. His calf muscles were well developed and slightly 
paretic. EMG of upper extremity muscles showed myopathic 
findings, but EMG of the anterior tibial muscle showed 
spontaneous fibrillation potentials and a single to mixed pattern 
on voluntary contraction with polyphasic action potentials and 
single potentials up to 1000 microvolts. A biopsy of the left 
biceps muscle in this patient revealed a marked var ia tion i n 
fibre diameter, ring fibres, sarcoplasmic masses and numerous 
central nuclei. Large numbers of moth-eaten fibres could be 
demonstrated (Figures 5.7. and 5 . 8.) . This . biopsy could have been 
compatible with myotonic dystrophy but neither myotonia nor other 
physical characteristics suggesting this disorder were present . 
The muscle biopsy in patient 0 Ill 6 could not be re-
examined : it was said to have shown myopathic changes. 
On EMG P Ill 2 demonstrated neurogenic features in some 
muscles in his arms and legs . Biopsy of the left triceps muscle 
revealed no abnormalities. EMG in P Ill 1 suggested a myopathy . 
Biopsy of the right biceps revealed small angulated fibres and 
type 2 predominance. Similar findings were present in patient R 
II 6. 
The neurogenic features on EMG of the leg muscles in patient 
Q Ill 5 could be explained by the diabetic polyneuropathy from 
which he suffered. EMG of the arm muscles showed a myopathic 
pattern. A muscle biopsy was refused. 
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Two patients of family S ( S III 2 and S III 6) had a 
myopathic pattern on EMG. Muscle biopsies revealed myopathic 
abnormalities on histological examination in both patients. 
Histochemical studies revealed poor fibre type differentiation in 
patient S III 2 in whom the anterior tibial muscle was biopsied. 
In patient S III 6 some fascicles suggested type 2 predominance, 
while a normal pattern was present in other fascicles . Such 
experiences emphasize that chance factors are involved in taking 
a biopsy. 
Several features of the muscle biopsies have been put 
forward in section 5 to be due possibly to neurogenic lesions. 
Such lesions could account for the neurogenic features on EMG in 
patients with FSHD. The most convincing features, suggesting a 
neurogenic factor in FSHD, are small groups of atrophic fibres, 
small angulated fibres and individual ampli~udes larger than 1000 
microvolts. These were present in nine out of 28 patients (32%) 
who had both EMG and muscle biopsy. Only one patient (H V 20) had 
no abnormalities in both. Neurogenic lesions occur in some 
members of the families and not in others, and are considered 
part of the disease. 
Chapter6 
Cases resembling facioscapulohumeral 
disease 
It has been argued that establishing an autosomal dominant 
pattern of inheritance is essential for the diagnosis of FSHD. So 
far, no solid proof has been put forward for an autosomal 
recessive disorder closely resembling FSHD . Sporadic cases have 
been observed but it is impossible to prove that they are not new 
mutants of FSHD. The opposi t e is equally difficult t o ascertain 
at the time of first examination. Genetic advice should be given 
with caution in these cases . We observed several patients who 
were proof to their parents of the autosomal dominant nature of 
the disorder. In several families (kindr eds G, K, R and S) the 
autosomal dominant pattern of inheritance had not been 
established before our study , nor was it suggested by t he family 
history. 
While studying the families of the probanda diagnosed on the 
basis of clinical criteria to suffer from FSHD, in three famil ies 
we were unable to establish an autosomal dominant pattern. In two 
families adequate family data were lacking. Extensive reporting 







In one family (kindred T) both parents were examined in 
detail: they demonstrated no abnormalities . Paternity 
investigation was not under taken. A brother (T III 14) and a 
sister (T Ill 15) of the proband were examined briefly; neither 
of these showed signs of muscle weakness or atrophy . Genealogical 
examination, going back 180 years, did not demonstrate or even 
suggest a relationship with the FSHD families reported in this 
study . The mother is sure that facial weakness was present in her 
daughter since the age of nine months. At the age of 12, the 
patient (T III 12) noticed difficulties writing on a blackboard. 
Her shoulder girdle weakness steadily progressed. When examined 
at the age of 24 , she had a marked facial weakness and she was 
just able to swing her arms up on a shelf above shoulder level . 
She also had a mild paresis of the abdominal muscles, foot 
extensor weakness and asymptomatic ankle contractures. 
Fasciculations and myotonia were not observed. Sensory 
examination was normal at the age of 15 . EMG and biopsy of the 
quadriceps femoris muscle had revealed no abnormalities. Serum CK 
activity at that time was raised twice the upper limit of normal. 
A definite diagnosis could not be made in this patient. Facial 
onset and the clinical picture , as it subsequently developed, is 
quite compatible with FSHD . 
u 
I *- 1920 
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In another family (kindred U), three sibs were affected. The 
parents and U II 6 had no complaints; they were not examined as 
they lived abroad. U II 1 had facial weakness before the age of 
five. Running became difficult at elementary school. Climbing 
stairs was possible until 21 years. She fractured her right tibia 
at the age of 32: after 11 weeks of immobilisation she was unable 
to walk. At the time of examination (34 years old) she had a 
marked facial paresis with good strength of the masseter muscles 
and no atrophy or fasciculations of the tongue. There was an 
asymmetric paresis of the shoulder and arm muscles, proximally 
more marked than dis tally . The legs were severely pare tic with 
the exception of the gastrocnemius muscles. Sensory examination 
was normal. All myotatic reflexes were absent, with the exception 
of the ankle jerks; no pathological reflexes could be elicited . 
Her brother (U II 3) developed a similar clinical picture, 
starting with facial weakness at the age of five. Progressive 
shoulder girdle weakness and footextensor weakness was noted 
since the age of eight. U II 4 was reported to have gait 
disturbances at the age of three. She remembered having needed 
speech therapy at the age of four, together with her brother. She 
could walk until the age of 15 and finally developed a picture 
very similar to that of her sister. I n both U II 1 and U II 3, 
EMG and muscle biopsy revealed myopathic changes. Two other sibs 
(U II 2 and U II 7) were examined and demonstrated no 
abnormalities. A brother (U II 5) , who was a marine, had died in 
an accident. Genealogical examination did not suggest any 
relationship with the FSHD families reported in this study. 
The clinical picture i n these three patients is similar to 
FSHD. The early onset of facial weakness and the rapidly 
progressive course would fit Brooke ' s description of the 
infantile form of FSHD . It is frequently observed in those 
instances that one of the parents has slight facial weakness; 
and, as facial weak ness may go unnoticed to the patient, FSHD is 
still a possible diagnosis in this family. 
In another sporadic case, family examination revealed the 
patient to be an illegitimate child . Nothing was known about the 
natural father, who could not be examined. Physical examination 
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of the mother revealed no abnormalities. 
All the cases discussed above demonstrate once more, that 
examination of the families is crucial in all instances where 
autosomal dominant inheritance is not apparent . In the true 
sporadic case in this material (T Ill 12) the myopathic nature of 
the disorder has not been documented sufficiently. 
Chapter 7 
General discussion 
This study describes facioscapulohumeral disease (PSHD) 
based on a survey of the relevant literature and on personal 
experience with 107 patients . After some historical remarks 
(Chapter 1), the picture of FSHD, as it emer ges from the 
literature, is described in Chapter 2 . The differential diagnosis 
of PSHD is dealt with in Chapter 3. The l e ngth of this chapter i s 
not so much caused by a long list of di seases as by t he attemp t 
to clear some of the confusion that has arisen after the 
introduction of the term facioscapulohumeral syndrome (FSHS). 
Originally, that term served only to summarize the clinical 
condition of patients in whom facial and shoulder g i r dle weakness 
and atrophy were the main features of the disorder (Van 
Wijngaarden and Bethlem, 1973). Described as such, and 
disregarding other clinical features, the clinical course, and 
the pattern of inheritance, it turned ou t to be a rather non-
specific syndrome. Later, this term was used to discuss the 
differential diagnosis of FSHD (Carroll, 1979). So 1t became 
customary to name several diseases in the differential diagnosis 
of FSHD that are not considered in daily practice , in which all 
clinical data, including the personal and the family history , are 
taken into account. Actually, the differential diagnosis of FSHD 
is rather limited and even more restricted if autosomal dominant 
inheritance has been established. In that case , only 
mitochondrial myopathies (Hudgson et al., 1972; Bradley at el. , 
1978) and spinal muscular atrophies (SMA) should be considered. 
In the latter, the muscle involvement spreads in an ascending 
order in contrast to FSHD. Autosomal dominant SMA with a 
descending course and otherwise resembling FSHD, has not been 
documented satisfactorily. The differential diagnosis becomes 
more extensive if the family cannot be examined and if heredity 
is not obvious. Autosomal recessive conditions resembling FSHD in 
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al l aspects, have not been demonstr'ated co nv incingly. Spot'adic 
cases have been descr'ibed: how many of these patients ar'e de novo 
mutations of FSHD is not known. 
The discussion on the diffet'ential diagnosis set'ves also to 
suppor't all other' at'guments that the patients desct'ibed in 
Chapter' 4 suffer' ft'om the same disot'det' . The t'esults of the 
physical examination and of the family studies in these patients 
will be discussed in mot'e detail below. 
Chapter' 5 desct'ibes the laborator'y data in out' patients. 
Serum creatine kinase (CK) activity was within nor'mal limits in 
34% of the cases . The elevation of the CK activity t'ar'ely 
exceeded four times the upper limit of normal . Similar' 
obser'vations have been t'epot'ted in the literature . Both with age 
and dut'ation of the disease a statistically significant decline 
of CK levels was observed. 
Possible linkage between the locus for FSHD and the loci for 
35 genetic mat'kers was studied, using blood and saliva of 62 
patients and 59 non-affected family members, including 17 non-
affected parents from ten kindt'eds (kindreds A - I). Statistical 
analysis , using the LIPED program (Ott, 1974), revealed no scores 
suggestive of linkage . The highest positive lod-score obtained 
was 1.428 for' GM at e 0.20 . 
Neut'ogenic featur:'es on electromyography (EMG) are reported 
in patients with FSHD (McComas, 1977). We obset'ved a large 
amplitude (1000 micr'ovolts or more) of single motor unit action 
potentials in some muscles of three patients (10%), while other 
muscles in these patients t'evealed a myopathic pat tern. Only 
myopathic patterns wet'e recot'ded in 74% of the patients. One 
patient (3%) had neut'ogenic features on EMG, but also a diabetic 
polyneuropathy in addition to FSHD. In four patients (13%) EMG 
was normal. 
Muscle biopsies yielded similar' results. Small angulated 
fibres, considered to suggest denet'vation, wet'e pr'esent in six 
(20%) biopsies . Six biopsies (20%) revealed no abnormalities . 
Eighteen biopsies (60%) showed myopathic features and other', less 
well explained changes such as groups of moth-eaten fibr'es . 
As there is ample documentation that myopathic features both 
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on EMG (Emery, 1981) and on muscle biopsy (Drachman et al ., 1967) 
may be found in cases with neurogenic muscular atrophy, and as 
the reverse is rarely mentioned (Dastur and Razzak, 1973), there 
is a distinct tendency in the literature to let the neurogenic 
features weigh heavier in the discussion on the primary lesion in 
neuromuscular conditions. This might explain that small angulated 
fibres in a muscle biopsy have led to the description of 
autosomal dominant FSH spinal muscular atrophy (Fenichel et al., 
1967). We consider the neurogenic features part and parcel of 
FSHD as they occur only in some members of families with FSHD and 
not in other members. 
The results of physical examination in 107 patients with 
FSHD and the analysis of the kindreds, as described in chapter 4, 
testify to the homogeneity of the disorder in these patients. 
Comparison with results reported in the li terature and mentioned 
in Chapter 2 will be made only when relevant. 
Presenting symptoms of shoulder girdle weakness were noted 
in 82% of our cases, those of facial weakness in 10% and 
presenting symtoms of foot extensor weakness were reported in 8% 
of the cases. In no instance the disease presented with symptoms 
of pelvic girdle weakness. This is in contrast to Chung and 
Morton's data (1959), collected largely from the literature, in 
which pelvic girdle onset was reported in 12% of the cases. They 
suggested that their patient material was genet ically 
heterogeneous , 
0.747. It is 
as they calculated an intraclass correlation of 
possible that cases with autosomal dominant 
neurogenic disorders were included, because most of their 
patients were studied before the age of modern laboratory tests. 
Chung and Morton (1959) also reported facial onset in 20% of 
their cases. It is not very clear which criteria they applied. We 
considered inability to whistle not specific for facial weakness. 
At the beginning of our study it was not certain if the symptom 
of inability to whistle was suffiently sensitive. Seven of our 
symptomatic patients (10%) remembered events, other than 
inability to whisle, indicating early facial weakness. Fifty-four 
of all our 107 patients (51%) never had been able to whistle: all 
these patients had facial weakness when examined. As the patients 
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who lost the ability to whistle (12%) could not indicate when 
this had happened, no specific age at onset of facial weakness 
could be given. Fourteen patients (13%) had weakness of the 
orbicularis oris, but could whistle. Seeker (1953) and Chung and 
Morton (1959) did not report foot extensor onset in their cases. 
Tyler and Stephens (1950) were the first authors who drew 
attention to early foot extensor weakness in FSHD : this was 
confirmed by others (Chyatte et al., 1966). Even if FSHD 
presented itself with complaints of foot extensor weakness, a 
fair degree of shoulder girdle weakness was observed on physical 
examination. 
Physical examination of 107 patients resulted in a rather 
circumscribed and uniform picture. We observed facial weakness in 
94% of the cases at the time of examination. Seeker (1953) 
reported 81% and Chung and Morton (1959) 83%. In eight of our 107 
patients (7%) facial weakness was the sole finding . All other 
patients (93%) had shoulder girdle weakness. Fbot extensor 
weakness was present in 72 cases (67%) and pelvic girdle weakness 
in 54 cases (50%). Similar figures are reported by Seeker (1953) 
and Chung and Morton (1959). It should be noted , however, that 
many of Seeker's cases are included in Chung and Morton's 
material . 
Judged by the degree of muscle weakness and based on 
anamnestic data we found the descending spread of muscle 
involvement characteristic of FSHD. 
We divided the course of the disease in six stages , each 
s tag.e characterized by the emergence of easily recognizable 
symptoms . These symptoms in themselves reflect degrees of 
disability . This simple sys tern proved to be a valuable tool in 
evaluating the course of a patient ' s disease. Facial weakness 
appeared within the first two stages in our material, but it 
could not be used to record progression, as many patients were 
unaware of it. 
After involvement of the scapular fixators (the rhomboidei, 
the lower trapezius and the anterior serratus) and of the 
pectoralis major and latissimus dorsi (stage 1), the foot and toe 
extensors (the anterior tibial, the peroneus longus and brevis, 
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the extensor hallucis and extensor digitorum muscles), the 
abdominal muscles, the other periscapular muscles and the upper 
arm muscles become involved (stage 2). The onset of pelvic girdle 
weakness characterizes the beginning of stage 3. In this stage, 
the onset of weakness of the lower arm muscles might be observed. 
The onset of stage 4 is marked by the loss of the ability to 
climb stairs. In stage 4 there is a further progression of the 
disease, leading to general involvement of most muscles, with 
notable exception of the extraocular, the pharyngeal, the lingual 
and masticatory muscles. A patient dependent on a wheelchair, 
when outdoors, is considered to be in stage 5; when walking 
inside the house, such patients lean heavily on chairs and 
tables. In stage 6 a patient is totally dependent on a wheelchair 
and on nursing care. 
We found a distinct asymmetry of muscle involvement in which 
the right shoulder or arm was significantly more frequently more 
severely involved than the left. This was not related to the body 
side; a similar asymmetry was observed in the legs but the more 
severe involvement occurred in equal frequencies on each side. A 
statistically significant positive correlation of upper limb 
involvement was observed with handedness. 
As a rule, the tendon reflexes were lower and finally absent 
with increasing muscle involvement, but there was no constant 
relation with muscle weakness or atrophy and no constant order of 
disappearance of reflexes. 
Muscle contractures are said to be rare in FSHD (Walton and 
Gardner-Medwin, 1981). Our experience confirms this general 
statement, but an exception has to be made for ankle 
contractures, which occurred in ten of our patients (10%). In 
three patients they brought about the first complaints. 
Pseudohypertrophy of calf muscles was observed in two 
unrelated male patients (2%), and was absent in other members of 
their families. A thoracolumbar scoliosis was present in 32% of 
the cases, and an increased thoracic kyphosis in 11%. The 
scoliosis was severe in one patient only; in all other patients 
the scoliosis was very mild. Cardiac symptoms were rare and 
cardiac disease appeared to be un related to the neuromuscular 
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disorder . 
A high percentage of the cases (32%) was abortive, defined 
as affected but asymptomatic. Tyler and Stephens (1950) reported 
41%. The decline of percentages of abortive cases with age was 
statistically not significant in our material. As it is plausible 
that a few of the young asymptomatic patients eventually will 
become symptomatic, a similarly small amount of sibs might become 
detectably affected though asymptomatic with advancing age, but 
the majority of the asymptomatic patients appear to remain so 
during their lives. 
The mean age of onset of the disease, calculated from the 
reported age of onset of first symptoms, was 17.0 years in the 
symptomatic patients (15 . 8 years in males and 19.0 years in 
females). Regression analysis of the segregation data of the 
cohort ages in 84 symptomatic and asymptomatic patients and in 80 
of their healthy sibs resulted in a mean age at onset of -9 
years, assuming that the relation between age at onset and 
percentage of affected cases is represented by an S-shaped curve. 
This odd figure is caused by the fact that already in the second 
decade all expected cases could be diagnosed. Both the cumulative 
percentages of symptomatic patients, and the regression analysis 
might be used to calculate genetic risks at different ages. 
We observed no patients with infantile onset of FSHD as 
reported by Brooke (1977), i.e . facial involvement within the 
first two years of life, followed by a rapid progression of 
facial and limb muscle weakness, leading to dependence on a 
wheelchair by the end of the first decade. However, there were 
several patients in our material who developed symptoms before 
the age of seven, which was reported to be the earliest age to 
detect muscle weakness in gene carriers (Tyler and Stephens, 
1950; Becker, 1953). Our observations are in agreement with those 
of Landouzy and Dejerine (1885), who reported onset before the 
age of five. The above- mentioned regression anal ysis, resulting 
in a mean age at onset of -9 years, and anamnestic data on a few 
patients suggested that an infantile onset is within the 
possibilities of the disorder represented by our patients. In our 
opinion, the onset of the disease may be observed from the first 
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to the last year in life. 
In the majority of cases the course of the disease was 
reported to be relentlessly progressive, Occasionally, long 
periods of arrest were noted, but their occurrence was rare . The 
rate of progression was quite variable. The average duration of 
spread from the shoulder girdle to the foot extensors was 8. 8 
years and from the foot extensors to the pelvic girdle muscles 
9.8 years (Table 4. 22.). The stages of the disease, as described 
above, reflect disability as well. As could be expected, 
disability increases with age and duration of the disease. 
Although a fair percentage of asymptomatic cases was found in the 
seventh decade (30%) , at least 20% of the patients in this decade 
will be unable to climb stairs. Total loss of the ability to walk 
is rare and occurred in 6% of all cases. Death of patients 
belonging to the kindreds under study apparently had not been 
related to the disease. No significant influence of the disease 
on the age at death could be detected . 
Analysis of the segregation data in the extensively studied 
sibships suggested complete penetrance. Personal experiences in 
the examination of the families testified to the possible biases 
in the examiner and, at the same time, suggested that the 
penetrance is more likely to be almost complete ( 98-99%). The 
possibility of an almost complete penetrance is supported by the 
regression analysis on the cohort ages of the segregation data in 
the extensively studied sibships. In this analysis 97.5% of the 
heterozygotes have come to expression at the age of 57, but the 
standard errors were rather large. 
Becker (1953) reported women to be less severely affected 
than men, and Chung and Morton (1959) reported a significant 
difference between the age of onset in males (16.8 years) and in 
females (13.7 years). We found no significant differences between 
the sexes on the i terns of age of onset, number of asymptomatic 
cases, and severity of the disease. A significant difference was 
found on the numbers of pro bands only (fifteen males, four 
females) . The reason for this finding is unclear. 
Grounds to suggest heterogeneity could not be found in our 




with individuals, gave no arguments for 
intraclass correlation (0 . 24875) suggested 
that environmental factors could play a role in the onset of the 
disease. Also, the significant asymmetry of shoulder girdle and 
arm involvement (described above) might be caused by environ-
mental factors. 
Fitness , judged by the number of offspring of children of an 
affected parent, appeared normal in patients with FSHD, compared 
to their healthy sibs . Genealogical investigations, going back an 
average of 180 year.s, suggested that none of the families were 
related. If mutations are the main factor in the emergence of new , 
kindreds with FSHD and if fitness had been normal in the past, 
one would have expected to encounter more large kindreds. They 
were not found and this inconsistency is not well explained. The 
prevalence of FSHD in the province of North-Holland in the 
Netherlands was estimated to be at lease 1 in 46.000. From the 
data available it appears that less than 45% of the kindreds have 
been found . 
Summary 
Observations in 107 patients with facioscapulohumeral 
disease (Landouzy-Dejerine' s disease or facioscapulohumeral 
muscular dystrophy) enabled us to summarize this disease as 
follows: 
- The mode of inheritance is autosomal dominant. 
- The majority of our patients (82%) had presenting symptoms of 
shoulder girdle weakness. Symptoms, other than inab111 ty to 
whistle, suggesting facial onset were reported in 10% of the 
cases: 8% of the patients had presenting symptoms of foot 
extensor weakness . Presenting symptoms of pelvic girdle 
weakness have never been reported. Inability to whistle never 
was a complaint, although 50% of our patients never had been 
able to whistle and 12% lost this ability in the course of 
their disease. Four patients related episodes of shoulder pain 
to the onset of the disease. 
- On physical examination 94% of the patients had facial 
weakness: in eight patients (7%) this was the only sign of the 
disease. Shoulder girdle weakness was present in 93%, foot 
extensor weakness in 67% and pelvic girdle weakness in 50% of 
the patients . 
- The disease has a descending order of muscle involvement. It is 
probable that facial weakness is the earliest detectable sign 
in the majority of cases but as facial weakness rarely leads to 
complaints, only longitudinal studies could prove such a 
statement. The truncal or 11mb muscles first to become involved 
are the scapular fixators, the pectonalis major and the 
latissimus dorsi. On examination the cases presenting with 
symptoms of foot extensor weakness had shoulder girdle weakness 
as well. Early abdominal muscle weakness was common in our 
patients. 
- The further spread of muscle involvement may occur in two ways. 
The majority of patients sho w early foot extensor weakness and, 
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subsequently, pelvic girdle involvement. In a few patients the 
reverse sequence is observed. Both sequences may be observed 
within one family. 
- The course of the disease is steadily progressive in the 
majority of the symptomatic patients. The rate of progression 
is quite variable. Long periods of apparent arrest of the 
disease have been reported by our patients, but they do not 
occur frequently. Also, a very rapidly progressive course is 
rare and occurred in only one patient in this material. The 
average duration of spread from shoulder girdle to foot 
extensor involvement was 8 . 8 years (range 0-28 vears), and from 
foot extensor to pelvic girdle involvement was 9 . 8 years (range 
0- 33 years). 
- Thirty- two percent of the patients were abortive cases, defined 
as affected but asymptomatic patients. The difference between 
males (13 cases) and females (21 cases) was statistically not 
significant . It is probable that the majority of these cases 
will remain asymptomatic . 
- The average age of onset, based on symptoms, was 17.0 years in 
our patients , which is in agreement with the findings in the 
literature. The difference between the age of onset in males 
(15 . 8 years) and in females (19 . 0 years) was statistically not 
significant. The age of onset varied from three to 44 years. 
Onset in infancy is possible and part of the disease. 
- Asymmetric involvement of the shoulder and arm muscles was 
frequently observed . The right side was significantly more 
frequently more severely involved than the left side. This 
asymmetry was significantly correlated with handedness, but was 
not related to the body side. 
- Pseudohypertrophy of muscles was rare . Calf hypertrophy with 
weakness was observed in two cases (2%). 
- Ankle contractures were present in ten cases 
Contractures of other muscles are extremely rare. 
(10%). 
- No evidence was found to suggest cardiac muscle involvement . 
- Men and women were equally affected. There were no sex-
differences in severity of involvement. The only significant 
difference between the sexes was observed in the number of 
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probanda (15 males, 4 females). 
- The penetrance was almost complete. Gene carriers that will not 
come to expression in a lifetime are rare, and probably do not 
exceed 2%. 
- Fitness , judged by offspring, was normal in our patients with 
FSHD compared to their non- affected sibs. 
- The prevalence of the disease in the province of North-Holland 
(The Netherlands) was at least 1 in 46.000 individuals. It is 
estimated that less than 45% of the kindreds have been found. 
This would bring the estimated prevalence in the province of 
North-Holland at at least 1 in 21.000 individuals. 
- Disability increases with age and duration of the disease. 
Complete loss of the ability to walk occur red in 6% of our 
cases. 
- The life span of the patients is probably not influenced by the 
disease. 
- The serum creatine kinase activity was normal in 34% of the 
cases, and rarely exceeded four times the upper limit of 
normal. The level of the creatine kinase activity declined 
significantly with age and duration of the disease. 
- Linkage between the locus for FSHD and the loci for 35 genetic 
markers has not been demonstrated. The highest lod-score 
(1.428) was obtained for GM at 6 0.20 . 
- Electromyography revealed no abnormalities in four patients 
(13%). A myopathic pattern was present in 23 patients (74%) , 
and both myopathic and neurogenic features were recorded in 
three patients (10%). One patient (3%) revealed a neurogeni c 
pattern due to a diabetic polyneuropathy. The neurogenic 
changes occurred in some family members and not in others, and 
are considered to be part of the disease. 
- Histology was normal in six muscle biopsies (20%). The other 
biopsies all showed various degrees of myopathic changes. A low 
grade of necrosis and an even lower grade of regeneration are 
striking. Small cell infiltrations of various sizes may be 
present as well. Small angular fibres, possibly suggesting 
denervation, were present in six biopsies (20%) . Occasionally 
groups of a few atrophic fibres were found and also moth- eaten 
- 206 -
fibres occurred in groups. In addition to the moth-eaten 
fibres, histochemistry showed poor fibre type differentiation 
in four (13%) biopsies. The examination of the muscle biopsy 
may yield an extremely variable picture. 
- In this material there were no grounds to assume that 
facioscapulohumeral disease, as described above, is genetically 
heterogeneous. 
- The differential diagnosis is limited and includes autosomal 
dominant scapuloperoneal spinal muscular atrophy and autosomal 
dominant mitochondrial myopathy. 
- The pathogenesis and cause of this disease are not known. 
Samenvatting 
De facioscapulohumerale ziekte (ook wel de ziekte van 
Landouzy - Dejerine of facioscapulohumerale spierdystrofie genoemd) 
werd bestudeerd aan de hand van de literatuur en 107 eigen 
gevallen. Na een historische inleiding (Hoofdstuk 1) werd het 
klinische beeld, zoals di t ui t de li teratuur naar voren komt, 
beschreven in Hoofdstuk 2. Bij veel aandoeningen kan zwakte en 
atrofie van de facialis musculatuur en van de schoudergordel-
spieren, het zogenaamde facioscapulohumerale syndroom, op de 
voorgrond staan; toch is de differenti~le diagnose van de facio-
scapulohumerale ziekte beperkt, mits het totale klinisch beeld en 
het erfelijkheidspatroon in de overwegingen betrokken warden. Het 
facioscapulohumerale syndroom wordt besproken in Hoofdstuk 3. In 
het vierde Hoofdstuk warden de resultaten van het klinische en 
het genetische onder~oek bij 107 patienten uit 19 families 
beschreven. Hoofdstuk 5 laat de resultaten zien van het onderzoek 
van de serum creatine kinase aktiviteit, de resultaten van het 
koppelingsonderzoek en de resultaten van het hulponderzoek 
(electromyografie en spierbiopsie) bij sommige van deze 
pati~nten. De resultaten van ons eigen onderzoek maken het 
mogelijk om de facioscapulohumerale ziekte als volgt samen te 
vat ten: 
- Het overervingspatroon is autosomaal dominant. 
- Bij de meeste pati~nten zijn de eerste klachten het gevolg van 
zwakte van de schoudergordelspieren. Dit werd door 82% van onze 
patienten gemeld; 10% van onze patienten bemerkte als eerste 
verschijnsel klachten die wezen op zwakte van de facialis 
musculatuur en 8% van de patienten klachten die wezen op zwakte 
van de voetheffers. Niet kunnen fluiten was nooit een klacht , 
hoewel 50% van onze patienten nooit heeft kunnen fluiten en 12% 
deze vaardigheid in de loop van de ziekte kwijt raakte. Vier 
patienten brachten een periode van schouderpijn in verband met 
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het begin van de ziekte. Klachten, die wijzen op een zwakte van 
de bekkengordelspieren, werden ni~t vermeld in verband met het 
begin van de ziekte . 
- Bij lichamelijk onderzoek bleek 94% van de patienten zwakte van 
de facialis musculatuur te hebben; bij acht patienten (7%) was 
dit het enige teken van de ziekte. Zwakte van de schoudergor-
delspieren werd gevonden bij 93%, zwakte van de voetheffers bij 
67% en zwakte van de bekkengordelspieren bij 50% van de 
patienten. 
- De ziekte breidt zich van boven naar beneden ui t. Waarschijn-
lijk is in de meeste gevallen zwakte van de facialis muscula-
tuur het eerste verschijnsel, maar omdat dit zelden tot 
klachten leidt, kan alleen longitudinaal onderzoek dit met 
zekerheid vaststellen. De spieren van de romp en de ledematen, 
die het eers t zijn aangedaan, zijn de m. serratus anterior, de 
m. rhombo i deus en het onderste deel van de m. trapezius. Zij 
fixeren de scapula bij bewegingen van de arm. Daarnaast zijn 
ook de m. pectoralis major en de m. latissimus dorsi vroeg 
aangedaan. In die gevallen, waarbij de eerste klachten 
veroorzaakt werden door zwakte van de voetheffers blijkt bij 
onderzoek reeds een zwakte van de schoudergordelspieren te 
bestaan. Zwakte van de buikspieren was een vroeg verschijnsel 
bij onze patienten. 
- De verdere uitbreiding van de aandoening vindt op twee manieren 
plaats: de meeste patienten ontwikkelen eerst een zwakte van de 
voetheffers en daarna een zwakte van de bekkengordelspieren; 
bij enkele patienten vindt de omgekeerde volgorde plaats . Beide 
manieren kwamen binnen een en dezelfde familie voor' zoda t 
hieraan geen argumenten ontleend kunnen worden dat de ziekte 
genetisch heterogeen zou zijn. 
- In de meerderheid van onze symptomatische patienten was de 
ziekte gestaag progressief . De snelheid van de progressie was 
zeer variabel. Slechts af en toe werden lange perioden van 
schijnbare stilstand van de ziekte gemeld . Zelden, en in ons 
ma teriaal bij een patient' werd een snel progressief be loop 
waargenomen. Het uitbreiden van de ziekte van de schoudergordel 
naar de voetheffers duurde bij onze patienten gemiddeld 8,8 
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jaar (varierend van 0 tot 28 jaar) en van de voetheffers naar 
de bekkengordel 9 , 8 jaren (varierend van 0 tot 33 jaar). 
- Twee-en-dertig procent van onze patienten had geen klachten. 
Dit zijn de zgn. abortieve of asympt omatische gevallen. Het 
verschil tussen mannen (13 patienten) en vrouwen (21 patienten) 
was statistisch niet signigifant . Het is waarschijnlijk dat de 
meerderheid van deze patienten asymptomatisch blijft . 
- De gemiddelde beginleeftijd van de ziekte, beoordeeld naar 
klachten, was 17 , 0 jaar. Dit getal stemt overeen met de 
gegevens in de literatuur. Het verschil tussen de beginleeftijd 
biJ mannen (15,8 jaar) en die bij vrouwen (19,0 jaar) was 
s ta tis tisch niet significant . De beginleeftijd varieerde van 
drie tot 44 jaar. Op grond van gegevens u i t ons materiaal lijkt 
het zeer wel mogelijk dat de ziekte zich binnen de eerste twee 
levensjaren kan openbaren. 
- De schoudergordel- en armspieren bleken vaak asymmetrisch te 
zijn aangedaan. De rechter kant was statistisch significant 
ernstiger aangedaan dan de linker kant . Deze voorkeur was 
statistisch significant gecorreleerd met rechts- of links-
hand1ghe1d . Ook de bekkengordel- en beenspieren waren vaak 
asymmetrisch aangedaan, maar hier bleek geen significant 
verschil tussen links en rechts te bestaan. De voorkeur voor de 
rechter schouder en arm leek niet bepaald door een voorkeur 
voor de rechter lichaamshelft. 
- Pseudohypertrofie van spieren komt zelden voor bij deze 
aandoening. Hyper t rofie van de kuitspieren met parese werd bij 
twee van onze patienten (2%) waargenomen. 
- Contrakturen van de enkel werden waargenomen bij tien patienten 
(10%) . Bij drie patienten had dit geleid tot de eerste klachten 
van deze ziekte. Contrakturen op andere plaatsen zijn zeer 
zeldzaam. 
- In ons materiaal werden geen aanwijzingen gevonden dat ook het 
hart is aangedaan bij deze ziekte . 
- Mannen en vrouwen waren even vaak aangedaan. Ook was er geen 
verschil tussen mannen en vrouwen wat betreft de ernst van de 
aandoening . Het enige statistisch significante verschil werd 
gevonden in het aantal probanden, n . l . 15 mannen versus v i er 
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vrouwen. 
- De penetrantie in ons materiaal was bijna compleet. Het aantal 
dragers dat niet tot expressie komt is waarschijnlijk niet 
groter dan 2%. 
- De "fitness", beoordeeld naar de groo tte van het nageslacht, 
was bij patH!nten uit ons materiaal, vergeleken met hun niet 
aangedane broers of zusters, normaal. 
- De prevalentie van de ziekte in de provincie Noord-Holland was 
tenminste 1 per 46.000 individuen. Het is waarschijnlijk dat 
minder dan 45% van de families met deze ziekte gevonden zijn. 
De geschatte prevalentie in Noord-Holland zou dan ten mi'nste 1 
per 21.000 individuen zijn. 
- De invaliditeit ten gevolge van de aandoening neemt toe met de 
leeftijd en de duur van de aandoening; 6% van onze patienten 
kon niet meer lopen. Overeenkomstige getallen worden vermeld in 
de l iteratuur. 
- De gemiddelde levensverwachting van de patienten wordt waar-
schijnlijk niet beinvloed door de ziekte. 
- De serum creatine kinase aktiviteit was normaal bij 34% van de 
patienten en was zelden hoger dan vier maal de bovengrens van 
normaal. Het niveau van creatine kinase aktiviteit daalde 
statistisch significant met het toenemen van de leeftijd en de 
duur van de ziekte. 
- Koppeling van het gen voor de ziekte met een van de 35 
bestudeerde merkgenen kon niet worden aangetoond. De hoogste 
positieve lod-score (1,428) werd gevonden voor GM bij e 0.20. 
- Electromyografie leverde geen afwijkingen op bij vier patienten 
(13%). Bij 23 pati~nten (74%) werd uitsluitend een myopathisch 
patroon waargenomen en bij drie patienten (10%) in sommige 
spieren een myopathisch patroon en in andere spieren een 
neurogeen patroon. Bij een patient (3%) werd een neurogeen 
patroon in de distale spieren van de extremiteiten 
toegeschreven aan een diabetische polyneuropathie. Het 
neurogene pa troon werd alleen bij sommige familieleden 
aangetroffen en moet beschouwd worden als een onderdeel van de 
ziekte. 
- Het histologisch onderzoek van spierbiopsie~n was normaal bij 
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zes patienten (20%). Alle andere biopsieen lieten in wisselende 
graden van ernst myopathische veranderingen zien. Er waren 
opvallend weinig tekenen van necrose en nog minder van 
regeneratie. Infiltraten van verschillende omvang werden 
regelmatig waargenomen. Kleine angulaire vezels waren aanwezig 
in zes biopsieen {20%). Dergelijke vezels suggereren 
denervatie; hun betekenis bij deze ziekte is onduidelijk. Een 
enkele maal werden groepjes atrofische vezels gezien en 
regelmatig werden z.g. "moth-eaten fibres" in groepjes 
aangetroffen. Bovendien bleek bij vier biopsieen ( 13%) 
differentiatie van de vezeltypen niet geed mogelijk. De 
spierbiopsie levert bij deze aandoening een zeer variabel beeld 
op; een neurogene factor lijkt hierbij mee te spelen en behoort 
bij deze ziekte. 
- Op grond van onze waarnemingen zijn er geen redenen om aan te 
nemen dat de facioscapulohumerale ziekte genetisch heterogeen 
is. 
- De differentiele diagnose is beperkt en bestaat uit autosomaal 
dominante scapuloperoneale spinale spieratrofie en aut osomaal 
dominante mitochondriale myopathie. 
- De pathogenese en de oorzaak van deze ziekte zijn niet bekend. 
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STELLINGEN 
behorende b1j het proefschr1ft Fac1oscapulohumeral Disease 
1. Hoewel facioscapulohumerale ziekte waarschijnlijk de meest 
frequente neuromusculaire aandoening in Nederland is, ziet de 
clinicus alechts het topje van de ijsberg. 
2. De extreme lumbale hyperlordose, die bij patienten met facio-
scapulohumerale ziekte kan voorkomen, is voornamelijk een 
gevolg van de uitgesproken parese van de buikspieren. 
3. De bevindingen bij de spierbiopsie~n van patienten met facio-
scapulohumerale ziekte zijn niet kenmerkend voor deze ziekte 
en extreem variabel in aard en intensiteit. 
4. Aangezien het syndroom van Davidenkow nooit meer is waarge-
nomen zoals het oorspronkelijk beschreven werd, heeft het 
geen bestaansrecht als een zelfstandige aandoening. 
5. Vanwege de voordelen voor pati~nt en onderzoeker verdient de 
percutane naaldbiopsie de voorkeur boven een open spier-
biopsie bij de diagnostiek van neuromusculaire ziekten. 
Q. Bij verdenking op een compressio medullae op thoracaal niveau 
verdient laterale cervicale of suboccipitale contrasttoedie-
ning de voorkeur. 
1. Er is geen indicatie voor een acuut operatief ingrijpen bij 
een reeds bestaande parese op basis van een lumbale hernia 
nuclei pulposi. 
8.Glucocortico!den bij de behandeling van hersenoedeem ten 
gevolge van trauma, hypoxie, ischaemie en infectie zijn 
vooralsnog alleen gerechtvaardigd in het kader van studies 
naar hun effect. 
9. Een CT- scan van de hersenen, gemaakt voor het aantonen of 
uitsluiten van hersenmetastasen, kan niet optimaal beoordeeld 
worden zonder klinische gegevens en de patient, bij wie zo'n 
scan gemaakt wordt, kan niet optimaal behandeld worden zonder 
dat hij neurologisch onderzocht is . 
10. Aangezien de EEG afwijkingen bij een hepatische encephalo-
pathie niet specifiek zijn en in beperkte mate correleren met 
het niveau van het bewustzijn heeft het maken van EEG ' s voor 
de behandeling van deze aandoening geen zin. 
11. Bi j het onttrekken van neuroleptische medicatie bij zwakzin-
nigen moet rekening gehouden worden met de mogelijkheid dat 
het ontstaan van gedragsstoornissen het gevolg kan zijn van 
de onttrekking zelf. 
12. Het geven van narcose bij kinderen voor een paracentese bij 
een otitis media is niet gerechtvaardigd vanwege de risico's 
van de narcose en de mogelijkheid van goede andere behande-
11ngsw1jzen. 
13. Strasser's kritiek op Levinas' eschatologische v1s1e in 
"Totalite et Infin1" berust op een misvers t and. Ten onrechte 
interpreteert Strasser " la convergence entre la moralite et 
la realite" als een te verwachten maatschappelijke ontwikke-
ling; het betreft bier echter een aanduiding van de mense-
lijke subject1v1te1t . 
Strasser, s.: Jense·its von Sein und Zeit . 
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